<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">90887</article-id><article-id pub-id-type="doi">10.7554/eLife.90887</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.90887.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>A TOPBP1 allele causing male infertility uncouples XY silencing dynamics from sex body formation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-264234"><name><surname>Ascenção</surname><given-names>Carolline</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0882-7390</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-232138"><name><surname>Sims</surname><given-names>Jennie R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-326891"><name><surname>Dziubek</surname><given-names>Alexis</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-264235"><name><surname>Comstock</surname><given-names>William</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-326892"><name><surname>Fogarty</surname><given-names>Elizabeth A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-264236"><name><surname>Badar</surname><given-names>Jumana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232842"><name><surname>Freire</surname><given-names>Raimundo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4473-8894</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-10363"><name><surname>Grimson</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93215"><name><surname>Weiss</surname><given-names>Robert S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3327-1379</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1619"><name><surname>Cohen</surname><given-names>Paula E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2050-6979</contrib-id><email>paula.cohen@cornell.edu</email><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-93102"><name><surname>Smolka</surname><given-names>Marcus B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9952-2885</contrib-id><email>mbs266@cornell.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05bnh6r87</institution-id><institution>Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University</institution></institution-wrap><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qndj312</institution-id><institution>Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), Unidad de Investigación, Hospital Universitario de Canarias</institution></institution-wrap><addr-line><named-content content-type="city">Santa Cruz de Tenerife</named-content></addr-line><country>Spain</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01r9z8p25</institution-id><institution>Instituto de Tecnologías Biomédicas, Universidad de La Laguna</institution></institution-wrap><addr-line><named-content content-type="city">La Laguna</named-content></addr-line><country>Spain</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00bqe3914</institution-id><institution>Universidad Fernando Pessoa Canarias</institution></institution-wrap><addr-line><named-content content-type="city">Las Palmas de Gran Canaria</named-content></addr-line><country>Spain</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05bnh6r87</institution-id><institution>Department of Biomedical Sciences, Cornell University</institution></institution-wrap><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Shinohara</surname><given-names>Akira</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035t8zc32</institution-id><institution>Osaka University</institution></institution-wrap><country>Japan</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>23</day><month>02</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP90887</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-07-18"><day>18</day><month>07</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-06-01"><day>01</day><month>06</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.05.31.543071"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-09-11"><day>11</day><month>09</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.90887.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-01-19"><day>19</day><month>01</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.90887.2"/></event></pub-history><permissions><copyright-statement>© 2023, Ascenção, Sims et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Ascenção, Sims et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-90887-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-90887-figures-v1.pdf"/><abstract><p>Meiotic sex chromosome inactivation (MSCI) is a critical feature of meiotic prophase I progression in males. While the ATR kinase and its activator TOPBP1 are key drivers of MSCI within the specialized sex body (SB) domain of the nucleus, how they promote silencing remains unclear given their multifaceted meiotic functions that also include DNA repair, chromosome synapsis, and SB formation. Here we report a novel mutant mouse harboring mutations in the TOPBP1-BRCT5 domain. <italic>Topbp1<sup>B5/B5</sup></italic> males are infertile, with impaired MSCI despite displaying grossly normal events of early prophase I, including synapsis and SB formation. Specific ATR-dependent events are disrupted, including phosphorylation and localization of the RNA:DNA helicase Senataxin. <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes initiate, but cannot maintain ongoing, MSCI. These findings reveal a non-canonical role for the ATR-TOPBP1 signaling axis in MSCI dynamics at advanced stages in pachynema and establish the first mouse mutant that separates ATR signaling and MSCI from SB formation.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>TOPBP1</kwd><kwd>ATR</kwd><kwd>meiosis</kwd><kwd>MSCI</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>R01-HD095296</award-id><principal-award-recipient><name><surname>Weiss</surname><given-names>Robert S</given-names></name><name><surname>Smolka</surname><given-names>Marcus B</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35-GM141159</award-id><principal-award-recipient><name><surname>Smolka</surname><given-names>Marcus B</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>R01HD041012</award-id><principal-award-recipient><name><surname>Cohen</surname><given-names>Paula E</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>P50HD104454</award-id><principal-award-recipient><name><surname>Grimson</surname><given-names>Andrew</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100011033</institution-id><institution>Spanish Agencia Estatal de Investigación</institution></institution-wrap></funding-source><award-id>PID2019-109222RB-877 I00/AEI/10.13039/501100011033</award-id><principal-award-recipient><name><surname>Freire</surname><given-names>Raimundo</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>European Union Regional Funds</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Freire</surname><given-names>Raimundo</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>2022 CVG Scholar Award from the Center of Vertebrates Genomics</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ascenção</surname><given-names>Carolline</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009818</institution-id><institution>2022 ASCB International training Scholarship</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ascenção</surname><given-names>Carolline</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A <italic>Topbp1</italic> mutant mouse reveals a non-canonical role for the ATR-TOPBP1 signaling axis in meiosis, separating ATR signaling and meiotic sex chromosome inactivation from sex body formation.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>During prophase I, the SPO11 topoisomerase-like enzyme and its cofactors induce programmed DNA double-strand breaks (DSBs) that are then recognized by the DNA damage response (DDR) machinery to promote recombination between homologous chromosomes (<xref ref-type="bibr" rid="bib35">Handel and Schimenti, 2010</xref>; <xref ref-type="bibr" rid="bib46">Joshi et al., 2015</xref>; <xref ref-type="bibr" rid="bib50">Keeney et al., 1997</xref>; <xref ref-type="bibr" rid="bib92">Subramanian and Hochwagen, 2014</xref>). Proper chromosome synapsis achieved through the formation of the proteinaceous synaptonemal complex, together with homologous recombination (HR)-mediated DNA repair (<xref ref-type="bibr" rid="bib77">Pereira et al., 2020</xref>), is critical for the formation of crossovers that ensure the correct segregation of chromosomes and the formation of healthy and genetically diverse haploid gametes (<xref ref-type="bibr" rid="bib32">Gray and Cohen, 2016</xref>). Chromosomes that fail to synapse as prophase I progresses trigger a process referred to as meiotic silencing of unsynapsed chromatin (MSUC) (<xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Burgoyne et al., 2009</xref>; <xref ref-type="bibr" rid="bib99">Turner, 2015</xref>; <xref ref-type="bibr" rid="bib97">Turner et al., 2006</xref>) to silence genes at unsynapsed regions. In the heterogametic sex (male mammals), the X and Y chromosomes pose a unique challenge for meiotic progression since they bear homology only at the pseudoautosomal region (PAR). The non-homologous arms of the sex chromosomes remain unsynapsed and must therefore undergo a sex-chromosome specific manifestation of MSUC, termed meiotic sex chromosome inactivation (MSCI) (<xref ref-type="bibr" rid="bib4">Alavattam et al., 2018</xref>; <xref ref-type="bibr" rid="bib85">Royo et al., 2010</xref>; <xref ref-type="bibr" rid="bib98">Turner, 2007</xref>; <xref ref-type="bibr" rid="bib97">Turner et al., 2006</xref>). MSCI is critical for normal prophase I progression through two complementary mechanisms, the silencing of toxic Y-linked genes, such as <italic>Zfy1</italic> and <italic>Zfy2</italic>, that enforce the pachytene checkpoint (<xref ref-type="bibr" rid="bib85">Royo et al., 2010</xref>; <xref ref-type="bibr" rid="bib100">Vernet et al., 2016</xref>) and through the accumulation of the DDR machinery at the X and Y chromosomes, away from the autosomes, during early pachynema (<xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>).</p><p>The apical serine-threonine kinase ataxia telangiectasia mutated and Rad-3 related (ATR) is a master regulator of DNA repair, checkpoints, and silencing during prophase I in spermatocytes. In response to DSBs and asynapsis, ATR activation promotes a range of downstream effects, including recombinational DNA repair, crossing over, chromosome synapsis, cell cycle arrest, and potentially apoptosis (<xref ref-type="bibr" rid="bib3">Abe et al., 2022</xref>; <xref ref-type="bibr" rid="bib75">Pacheco et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Pereira et al., 2020</xref>; <xref ref-type="bibr" rid="bib86">Royo et al., 2013</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>). During leptonema and zygonema, shortly after DSB formation, ATR and its cofactor ATRIP are recruited to RPA-coated regions of single-stranded DNA (ssDNA) that accumulate upon 5′–3′ resection of both ends of DSBs (<xref ref-type="bibr" rid="bib22">Cimprich and Cortez, 2008</xref>; <xref ref-type="bibr" rid="bib31">Fanning et al., 2006</xref>). ATR activation requires recruitment of TOPBP1 (topoisomerase 2 binding protein 1), a multi-BRCT (BRCA C-terminus motif) domain protein that stimulates ATR kinase activity through its ATR-activation domain (AAD) (<xref ref-type="bibr" rid="bib22">Cimprich and Cortez, 2008</xref>; <xref ref-type="bibr" rid="bib54">Kumagai et al., 2006</xref>; <xref ref-type="bibr" rid="bib71">Mordes et al., 2008</xref>; <xref ref-type="bibr" rid="bib112">Zhou et al., 2013</xref>). In addition to activating ATR, TOPBP1 also serves as a scaffold for a range of DDR factors, interacting with, and often recruiting them via its multiple BRCT domains (<xref ref-type="bibr" rid="bib12">Bigot et al., 2019</xref>; <xref ref-type="bibr" rid="bib13">Blackford et al., 2015</xref>; <xref ref-type="bibr" rid="bib20">Cescutti et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Delacroix et al., 2007</xref>; <xref ref-type="bibr" rid="bib59">Leimbacher et al., 2019</xref>; <xref ref-type="bibr" rid="bib61">Leung et al., 2011</xref>; <xref ref-type="bibr" rid="bib63">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Pereira et al., 2022</xref>). TOPBP1 is composed of nine BRCT domains, which are protein-interacting modules that typically recognize phosphorylated motifs (<xref ref-type="bibr" rid="bib63">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Manke et al., 2003</xref>; <xref ref-type="bibr" rid="bib83">Rodriguez et al., 2003</xref>). Through the recognition of phosphoproteins, TOPBP1 is able to assemble multisubunit complexes to promote discrete pathways (<xref ref-type="bibr" rid="bib12">Bigot et al., 2019</xref>; <xref ref-type="bibr" rid="bib13">Blackford et al., 2015</xref>; <xref ref-type="bibr" rid="bib20">Cescutti et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Delacroix et al., 2007</xref>; <xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Jeon et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Leimbacher et al., 2019</xref>; <xref ref-type="bibr" rid="bib61">Leung et al., 2011</xref>; <xref ref-type="bibr" rid="bib63">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Pereira et al., 2022</xref>; <xref ref-type="bibr" rid="bib77">Pereira et al., 2020</xref>; <xref ref-type="bibr" rid="bib79">Perera et al., 2004</xref>). TOPBP1 interacts with the C-terminal tail of RAD9, a component of the 9-1-1 PCNA-like clamp that is loaded at 5′ recessed junctions adjacent to DSBs (<xref ref-type="bibr" rid="bib76">Parrilla-Castellar et al., 2004</xref>). The 9-1-1-TOPBP1 complex is essential for canonical ATR signaling during prophase I (<xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Jeon et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Perera et al., 2004</xref>). The interaction of proteins with TOPBP1 may facilitate their phosphorylation by ATR, suggesting a role for TOPBP1 in the control of ATR substrate selection.</p><p>As cells progress from zygonema into pachynema, ATR and TOPBP1 localize to the unsynapsed axes of the X and Y chromosomes (<xref ref-type="bibr" rid="bib15">Broering et al., 2014</xref>; <xref ref-type="bibr" rid="bib69">Moens et al., 1999</xref>; <xref ref-type="bibr" rid="bib81">Reini et al., 2004</xref>), leading to phosphorylation of the histone variant H2AX on serine 139 (γH2AX), a major hallmark of MSCI (<xref ref-type="bibr" rid="bib86">Royo et al., 2013</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>). During establishment of MSCI, a phase-separated structure termed the sex body is formed (<xref ref-type="bibr" rid="bib70">Monesi, 1965</xref>; <xref ref-type="bibr" rid="bib91">Solari, 1974</xref>; <xref ref-type="bibr" rid="bib109">Xu and Qiao, 2021</xref>), allowing the confinement of ATR signaling, DDR factors, and silencing to the X and Y (<xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>; <xref ref-type="bibr" rid="bib98">Turner, 2007</xref>) as part of a checkpoint that may induce cell death if DDR proteins aberrantly accumulate and remain on autosomes (<xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>). Recruitment of ATR and TOPBP1 to unsynapsed regions of the XY requires a distinct set of factors compared to their mode of recruitment to autosomal DSB sites mentioned above and involves factors such as BRCA1 and HORMAD (<xref ref-type="bibr" rid="bib89">Shin et al., 2010</xref>; <xref ref-type="bibr" rid="bib96">Turner et al., 2004</xref>). Activated ATR phosphorylates H2AX at the unsynapsed cores of the X and Y chromosomes, a signaling that is propagated to chromatin loops of the X and Y, via a feed-forward process mediated by recruitment of the MDC1 adaptor, which further recruits and mobilizes additional TOPBP1-ATR complexes, therefore spreading ATR signaling to promote the broad chromosome-wide silencing required for MSCI (<xref ref-type="bibr" rid="bib41">Ichijima et al., 2011</xref>). It has also been proposed that the initiation of MSCI accumulates DDR proteins from autosomes to the X and Y chromosomes to prevent excessive DDR signaling at autosomes from activating cellular checkpoints that can stop meiotic progression (<xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>).</p><p>Despite mounting evidence pointing to the importance of ATR and TOPBP1 for MSCI, the precise mechanisms by which they promote sex body formation and XY silencing remain unknown. Moreover, it remains unclear how these two processes are spatiotemporally coordinated and how ATR and TOPBP1 mediate such coordination. Since both proteins are essential for organismal viability (<xref ref-type="bibr" rid="bib16">Brown and Baltimore, 2000</xref>; <xref ref-type="bibr" rid="bib25">de Klein et al., 2000</xref>; <xref ref-type="bibr" rid="bib44">Jeon et al., 2011</xref>; <xref ref-type="bibr" rid="bib74">O’Driscoll, 2009</xref>; <xref ref-type="bibr" rid="bib73">O’Driscoll et al., 2007</xref>; <xref ref-type="bibr" rid="bib110">Yamane et al., 2002</xref>; <xref ref-type="bibr" rid="bib112">Zhou et al., 2013</xref>), conditional knockouts (<xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Royo et al., 2013</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>) or hypomorphic (<xref ref-type="bibr" rid="bib75">Pacheco et al., 2018</xref>) models have been used to explore their roles during prophase I in spermatocytes. However, given the strong pleiotropic effects in these models, especially in DSB repair, synapsis, MSCI, and sex body formation, it is difficult to dissect the distinct molecular mechanisms involved and untangle direct versus indirect effects. Here we present a separation-of-function mouse mutant that deconvolutes TOPBP1-dependent ATR signaling in male meiosis. We generated mice bearing multiple mutations in BRCT-domain 5 (<italic>Topbp1<sup>B5/B5</sup></italic> mice) that are viable and grossly indistinguishable from wild-type littermates; yet, the males are sterile, having reduced testes size, reduced seminiferous tubule cellularity, and a complete loss of sperm. Strikingly, while <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes fail to progress into diplotene, they display largely normal chromosome synapsis, sex body formation, recruitment of DDR proteins to the X and Y, and DNA repair during prophase I, in sharp contrast to previous models of TOPBP1 or ATR impairment (<xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>). Single-cell RNA sequencing data showed that while MSCI is initiated in <italic>Topbp1<sup>B5/B5</sup></italic>, the dynamics of silencing progression and reinforcement is defective, which is accompanied by a defect in the localization of the RNA:DNA helicase Senataxin to chromatin loops of the XY chromosomes. We propose that the <italic>Topbp1<sup>B5/B5</sup></italic> is a separation of function mutant that allows the untangling of XY silencing from sex body formation and DDR recruitment to the XY, representing a unique model to study the establishment, maintenance, reinforcement, and progression of MSCI.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>A TOPBP1 mutant separating its role in fertility from organismal viability</title><p><italic>Topbp1</italic> knockout mice exhibit strong defects early in embryonic development, reaching blastocyst stage but not progressing beyond embryonic day (E) 8, with embryos likely dying at the preimplantation stage (<xref ref-type="bibr" rid="bib44">Jeon et al., 2011</xref>). In the context of meiosis, conditional knockout of <italic>Topbp1</italic> in spermatocytes leads to pleiotropic effects, including defects in chromosome synapsis, impaired recruitment of DDR factors to XY chromosomes, defects in condensation of the XY chromosomes, abnormal formation of the sex body, lack of γH2AX spreading to chromatin loops, all of which contribute to a strong MSCI defect as indicated by the complete absence of downstream markers of MSCI, such as USP7, H3K9me3, poly-ubiquitination, and sumoylation (<xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Pereira et al., 2020</xref>). The availability of a separation of function mutant for <italic>Topbp1</italic> is therefore needed to dissect its distinct roles in development, organismal maintenance, and multiple meiotic processes such as DNA repair, silencing, and sex body formation. To generate a separation of function mouse model, we inserted eight charge reversal point mutations in BRCT domain 5 of TOPBP1 (hereafter referred to as <italic>Topbp1<sup>B5/B5</sup></italic>) using CRISPR/Cas9 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). After validating the point mutations through Sanger sequencing, (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), we found that <italic>Topbp1<sup>B5/B5</sup></italic> mice were viable, with no difference in body mass when compared to WT littermates (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>), and no sensitivity to ionizing radiation (IR) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Strikingly, <italic>Topbp1<sup>B5/B5</sup></italic> mice displayed male-specific infertility (<xref ref-type="fig" rid="fig1">Figure 1E</xref>), with a threefold reduction in testis size (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>) and complete lack of spermatozoa (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). H&amp;E-stained histological testis sections revealed mainly spermatogonia and spermatocytes within the seminiferous epithelium (<xref ref-type="fig" rid="fig1">Figure 1I</xref>), together with an increased number of TUNEL-positive spermatocytes in seminiferous tubules (<xref ref-type="fig" rid="fig1">Figure 1J and K</xref>). Cytological evaluation of surface-spread spermatocytes from <italic>Topbp1<sup>B5/B5</sup></italic> revealed the presence of meiotic prophase I stages from leptonema to pachynema but a total absence of diplonema-staged spermatocytes (<xref ref-type="fig" rid="fig1">Figure 1L</xref>). Moreover, the staining of the synaptonemal complex proteins SYCP1 and SYCP3 revealed normal pachytene entry and no gross defects in chromosome synapsis, distinct from previous models of ATR and TOPBP1 conditional depletion (<xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>). Furthermore, unlike reported DDR CKO (conditional knockouts) models such as <italic>Rad1</italic> and <italic>Brca1</italic> (<xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>; <xref ref-type="bibr" rid="bib15">Broering et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Pereira et al., 2022</xref>), <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes reach mid-pachynema, as demonstrated by the accumulation of signal for H1t (<xref ref-type="bibr" rid="bib43">Inselman et al., 2003</xref>; <xref ref-type="fig" rid="fig1">Figure 1L</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>A new TOPBP1 mutant separating its role in fertility from organismal viability.</title><p>(<bold>A</bold>) Schematic showing mutations in the <italic>Topbp1 B5</italic> allele. (<bold>B</bold>) Body mass (<italic>Topbp1<sup>+/+</sup></italic> mean = 25.26, SD = 2.38; <italic>Topbp1<sup>B5/B5</sup></italic> mean = 26.43, SD = 2.28, n = 9) and (<bold>C</bold>) appearance of <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> littermate mice. (<bold>D</bold>) Effect of full body ionizing radiation (IR) (7 Gy) on changes in body mass of <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> littermate mice (<bold>E</bold>) Breeding scheme and resulting litters. (<bold>F, G</bold>) Comparison of testes size (<italic>Topbp1<sup>+/+</sup></italic> mean = 0.038, SD = 0.006; <italic>Topbp1<sup>B5/B5</sup></italic> mean = 0.011, SD = 0.004, n = 9), and (<bold>H</bold>) sperm count, of <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> littermate mice (<italic>Topbp1<sup>+/+</sup></italic> mean = 2.1 × 10<sup>7</sup>, SD = 6 × 10<sup>6</sup>; <italic>Topbp1<sup>B5/B5</sup></italic> mean = 0.0, SD = 0.0, n = 9). (<bold>I</bold>) H&amp;E-stained histological testes sections displaying loss of cellularity in <italic>Topbp1<sup>B5/B5</sup></italic>. Green arrow = spermatogonia, red arrow = healthy spermatocyte, blue arrow = dying spermatocyte. (<bold>J, K</bold>) TUNEL assay performed on histological testes sections (<italic>Topbp1<sup>+/+</sup></italic> mean = 0.36, SD = 0.15; <italic>Topbp1<sup>B5/B5</sup></italic> mean = 4.80, SD = 0.43, n = 3). (<bold>L</bold>) Meiotic spreads stained for SYCP3, SYCP1, and H1t. ****p&lt;0.0001, n = number of mice. p-Values were calculated using unpaired <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Genotyping of <italic>Topbp1<sup>B5/B5</sup></italic> mice.</title><p>Sanger sequencing confirms the eight-charge reversal point mutations on the BRCT 5 domain of TOPBP1 from homozygous <italic>Topbp1<sup>B5/B5</sup></italic> mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig1-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title><italic>Topbp1<sup>B5/B5</sup></italic> MEFs display no detectable DDR defects</title><p>To assess the possibility of a somatic phenotype, we derived mouse embryonic fibroblasts (MEFs) from <italic>Topbp1<sup>B5/B5</sup></italic> and wild-type littermates at E13.5. Consistent with the observed organismal viability and the lack of IR sensitivity, <italic>Topbp1<sup>B5/B5</sup></italic> MEFs showed no sensitivity to hydroxyurea (replication stress) or phleomycin (DSBs) in a long-term cell survival assay (<xref ref-type="fig" rid="fig2">Figure 2A–D</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Genotoxic stress activates the apical kinases ATR, ATM, and DNA-PKcs (<xref ref-type="bibr" rid="bib14">Blackford and Jackson, 2017</xref>; <xref ref-type="bibr" rid="bib30">Falck et al., 2005</xref>; <xref ref-type="bibr" rid="bib65">Maréchal and Zou, 2013</xref>) to trigger a signaling cascade that promotes DNA repair and cell cycle arrest via activation of the downstream checkpoint kinases CHK1 and CHK2 (<xref ref-type="bibr" rid="bib37">Hartwell and Kastan, 1994</xref>; <xref ref-type="bibr" rid="bib56">Lanz et al., 2019</xref>; <xref ref-type="bibr" rid="bib88">Shiloh, 2003</xref>). Similar to wild-type MEFs, <italic>Topbp1<sup>B5/B5</sup></italic> MEFs were able to activate DDR signaling responses when challenged with hydroxyurea and phleomycin as demonstrated by the induction of established damage-induced phosphorylation of CHK1, CHK2, RPA2, and KAP1 (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). In addition, <italic>Topbp1<sup>B5/B5</sup></italic> MEFs were able to recruit MDC1 to γH2AX-marked DSB foci when subjected to IR (<xref ref-type="fig" rid="fig2">Figure 2F</xref>) and showed no increased number of micronuclei, a known marker of defective DDRs (<xref ref-type="bibr" rid="bib55">Kwon et al., 2020</xref>), when compared to <italic>Topbp1<sup>+/+</sup></italic> MEFs (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A and B</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> mouse embryonic fibroblasts (MEFs) display no detectable DNA damage response (DDR) defects.</title><p>(<bold>A</bold>) MEFs obtained from littermate mice of indicated genotypes were subjected to clonogenic survival assay in the indicated concentrations of hydroxyurea or (<bold>C</bold>) phleomycin. (<bold>B, D</bold>) Quantification of clonogenic survival assays from (<bold>A</bold>) and (<bold>C</bold>), respectively, performed in biological and experimental triplicates (n = 3), error bars are displayed as standard deviation. (<bold>E</bold>) Western blot for indicated DDR markers in MEFs obtained from <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> littermate mice. The data from MEFs were performed using littermate pairs and validated using a second pair of <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> littermate mice. (<bold>F</bold>) Immunofluorescence of MDC1 and phosphoH2AX_S139-stained nuclei from <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> MEFs treated with ionizing radiation (IR) (7 Gy).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Original file for the western blot analysis in <xref ref-type="fig" rid="fig2">Figure 2E</xref> (anti-CHK1, anti-CHK2, and anti-GAPDH).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-90887-fig2-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Survival assays of <italic>Topbp1<sup>B5/B5</sup></italic> mouse embryonic fibroblasts (MEFs).</title><p>(<bold>A</bold>) MEFs obtained from littermate mice (second independent litter) of indicated genotypes were subjected to clonogenic survival assay in the indicated concentrations of hydroxyurea or (<bold>B</bold>) phleomycin. The clonogenic survival assays were performed in biological and experimental triplicates (n = 3), error bars are displayed as standard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Absence of an increased number of micronuclei in <italic>Topbp1<sup>B5/B5</sup></italic> mouse embryonic fibroblasts (MEFs).</title><p>Immunofluorescence showing DAPI-stained nuclei and micronuclei quantification of <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> (<bold>A</bold>) MEFs #1 and (<bold>B</bold>) MEFs #2. (MEFs #2 is a second independent litter.) Ns = p&gt;0.05. p-Values were calculated using unpaired <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>TOPBP1-B5 shows disruption in binding 53BP1 and BLM.</title><p>(<bold>A</bold>) HEK-293T cells were transfected with plasmids expressing wild-type TOPBP1 or indicated BRCT mutants (K155A – BRCT 1, K250A – BRCT 2, K704A – BRCT 5, K1713A – BRCT 7, and B5 – 8 mutations in BRCT 5), with a 3xFlag tag. After cell lysis and anti-Flag IP, lysate and elution were analyzed by western blot for the indicated proteins. (<bold>B</bold>) IP-mass spectrometry of flagTOPBP1 wild type versus flag-TOPBP1-B5 was performed in silac-labeled HEK-293T cells. Cell transfections, lysis, protein IP, and elution were performed as described in (<bold>A</bold>). From left to right, the TOPBP1 interactors were plotted from highest to lowest binding. The size of circles represents the number of peptide hits.</p><p><supplementary-material id="fig2s3sdata1"><label>Figure 2—figure supplement 3—source data 1.</label><media mimetype="application" mime-subtype="zip" xlink:href="elife-90887-fig2-figsupp3-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> mouse embryonic fibroblasts (MEFs) show lower TOPBP1 protein abundance than <italic>Topbp1<sup>+/+</sup></italic> MEFs.</title><p>Western blot probing TOPBP1 in MEFs, <italic>Topbp1 <sup>+/+</sup></italic>, <italic>Topbp1<sup>B5/+</sup>,</italic> and <italic>Topbp1<sup>B5/B5</sup></italic> in two biological replicates.</p><p><supplementary-material id="fig2s4sdata1"><label>Figure 2—figure supplement 4—source data 1.</label><caption><title>Original file for the western blot analysis in <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref> (anti-TOPBP1 and anti-TUBULIN).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-90887-fig2-figsupp4-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2s4sdata2"><label>Figure 2—figure supplement 4—source data 2.</label><caption><title>PDF containing <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref> and original scans of the relevant western blot analysis (anti-TOPBP1 and anti-TUBULIN) with highlighted bands and labels.</title></caption><media mimetype="application" mime-subtype="pdf" xlink:href="elife-90887-fig2-figsupp4-data2-v1.pdf"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig2-figsupp4-v1.tif"/></fig></fig-group><p>The BRCT-5 domain of TOPBP1 is known to interact with the DDR factors 53BP1 (<xref ref-type="bibr" rid="bib12">Bigot et al., 2019</xref>; <xref ref-type="bibr" rid="bib20">Cescutti et al., 2010</xref>; <xref ref-type="bibr" rid="bib63">Liu et al., 2017</xref>), MDC1 (<xref ref-type="bibr" rid="bib101">Wang et al., 2011</xref>), and BLM (<xref ref-type="bibr" rid="bib13">Blackford et al., 2015</xref>) through phospho-protein binding modules. To investigate which, if any, of these interactions are disrupted upon mutating the eight BRCT5 residues, we ectopically expressed Flag-TOPBP1-WT or Flag-TOPBP1-B5 in HEK293T cells. We found that binding of Flag-TOPBP1-B5 to BLM and 53BP1 was impaired, as expected (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3A and B</xref>). Moreover, we noticed a twofold reduction in protein levels of Flag-TOPBP1-B5 compared to Flag-TOPBP1-WT, which could be explained by the loss of interaction with BLM (that was proposed to lead to protein stabilization; <xref ref-type="bibr" rid="bib7">Balbo Pogliano et al., 2022</xref>; <xref ref-type="bibr" rid="bib102">Wang et al., 2013</xref>) or by protein misfolding caused by the eight K to E/D mutations. In addition, the reduction in protein levels was detected on MEFs (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). In either case, the results presented here show that the TOPBP1-B5 mutant offers a unique model to separate roles of TOPBP1 in male meiosis from the canonical DDR functions of TOPBP1 in somatic cells.</p></sec><sec id="s2-3"><title><italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes display normal markers of canonical ATR signaling, chromosome synapsis, DNA repair, sex body formation, and DDR protein localization at the X and Y</title><p>TOPBP1 and ATR play multiple roles in spermatocytes during prophase I. Mice conditionally depleted for TOPBP1 (<xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>) or ATR (<xref ref-type="bibr" rid="bib86">Royo et al., 2013</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>) display severe defects in chromosome synapsis, DNA DSB repair, sex body formation, and MSCI, as well as impaired recruitment of DDR factors to the XY (<xref ref-type="bibr" rid="bib77">Pereira et al., 2020</xref>). Strikingly, analysis of <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes via meiotic spreads revealed normal repair of DNA DSBs, with γH2AX staining grossly unchanged at pachynema, being confined only to the XY chromosomes and being excluded from the autosomes (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). RAD51 localized only to the X and Y chromosomes during mid-pachytene (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>), indicating normal DSB repair at the autosomes. We were unable to detect chromosome synapsis abnormalities in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes as <italic>Topbp1<sup>B5/B5</sup></italic> mutant spermatocytes transit from zygotene into pachytene with normal patterns of HORMAD1 and HORMAD2 localization (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>) and with SYCP1 overlapping with SYCP3 on chromosome cores from all autosomal chromosomes during pachynema (<xref ref-type="fig" rid="fig1">Figures 1L</xref> and <xref ref-type="fig" rid="fig3">3E</xref>). Since ATR orthologs regulate crossing over in budding yeast (<xref ref-type="bibr" rid="bib92">Subramanian and Hochwagen, 2014</xref>) and in <italic>Drosophila melanogaster</italic> (<xref ref-type="bibr" rid="bib19">Carpenter, 1979</xref>), we also investigated the localization of factors involved in regulating DNA crossovers, including MLH1 and MLH3. In <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes, while the number of MLH1 foci were significantly increased, the number of MLH3 foci did not differ significantly (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>). Due to the lack of diplotene cells, and any other stage after pachynema, we were not able to test whether <italic>Topbp1<sup>B5/B5</sup></italic> display defects in crossing over.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Markers of DNA repair, synapsis, sex body formation, and TOPBP1 localization are mostly normal in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes.</title><p>(<bold>A</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes stained with SYCP3 and γH2AX, prepared as described in ‘Materials and methods’. (<bold>B</bold>) Quantification of γH2AX-stained pachytene spreads, upper graph XY body (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 386, number of mice = 8; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 410, number of mice = 8; p-value=0.3063), bottom graph autosomal chromosomes (each dot represents the average of signal from all autosomes in each mouse, <italic>Topbp1<sup>+/+</sup></italic> number of cells = 160, number of mice = 8; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 161, number of mice = 8; p-value=0.5081). (<bold>C</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and RAD51. (<bold>D</bold>) Quantification of RAD51 foci/cell of mid-pachytene meiotic spreads (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 149, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 183, number of mice = 3; p-value=0.2174). (<bold>E</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and SYCP1. (<bold>F</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and TOPBP1. (<bold>G</bold>) Quantification of TOPBP1 on X and Y chromosome cores from (<bold>F</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 246, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 233, number of mice = 3; p-value=0.8546). (<bold>H</bold>) Quantification of TOPBP1 on X and Y chromatin loops from (<bold>F</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 246, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 233, number of mice = 3; p-value=0.6755). n = number of mice. p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> mid-pachytene spermatocytes show normal HORMAD1, HORMAD2, pHORMAD2, and pCHK1_S345 localization and intensities.</title><p>(<bold>A</bold>) <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with HORMAD1 and SYCP3, prepared as described in ‘Materials and methods’. (<bold>B</bold>) <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with HORMAD2 and SYCP3. (<bold>C</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and pMDC1-T4 prepared as described in ‘Materials and methods’. (<bold>D</bold>) Quantification of pMDC1-T4-stained pachytene spreads from (<bold>C</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 60, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 159, number of mice = 3; p-value=0.8193). (<bold>E</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and pCHK1-S345. (<bold>F</bold>) Quantification of pCHK1-S345-stained pachytene spreads from (<bold>E</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 168, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 125, number of mice = 2; p-value=0.6536). (<bold>G</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and pHORMAD2-S271. (<bold>H</bold>) Quantification of pHORMAD2-S271-stained pachytene spreads from (<bold>G</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 224, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 254, number of mice = 3; p-value=0.2811). p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> mid-pachytene spermatocytes show an increased number of MLH1 foci/cell but no difference in the number of MHL3 foci/cell.</title><p>(<bold>A</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and MLH1, prepared as described in ‘Materials and methods’ on the left, and on the right, the foci count of MLH1-stained pachytene spreads (each dot represents the number of foci/cell; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 84, number of mice = 4; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 94, number of mice = 4; p-value&lt;0.0001). (<bold>B</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and MLH3 prepared as described in ‘Materials and methods’ on the left, and on the right, the Foci count of MLH3-stained pachytene spreads (each dot represents the number of foci/cell; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 48, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 91, number of mice = 3; p-value=0.4088). p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> mid-pachytene spermatocytes form a normal sex body.</title><p><italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> mid-pachytene spermatocytes stained with DAPI and SYCP3, prepared as described in ‘Materials and methods’.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig3-figsupp3-v1.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> mid-pachytene spermatocytes show subtle defects/delays in the spreading of γH2AX on XY chromosomes.</title><p>Quantification and representative images of <italic>Topbp1<sup>B5/B5</sup></italic> mid-pachytene spermatocytes showing: (<bold>A</bold>) normal spreading of γH2AX on XY chromosomes; (<bold>B</bold>) defect/delay in the spreading of γH2AX at the PAR; (<bold>C</bold>) defect/delay in the spreading of γH2AX at the pericentromeric region of the Y chromosome; (<bold>D</bold>) spreading of γH2AX into an autosomal chromosome fused to the X chromosome; and (<bold>E</bold>) other types of defects/delays in the spreading of γH2AX onto the XY chromosomes. Each dot in the graph represents the sum of the cells counted per mouse. (<bold>F</bold>) Percentage of the previously described defects found in <italic>Topbp1<sup>+/+</sup></italic> or (<bold>G</bold>) <italic>Topbp1<sup>B5/B5</sup></italic> mid-pachytene spermatocytes. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. p-Values were calculated using unpaired <italic>t</italic>-test in GraphPad. n = number of mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig3-figsupp4-v1.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>TOPBP1 is normally localized in all stages of prophase I in <italic>Topbp1<sup>B5/B5</sup></italic>.</title><p>Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes stained with SYCP3 and TOPBP1, prepared as described in ‘Materials and methods’.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig3-figsupp5-v1.tif"/></fig></fig-group><p>The sex body appeared normal in its shape and was normally formed in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplements 3</xref> and <xref ref-type="fig" rid="fig3s4">4A</xref>), exhibiting only subtle defects/delays in the spreading of the γH2AX signal on the PAR and pericentromeric regions (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4B–G</xref>). Although the defect was subtle in its severity, it accounted for 56% of all γH2AX-stained mid-pachytene cells. Importantly, TOPBP1 was normally localized to X and Y chromosomes during prophase I (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>, <xref ref-type="fig" rid="fig3">Figure 3F–H</xref>). Similarly, localization of the TOPBP1 interactors ATR, BRCA1, MDC1, and 53BP1 in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes spreads was also indistinguishable from that observed in <italic>Topbp1<sup>+/+</sup></italic> spermatocytes (<xref ref-type="fig" rid="fig4">Figure 4A–F</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Markers of ATR signaling were also mostly normal, as measured by its canonical targets pMDC1 T4 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C and D</xref>), pCHK1 S345 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and F</xref>), and pHORMAD2 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G and H</xref>). Notably, we did observe that phosphorylation of CHK1 on S317 was significantly decreased in <italic>Topbp1<sup>B5/B5</sup></italic> when compared to <italic>Topbp1<sup>+/+</sup></italic> spermatocytes (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref>). However, since <italic>Chek1</italic> CKO spermatocytes complete prophase I and differentiate into spermatozoa, with only minor defects such as a delay in the removal of γH2AX from autosomes (<xref ref-type="bibr" rid="bib1">Abe et al., 2018</xref>), the observed defect in CHK1 S317 phosphorylation is unlikely to be the cause of the infertility observed in <italic>Topbp1</italic> B5 mutants. Overall, as summarized in <xref ref-type="fig" rid="fig4">Figure 4I</xref>, <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes appear to progress normally through early stages of prophase I up until the end of pachynema as demonstrated by largely normal localization of markers for DNA repair, chromosome synapsis, and ATR signaling. These findings are surprising because the lack of sex body formation, synapsis defects, or unrepaired DSBs, which are the expected causes of the drastic loss of diplotene cells and the lack of spermatozoa, were not observed.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes display normal localization of ATR, BRCA1, and MDC1.</title><p>(<bold>A</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and ATR. (<bold>B</bold>) Quantification of ATR in pachytene spreads from (<bold>A</bold>). Left: ATR on X and Y chromosome cores (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 127, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 127, number of mice = 3; p-value=0.4068). Right: ATR on X and Y chromatin loops (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 127, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 127, number of mice = 3; p-value=0.9396). (<bold>C</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and BRCA1. (<bold>D</bold>) Quantification of BRCA1 in pachytene spreads from (<bold>C</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 152, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 140, number of mice = 3; p-value=0.6509). (<bold>E</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and MDC1. (<bold>F</bold>) Quantification of MDC1 in pachytene spreads from (<bold>E</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 696, number of mice = 8; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 988, number of mice = 8; p-value=0.3603). (<bold>G</bold>) Meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and pCHK1-S317. (<bold>H</bold>) Quantification of pCHK1-S317 in pachytene spreads from (<bold>G</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 223, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 254, number of mice = 3; **p-value=0.0023). p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details). (<bold>I</bold>) Table summarizing the normal or disrupted ATR and TOPBP1-dependent events during male fertility accessed in <italic>Topbp1<sup>B5/B5</sup></italic>. n = number of mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>53BP1 localization in <italic>Topbp1<sup>B5/B5</sup></italic> mid-pachytene spermatocytes.</title><p>Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and 53BP1 on the left, and quantification of 53BP1-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 95, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 171, number of mice = 2; p-value=0.2384). p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Defective phosphorylation and XY localization of the RNA:DNA helicase SETX in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes</title><p>With the exception of CHK1 phosphorylation at serine 317, the analysis of other canonical markers of ATR signaling on meiotic prophase I spreads did not reveal obvious defects in their distribution or intensity at the XY body (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C–H</xref>). Since altered CHK1 regulation is unlikely to be the cause of the drastic defect in meiotic progression observed in <italic>Topbp1<sup>B5/B5</sup></italic> males, we investigated whether other branches of ATR signaling were altered in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes by performing unbiased quantitative phosphoproteomics based on TMT (Tandem Mass Tag; <xref ref-type="bibr" rid="bib94">Thompson et al., 2003</xref>) labeling of whole testes. Following a similar approach previously used by our group (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>), we analyzed the phosphoproteome of <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> testes, and then compared the results with our previously reported dataset comparing the phosphoproteome of testes from mice treated with vehicle or the ATR inhibitor AZ20 (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). The resulting plot revealed that ATR-dependent signaling is not drastically impaired in <italic>Topbp1<sup>B5/B5</sup></italic> testes, as opposed to the marked impairment of ATR signaling previously observed in testes of <italic>Rad1</italic> CKO mice (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). This finding is in agreement with the results from meiotic spreads of <italic>Topbp1<sup>B5/B5</sup></italic> showing no detectable defects in canonical markers of ATR signaling described above. Nonetheless, our phosphoproteomic analysis did reveal phosphorylation sites mildly disrupted in <italic>Topbp1<sup>B5/B5</sup></italic> testes compared to <italic>Topbp1<sup>+/+</sup></italic> testes. In particular, we noticed that several phosphorylation sites in the RNA:DNA helicase, Senataxin (SETX) (<xref ref-type="bibr" rid="bib23">Cohen et al., 2018</xref>), including a phosphorylation in the preferred motif for ATR phosphorylation (S/T-Q), were downregulated in <italic>Topbp1<sup>B5/B5</sup></italic> mice (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Interestingly, SETX was previously associated with meiotic ATR functions and found to be indispensable for MSCI (<xref ref-type="bibr" rid="bib10">Becherel et al., 2013</xref>; <xref ref-type="bibr" rid="bib111">Yeo et al., 2015</xref>). Moreover, we recently reported that mice treated with the ATR inhibitor AZ20 or lacking <italic>Rad1</italic> display reduced phosphorylation of SETX at S/T-Q site and SETX mislocalization during pachynema (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). Based on our findings, we propose that TOPBP1 regulates SETX distribution and/or function during meiosis, and that defects in meiotic progression and fertility observed in <italic>Topbp1<sup>B5/B5</sup></italic> mice might be associated with SETX dysfunction. Consistent with this possibility, we found that pachytene spermatocytes from <italic>Topbp1<sup>B5/B5</sup></italic> display significantly decreased spreading of SETX to XY chromatin loops while still displayed SETX at the unsynapsed axes of the X and Y chromosomes (<xref ref-type="fig" rid="fig5">Figure 5C–F</xref>). Overall, these findings reveal that <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes display largely normal progression through mid-pachynema, as demonstrated by normal distribution of a range of markers of meiotic progression, including canonical markers of ATR signaling. However, in-depth phosphoproteomic and imaging analyses identify specific defects in the regulation of SETX, a target of ATR signaling during prophase I (<xref ref-type="bibr" rid="bib78">Pereira et al., 2022</xref>; <xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>) and a key factor required for MSCI (<xref ref-type="bibr" rid="bib10">Becherel et al., 2013</xref>; <xref ref-type="bibr" rid="bib111">Yeo et al., 2015</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Defective Senataxin (SETX) phosphorylation and localization in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes.</title><p>(<bold>A</bold>) Scatter plot of phosphoproteomic datasets corresponding to <italic>Topbp1<sup>+/+</sup></italic>/<italic>Topbp1<sup>B5/B</sup></italic> (Y axis) and <italic>Topbp1<sup>+/+</sup></italic>(vehicle)/<italic>Topbp1<sup>+/+</sup></italic>(AZ20) (X axis) from whole testes of mice. (<bold>B</bold>) SETX phosphopeptides identified in the <italic>Topbp1<sup>+/+</sup>/Topbp1<sup>B5/B</sup></italic> phosphoproteomic experiment shown in (<bold>A</bold>). Red: reduced in <italic>Topbp1<sup>B5/B</sup></italic> mutant; blue: unchanged. (<bold>C</bold>) Meiotic spreads showing pachytene spermatocytes from <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> mice stained with SYCP3 and SETX in regular immunofluorescence. (<bold>D</bold>) 3D-SIM analysis of meiotic spreads described in (<bold>C</bold>). (<bold>E</bold>) Quantification of SETX on X and Y chromatin loops in pachytene spreads from (<bold>C</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 152, number of mice = 4; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 174, number of mice = 4; *p-value=0.0452). (<bold>F</bold>) Quantification of SETX on X and Y chromosome cores in pachytene spreads from (<bold>C</bold>) (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 152, number of mice = 4; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 174, number of mice = 4; p-value=0.5987). p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig5-v1.tif"/></fig></sec><sec id="s2-5"><title><italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes initiate MSCI but fail to promote full XY silencing</title><p>During mid-pachynema, spermatocytes that fail to properly silence the X and Y chromosomes arrest and trigger apoptosis-induced cell death (<xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Ichijima et al., 2012</xref>; <xref ref-type="bibr" rid="bib99">Turner, 2015</xref>; <xref ref-type="bibr" rid="bib98">Turner, 2007</xref>). In mice, the MSCI process initiates in leptonema (<xref ref-type="bibr" rid="bib57">Lau et al., 2020</xref>), and during early pachynema key events occur at the XY chromosomes, such as exclusion of RNA polymerase 2 (RNA Pol2), recruitment of DDR proteins and chromatin remodelers, and establishment of heterochromatin marks (<xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>; <xref ref-type="bibr" rid="bib51">Khalil et al., 2004</xref>) to maintain the active silencing of the X and Y chromosomes (<xref ref-type="bibr" rid="bib3">Abe et al., 2022</xref>). This process leads to the formation of a membrane-less phase separated structure termed the sex body (<xref ref-type="bibr" rid="bib5">Alavattam et al., 2021</xref>; <xref ref-type="bibr" rid="bib109">Xu and Qiao, 2021</xref>). Spermatocytes from <italic>Topbp1<sup>B5/B5</sup></italic> males formed a sex body of grossly normal appearance (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>), with undisrupted patterns of the sex body markers CHD4, SUMO, and USP7 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes also display normal patterns of a range of chromatin marks, including H3K9ac, H3K9me3, H3K27ac, H3K36me3, H3K4me3, H4K16ac, H4ac, H2AK116ub, H3K4me1, as well as proper exclusion of RNA Pol2 from the sex body (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplements 2</xref>–<xref ref-type="fig" rid="fig6s6">6</xref>). Collectively the evidence presented herein shows that <italic>Topbp1<sup>B5/B5</sup></italic> mutants are able to form grossly normal XY bodies, with proper localization of over 28 markers. The severe loss of diplotene cells and the reduction of SETX at the chromatin loops of the X and Y lead us to speculate that <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes may still have a defective MSCI. To investigate potential MSCI defects, we employed single-cell RNA sequencing (scRNAseq) in germ cells (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) using a similar approach recently used to follow spermatogenesis progression and evaluate MSCI in mammals (<xref ref-type="bibr" rid="bib34">Grive et al., 2019</xref>; <xref ref-type="bibr" rid="bib47">Jung et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Lau et al., 2020</xref>). Using the 10X platform, we performed scRNAseq on a germ cell-enriched population of cells extracted from adult <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> testes (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). The data were analyzed as previously described (<xref ref-type="bibr" rid="bib34">Grive et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Lau et al., 2020</xref>) using signature genes as markers of different stages in spermatogenesis such as <italic>Sal4</italic> and <italic>Dmrt1</italic> for spermatogonia, <italic>Dazl</italic> for early spermatocytes, <italic>Id4</italic>, <italic>Sycp3</italic> and <italic>Shcbp1l</italic> for late spermatocytes, <italic>Acrv1</italic> for round spermatids, and <italic>Oaz3</italic> and <italic>Prm2</italic> for elongated spermatids (<xref ref-type="fig" rid="fig6s7">Figure 6—figure supplements 7</xref> and <xref ref-type="fig" rid="fig6s8">8</xref>). <italic>Col1a2</italic>, <italic>Acta2</italic>, <italic>Vcam1</italic>, <italic>Lnsl3</italic>, <italic>laptm5</italic>, <italic>Hbb-bt</italic>, <italic>Ptgds,</italic> and <italic>Wt1</italic> were used as markers of somatic cells (<xref ref-type="fig" rid="fig6s9">Figure 6—figure supplement 9</xref>). Analysis of the testicular transcriptome of <italic>Topbp1<sup>+/+</sup></italic> males revealed 47 sub-clusters of cells covering spermatogonia, spermatocytes, spermatids, and somatic cells (<xref ref-type="fig" rid="fig6">Figure 6B–D</xref>, <xref ref-type="fig" rid="fig6s10">Figure 6—figure supplements 10</xref> and <xref ref-type="fig" rid="fig6s11">11</xref>). In sharp contrast, analysis of <italic>Topbp1<sup>B5/B5</sup></italic> germ cell population revealed only somatic, spermatogonia, and the initial populations of spermatocytes (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). This result corroborates the H&amp;E-stained testes histological sections (<xref ref-type="fig" rid="fig1">Figure 1I</xref>) and meiotic spreads (<xref ref-type="fig" rid="fig1">Figure 1L</xref>). Importantly, Pearson correlation values from all RNA reads between cell groups separated by cluster and genotype, demonstrated the similarity of spermatocytes from <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> (<xref ref-type="fig" rid="fig6s12">Figure 6—figure supplement 12</xref>). As shown in <xref ref-type="fig" rid="fig6">Figure 6E</xref>, we were able to monitor the dynamics of X chromosome silencing in the early-stage spermatocytes and compare the results between RNA from <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> males. Strikingly, <italic>Topbp1<sup>B5/B5</sup></italic> early-stage spermatocytes could initiate MSCI and promote robust, albeit incomplete, X chromosome silencing. Both X and Y chromosomes showed increased gene expression levels in the last spermatocyte stage captured in <italic>Topbp1<sup>B5/B5</sup></italic> males when compared to RNA from wild-type males (<xref ref-type="fig" rid="fig6">Figure 6E</xref>, <xref ref-type="fig" rid="fig6s13">Figure 6—figure supplement 13</xref>). Moreover, although certain X-genes from <italic>Topbp1<sup>B5/B5</sup></italic> pachytene cells consistently demonstrated defects in silencing by being expressed in numerous cells, other genes were only expressed in a small number of cells. This highlights the non-uniformity of the MSCI defect in all pachytene cells (<xref ref-type="fig" rid="fig6s13">Figure 6—figure supplement 13</xref>). Notably, while we detected only a minor elevation in the levels of X-linked gene expression in <italic>Topbp1<sup>B5/B5</sup></italic> spermatogonia when compared to <italic>Topbp1<sup>+/+</sup></italic>, the expression of X-linked genes at spermatocyte 3 stage was drastically higher in <italic>Topbp1<sup>B5/B5</sup></italic> males when compared to <italic>Topbp1<sup>+/+</sup></italic> males. To improve the accuracy of the downstream analysis, the expression levels of X-linked genes were normalized by their respective expression level at the pre-leptotene stage.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Single-cell RNAseq reveals that <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes initiate meiotic sex chromosome inactivation (MSCI) but fail to promote full silencing.</title><p>(<bold>A</bold>) scRNAseq workflow for isolation and purification of single cells for RNAseq. (<bold>B</bold>) Uniform Manifold Approximation and Projection (UMAP) analysis of sub-clusters captured in the scRNAseq, representing all cells captured for both <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic>. (<bold>C</bold>) UMAP analysis of sub-clusters captured in the scRNAseq of <italic>Topbp1<sup>+/+</sup></italic>. (<bold>D</bold>) UMAP analysis of sub-clusters captured in the scRNAseq of <italic>Topbp1<sup>+/+</sup></italic> (gray) and <italic>Topbp1<sup>B5/B5</sup></italic> (blue). (<bold>E</bold>) Violin plots displaying the ratio of the average expression of X chromosome genes by the average expression of chromosome 9 genes at different stages of spermatogenesis for <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> cells. The level of X-genes expression in spermatocyte 3 is significantly higher in <italic>Topbp1<sup>B5/B5</sup></italic> cells when compared to <italic>Topbp1<sup>+/+</sup></italic> cells, with a p-value of 1.5e-178 using a two-sided Wilcoxon rank-sum test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes do not exhibit any difference in CHD4, Sumo2-3, and USP7 intensities and localization compared to <italic>Topbp1<sup>+/+</sup></italic>.</title><p>(<bold>A</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and CHD4 on the left, and quantification of CHD4-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 176, number of mice = 4; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 215, number of mice = 4; p-value=0.2125). (<bold>B</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and SUMO2.3 on the left, and quantification of SUMO2.3-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 155, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 126, number of mice = 2; p-value=0.8951). (<bold>C</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and USP7 on the left, and quantification of USP7-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 73, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 48, number of mice = 2; p-value=0.8610). p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes show no difference in H3K9ac or K3K9me3 staining compared to <italic>Topbp1<sup>+/+</sup></italic>.</title><p>(<bold>A</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and H3K9ac on the left, and quantification of H3K9ac-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 214, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 203, number of mice = 3; p-value=0.4948). (<bold>B</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and H3K9me3 on the left, and quantification of H3K9me3-stained pachytene spreads on the right. (Early-pachytene spreads: each dot represents one cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 31, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 48, number of mice = 2; p-value=0.6374; mid-pachytene spreads: each dot represents one cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 35, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 86, number of mice = 2; p-value=0.3990; late-pachytene: each dot represents one cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 49, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 14, number of mice = 2; p-value=0.3474.) p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes display no difference in H3K27ac, H3K36me3, or K3K4me3 staining compared to <italic>Topbp1<sup>+/+</sup></italic>.</title><p>(<bold>A</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and H3K27ac on the left, and quantification of H3K27ac-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 143, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 56, number of mice = 2; p-value=0.7881). (<bold>B</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and H3K36me3 on the left, and quantification of H3K36me3-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 79, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 52, number of mice = 2; p-value=0.2778). (<bold>C</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and H3K4me3 on the left, and quantification of H3K4me3-stained pachytene spreads on the right. (Early-pachytene spreads: each dot represents one cell measured <italic>Topbp1<sup>+/+</sup></italic> number of cells = 7, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 46, number of mice = 2; p-value=0.9895; mid-pachytene spreads: each dot represents one cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 26, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 58, number of mice = 2; p-value = 0.3292.). p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes display no difference in H4K16ac, H4ac, or H2AK166ub staining compared to <italic>Topbp1<sup>+/+</sup></italic>.</title><p>(<bold>A</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and H4K16ac on the left, and quantification of H4K16ac-stained pachytene spreads, on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 19, number of mice = 1; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 53, number of mice = 2; p-value=0.7314). (<bold>B</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and H4ac on the left, and quantification of H4ac-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 26, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 87, number of mice = 2; p-value=0.6795). (<bold>C</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and H2A-K199-ub on the left, and quantification of H2A-K199-ub-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 35, number of mice = 2; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 20, number of mice = 2; p-value=0.9941). p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp4-v1.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>From early pachytene to beginning of late pachytene, <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes exhibit the same localization pattern of H3K4me1 compared to <italic>Topbp1<sup>+/+</sup></italic>.</title><p>Representative images of <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> early, mid, and late pachytene spermatocytes stained with H3K4me1 and SYCP3.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp5-v1.tif"/></fig><fig id="fig6s6" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 6.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes exhibit no differences in the intensity or localization patterns of RNApol2, pRNApol2_Ser2, or pRNApol2_ser5 compared to <italic>Topbp1<sup>+/+</sup></italic>.</title><p>(<bold>A</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and RNApol2 on the left, and quantification of RNApol2-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 242, number of mice = 6; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 289, number of mice = 6; p-value for X and Y cores = 0.2026, p-value for X and Y chromatin loops = 0.4407). (<bold>B</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and pRNApol2-Ser2 on the left, and quantification of pRNApol2-Ser2-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 66, number of mice = 5; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 66, number of mice = 5; p-value=0.3862). (<bold>C</bold>) Representative images of meiotic spreads showing <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes stained with SYCP3 and pRNApol2-Ser5 on the left, and quantification of pRNApol2-Ser5-stained pachytene spreads on the right (each dot represents one pachytene cell measured; <italic>Topbp1<sup>+/+</sup></italic> number of cells = 47, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells = 21, number of mice = 2; p-value=0.5104). p-Values were calculated in GraphPad using a linear mixed effect model. p-Values were calculated using a linear mixed effect model (see ‘Materials and methods’ for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp6-v1.tif"/></fig><fig id="fig6s7" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 7.</label><caption><title>Genes used as markers to define the stages of the germ cells in the scRNAseq analysis.</title><p>Uniform Manifold Approximation and Projection (UMAP) plots showing markers for spermatogonia (<italic>Sal1</italic> and <italic>Dmrt1</italic>), spermatocytes (<italic>Dazl</italic>, <italic>Id4</italic>, <italic>Sycp3</italic>, and <italic>Shcbp1l</italic>), and spermatids (<italic>Acrv1</italic>, <italic>Oaz3,</italic> and <italic>Prm2</italic>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp7-v1.tif"/></fig><fig id="fig6s8" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 8.</label><caption><title>Genes used as markers to track spermatogenesis progression and form the 47 sub-cluster for all cells captured in the 10X platform in the scRNAseq analysis.</title><p>Bubble plot displaying gene markers and their respective pattern of expression during spermatogenesis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp8-v1.tif"/></fig><fig id="fig6s9" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 9.</label><caption><title>Genes used as markers of somatic cells captured in the scRNAseq analysis.</title><p>Uniform Manifold Approximation and Projection (UMAP) plots show markers for the somatic cells captured on the germ cell-enriched population, endothelial and hematopoietic (<italic>Col1a2</italic>, <italic>Vcam1</italic>, <italic>Laptm5,</italic> and <italic>Insl3</italic>), smooth muscle (<italic>Acta2</italic>), and Sertoli (<italic>Ptgds</italic> and <italic>Wt1</italic>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp9-v1.tif"/></fig><fig id="fig6s10" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 10.</label><caption><title>Analysis of sub-clusters of all cells captured in the 10X platform.</title><p>Uniform Manifold Approximation and Projection (UMAP) plot displaying the 47 sub-clusters of cells captured in the scRNAseq analysis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp10-v1.tif"/></fig><fig id="fig6s11" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 11.</label><caption><title>Analysis of the main 24 sub-clusters captured in the germ cells-enriched scRNAseq analysis.</title><p>Uniform Manifold Approximation and Projection (UMAP) plot showing 24 sub-clusters for spermatogonia, spermatocytes, round spermatids, spermatids, Sertoli, smooth muscle, and endothelial and hematopoietic cells captured in the 10X platform.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp11-v1.tif"/></fig><fig id="fig6s12" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 12.</label><caption><title>Spermatocytes from <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> show correlation greater than 0.9.</title><p>Plot of Pearson correlation values between cell groups separated by cluster and genotype using log-normalized average expression of all genes.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp12-v1.tif"/></fig><fig id="fig6s13" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 13.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes show increased expression of X-linked genes.</title><p>Heatmap displaying the expression levels of X-chromosome genes in spermatocyte 3 stage (pachytene) of <italic>Topbp1<sup>B5/B5</sup></italic> on the right and <italic>Topbp1<sup>+/+</sup></italic> on the left. Each line represents a gene, and each row is a cell.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp13-v1.tif"/></fig><fig id="fig6s14" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 14.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes show increased expression of XY ‘killer genes’ and other X and Y genes typically used to illustrate meiotic sex chromosome inactivation (MSCI) defects.</title><p>Violin plots showing the level of expression and number of cells expressing the XY chromosome genes in SP3 (pachytene): <italic>Zfy1</italic>, <italic>Zfy2</italic>, <italic>Kdm6a</italic>, <italic>Lamp2</italic>, <italic>Scml2</italic>, <italic>Zfx</italic>, <italic>Uba1y,</italic> and <italic>Rhox13</italic> in <italic>Topbp1<sup>B5/B5</sup></italic> and in <italic>Topbp1<sup>+/+</sup></italic>. The Wilcoxon test was used to calculate the p-values. **p&lt;0.01, ***p&lt;0.001, and **** p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp14-v1.tif"/></fig><fig id="fig6s15" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 15.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes show increased expression of XY-linked genes.</title><p>Bar plots showing the number of cells expressing the XY chromosome genes in SP3 (pachytene): <italic>Zfy1</italic>, <italic>Zfy2</italic>, <italic>Kdm6a</italic>, <italic>Lamp2</italic>, <italic>Scml2</italic>, <italic>Zfx</italic>, <italic>Uba1y,</italic> and <italic>Rhox13</italic> in <italic>Topbp1<sup>B5/B5</sup></italic> and in <italic>Topbp1<sup>+/+</sup></italic>. Fisher’s exact test was used to calculate the p-values. **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp15-v1.tif"/></fig><fig id="fig6s16" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 16.</label><caption><title>Quality control of the scRNAseq data.</title><p>Violin plots show the quality control for the scRNAseq data, displaying the distribution of gene counts, UMI counts, and mitochondrial gene percentage per library before filtering data.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig6-figsupp16-v1.tif"/></fig></fig-group><p>MSCI is a dynamic process that involves the accumulation of DDR factors at the X and Y chromosomes as cells enter pachynema (<xref ref-type="bibr" rid="bib3">Abe et al., 2022</xref>; <xref ref-type="bibr" rid="bib2">Abe et al., 2020</xref>), as well as the inactivation of specific X and Y genes that lead to cell death if expressed at this stage (the so-called ‘killer genes’) (<xref ref-type="bibr" rid="bib85">Royo et al., 2010</xref>; <xref ref-type="bibr" rid="bib100">Vernet et al., 2016</xref>). Similar to previous reports based on mutants or treatments that impaired MSCI (<xref ref-type="bibr" rid="bib3">Abe et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Hirota et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Modzelewski et al., 2012</xref>; <xref ref-type="bibr" rid="bib78">Pereira et al., 2022</xref>; <xref ref-type="bibr" rid="bib86">Royo et al., 2013</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>), transcriptomics profiles from <italic>Topbp1<sup>B5/B5</sup></italic> testicular cells showed an increased number of stage 3 spermatocytes (SP3 – pachytene) expressing the spermatocyte-toxic genes <italic>Zfy1</italic> and <italic>Zfy2</italic> compared to <italic>Topbp1<sup>+/+</sup></italic> (<xref ref-type="fig" rid="fig6s14">Figure 6—figure supplements 14</xref> and <xref ref-type="fig" rid="fig6s15">15</xref>). Other genes typically used to illustrate MSCI defects, such as <italic>Kdm6a</italic>, <italic>lamp2</italic>, <italic>Zfx</italic>, <italic>Uba1y,</italic> and <italic>Rhox13,</italic> were also expressed in a higher number of SP3 cells in <italic>Topbp1<sup>B5/B5</sup></italic> (<xref ref-type="fig" rid="fig6s14">Figure 6—figure supplements 14</xref> and <xref ref-type="fig" rid="fig6s15">15</xref>). In the case of <italic>Scml2</italic>, <italic>Topbp1<sup>B5/B5</sup></italic> cells not only displayed an increased number of SP3 (pachytene) cells expressing it but also displayed an increase in expression levels in these cells compared to <italic>Topbp1<sup>+/+</sup></italic> testes (<xref ref-type="fig" rid="fig6s14">Figure 6—figure supplements 14</xref> and <xref ref-type="fig" rid="fig6s15">15</xref>). In summary, various Y and X genes that had previously been shown to be expressed in other MSCI-defective mutants were found de-repressed in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes.</p><p>Detailed analysis of the scRNAseq data for the X-linked genes monitored during the early spermatocyte stages revealed important differences in the silencing dynamics of these X genes between <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> spermatocytes. Out of the roughly 700 genes present on the X chromosome, 233 had reads detected from pre-leptotene to spermatocyte 3 clusters for both <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> cells, and therefore were used during the downstream analysis. As shown in <xref ref-type="fig" rid="fig7">Figure 7A</xref>, we clustered the X-linked genes into three distinct categories based on the change of RNA level between the stages: reduced, unaltered, or increased silencing (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). SP1 (spermatocyte 1) was defined as leptonema using the gene marker <italic>Gm960</italic> (<xref ref-type="bibr" rid="bib21">Chen et al., 2018</xref>; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>), and SP2 (spermatocyte 2) as zygonema due to its profile of low expression of <italic>Gm960</italic> and high expression of <italic>Dazl</italic>. SP3 (spermatocyte 3) was defined as pachynema due to its lower expression of <italic>Dazl</italic> and increased expression of <italic>Id4</italic> and <italic>Shcbp1l</italic>. When comparing the distribution of genes in these clusters between <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> spermatocytes (RNA level normalized to pre-leptotene stage) (<xref ref-type="fig" rid="fig7">Figure 7B</xref>), we observed no major differences in the pre-leptotene to spermatocyte 1 (PL to SP1) and in the spermatocyte 1 to spermatocyte 2 (SP1 to SP2) transitions. In contrast, when comparing the spermatocyte 2 to spermatocyte 3 (SP2 to SP3) transition between <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic> spermatocytes we noticed a major difference in the distribution of the clusters, with 74 genes in <italic>Topbp1<sup>B5/B5</sup></italic> versus 4 in <italic>Topbp1<sup>+/+</sup></italic> exhibiting reduced silencing (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Moreover, while 134 genes showed unaltered silencing, and only 24 increased silencing in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes during the SP2 to SP3 transition, 43 genes showed unaltered silencing and 185 increased silencing in <italic>Topbp1<sup>+/+</sup></italic> (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). <italic>Xiap</italic>, <italic>Zc3h12b,</italic> and <italic>Cetn2</italic> are examples of X-linked genes displaying altered silencing behaviors in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). The difference of expression between <italic>Topbp1<sup>+/+</sup></italic>and <italic>Topbp1<sup>B5/B5</sup></italic> was markedly higher in the SP2 to SP3 transition compared to the other transitions (<xref ref-type="fig" rid="fig7">Figure 7D and E</xref>) and was used to further split genes into three categories based on the severity of the silencing defect in <italic>Topbp1<sup>B5/B5</sup></italic>: no defect (13 genes), mild (45 genes), or strong defect (170 genes) (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). Notably, the severity of the silencing defect of a gene had some correlation with its RNA level in the pre-leptotene stage, with highly expressed genes having a higher tendency to have a more severe silencing defect (<xref ref-type="fig" rid="fig7">Figure 7G</xref>, <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). Taken together, these data characterize the specific silencing defect in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes and point to a specific role for TOPBP1 in ensuring proper silencing dynamics after an initial wave of MSCI, likely through later waves of silencing reinforcement. Our data is consistent with the notion that silencing of the X and Y chromosomes is a dynamic process that needs active and continuous engagement by the ATR-TOPBP1 signaling axis. Since the majority of the mouse models of male infertility accumulate pleiotropic defects, with disrupted MSCI and absence of sex body, the <italic>Topbp1<sup>B5/B5</sup></italic> mouse reported here provides a unique model of DDR impairment in which MSCI can be uncoupled from sex body formation (<xref ref-type="fig" rid="fig8">Figure 8</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>TOPBP1 regulates silencing dynamics of X genes at the spermatocyte 3 stage.</title><p>(<bold>A</bold>) Illustration of the gene markers used to define spermatocyte 1 as leptotene, spermatocyte 2 as zygotene, and spermatocyte 3 as pachytene; hypothetical examples illustrating the categorization of transitions in silencing dynamics between the stages of pre-leptotene (PL), spermatocyte 1 (SP1), spermatocyte 2 (SP2), and spermatocyte 3 (SP3). (<bold>B</bold>) Number of genes in each of the categories described in (<bold>A</bold>), during the different stage transitions and respective p-values above each graph (the p-values were calculated using the Fisher’s exact test). (<bold>C</bold>) Examples of genes with altered silencing dynamics in the <italic>Topbp1<sup>B5/B5</sup></italic>, red = reduced silencing, blue = unaltered silencing and green = increased silencing (<bold>D</bold>) Scatter plot showing the difference in RNA level between <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> for each of the indicated stage transitions. (<bold>E</bold>) Scatter plot showing expression level of X-chromosome genes, normalized to pre-leptotene levels, in <italic>Topbp1<sup>+/+</sup></italic> (gray) and <italic>Topbp1<sup>B5/B5</sup></italic> (blue) at SP3. (<bold>F</bold>) Graph plotting expression levels of X-chromosome genes, normalized to pre-leptotene levels, in <italic>Topbp1<sup>+/+</sup></italic> (Y axis) and <italic>Topbp1<sup>B5/B5</sup></italic> (X axis) and split in three categories based on the severity of silencing defect. (<bold>G</bold>) Box plot showing PL expression levels of X-chromosome genes in each of the categories of silencing defect severity shown in (<bold>F</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Analysis of the gene marker used to define the zygotene stage.</title><p>Uniform Manifold Approximation and Projection (UMAP) analysis of the gene <italic>Gm960</italic> was used as a gene marker to define the zygotene stage.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Expression levels of genes with no defects, mild defects, and strong defects in <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic>.</title><p>Boxplot showing the expression levels of the clusters of genes with no defects, mild defects, and strong defects from pre-leptotene to Spermatocyte 3 (pachytene) in <italic>Topbp1<sup>B5/B5</sup></italic> and <italic>Topbp1<sup>+/+</sup></italic>. The Wilcoxon rank-sum test was used to calculate the p-values. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig7-figsupp2-v1.tif"/></fig></fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>A new TOPBP1 mutant separates XY silencing from sex body formation.</title><p>Schematic of sub-stages of meiotic prophase I. In wild-type mice, meiotic sex chromosome inactivation (MSCI) initiates following the accumulation of the DNA damage response (DDR) proteins at the XY chromosomes. During mid-pachytene, the XY body is fully formed, and transcription is restricted to the autosomes. In <italic>Atr</italic> or <italic>Topbp1</italic> CKOs, the sex body is not formed, and the DDR proteins are not sequestered to the XY. Asynapsis events and transcription of toxic genes at the sex chromosomes are observed, triggering mid-pachytene arrest. In <italic>Topbp1<sup>B5/B5</sup></italic>, MSCI initiates, the sex body is normally formed with normal recruitment of DDR proteins to the X and Y chromosomes, yet cells fail in the reinforcement/maintenance of silencing. Cells progress through mid-pachytene but not into diplonema.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-fig8-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In male meiosis I, DDR factors such as ATR, TOPBP1, BRCA1, and the 9-1-1 complex play crucial roles in DNA repair, chromosome synapsis, recombination, sex body formation, and silencing (<xref ref-type="bibr" rid="bib15">Broering et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Pacheco et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Pereira et al., 2022</xref>; <xref ref-type="bibr" rid="bib86">Royo et al., 2013</xref>; <xref ref-type="bibr" rid="bib96">Turner et al., 2004</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>). Conditional depletion of these factors results in pleiotropic phenotypes from compound effects in multiple processes, with cells ultimately undergoing apoptosis-induced cell death during the pachytene checkpoint. Here, we report a mutant mouse model capable of deconvoluting TOPBP1’s roles during meiosis I in males, separating its role in silencing from its roles in DNA repair, synapsis, and checkpoint signaling (<xref ref-type="fig" rid="fig8">Figure 8</xref>). While <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes initiate XY silencing with similar dynamics as observed in <italic>Topbp1<sup>+/+</sup></italic>, these cells fail to complete silencing at the final steps of MSCI. Of note, <italic>Topbp1<sup>B5/B5</sup></italic> cells displayed slightly higher expression of X-linked genes than <italic>Topbp1<sup>+/+</sup></italic> cells in the earlier spermatogenic stages (from spermatogonia 1 to spermatocyte 3). Furthermore, not all X-linked genes in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes were silenced; instead, some genes were only partially silenced while others exhibited increased expression after initial silencing. This is consistent with previous reports using mouse mutants with more severe MSCI defects, such as <italic>Ago4<sup>-/-</sup></italic> and <italic>Topbp1</italic> CKO, in which not all X-linked genes exhibited altered levels of expression (<xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Modzelewski et al., 2012</xref>). Interestingly, a sex body is formed that is morphologically indistinguishable from the sex body in wild-type animals. Several heterochromatin markers, as well as multiple canonical markers of sex body formation, localize properly in the sex body of <italic>Topbp1<sup>B5/B5</sup></italic> mice. Overall, these findings suggest a non-canonical role for the ATR-TOPBP1 signaling axis in ensuring proper XY silencing dynamics during pachynema. This is the first DDR mutant that separates XY silencing from sex body formation, and that separates TOPBP1’s role in spermatogenesis from its roles in organismal viability.</p><p>The <italic>B5</italic> allele reported here, which carries eight lysine to glutamic/aspartic acid substitutions in BRCT domain 5, is the first mutation shown to impair the meiotic silencing function of TOPBP1 in spermatocytes without severely disturbing TOPBP1’s role in synapsis and sex body formation. Consistent with this being a separation of function mutant, <italic>Topbp1<sup>B5/B5</sup></italic> males are viable and grossly normal, while completely sterile, whereas <italic>Topbp1</italic> null, or AAD mutated, mice are embryonic lethal (<xref ref-type="bibr" rid="bib44">Jeon et al., 2011</xref>; <xref ref-type="bibr" rid="bib112">Zhou et al., 2013</xref>). Moreover, depletion of TOPBP1 in mammalian cell lines triggers a robust G2/M arrest followed by cell senescence and loss of viability (<xref ref-type="bibr" rid="bib44">Jeon et al., 2011</xref>) <italic>Topbp1<sup>B5/B5</sup></italic> MEFs do not display issues with cell proliferation or DDR defects. Based on these observations, and the finding of a silencing defect in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes, it is likely that the role of TOPBP1 in silencing documented here could be specifically relevant in the context of male meiosis. It is important to note that other mutants previously reported to have XY silencing defects during meiotic prophase I, such as <italic>Ago4</italic> null and <italic>Dicer</italic> CKO, do not result in complete loss of sperm production, but a sub-fertility phenotype (<xref ref-type="bibr" rid="bib33">Greenlee et al., 2012</xref>; <xref ref-type="bibr" rid="bib67">Modzelewski et al., 2012</xref>). Therefore, we speculate that the specific type of silencing defect in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes is particularly toxic, similar to other mutations in the DDR pathway that result in MSCI defects, which would explain the highly penetrant defect in sperm production.</p><p>The model that distinct TOPBP1 interactions mediate distinct ATR signaling pathways offers a potential explanation for why <italic>Topbp1<sup>B5/B5</sup></italic> have specific defects in silencing without noted effects in other key processes regulated by ATR, such as synapsis. In addition to binding and activating ATR through its AAD domain (<xref ref-type="bibr" rid="bib71">Mordes et al., 2008</xref>; <xref ref-type="bibr" rid="bib77">Pereira et al., 2020</xref>), TOPBP1 can bind to several proteins through its BRCT domains (<xref ref-type="bibr" rid="bib110">Yamane et al., 2002</xref>) and act as a scaffolding protein to bring substrates in close proximity to ATR, thus facilitating the propagation of specific ATR signaling pathways. Experiments using ectopic expression of Flag-tagged TOPBP1 in HEK293T cells revealed that the set of mutations in <italic>B5</italic> disrupt the ability of TOPBP1 to interact with 53BP1 and BLM, as expected from previous reports (<xref ref-type="bibr" rid="bib12">Bigot et al., 2019</xref>; <xref ref-type="bibr" rid="bib13">Blackford et al., 2015</xref>; <xref ref-type="bibr" rid="bib20">Cescutti et al., 2010</xref>; <xref ref-type="bibr" rid="bib63">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib102">Wang et al., 2013</xref>). However, it is unclear whether the same interactions are also disrupted in spermatocytes or whether additional TOPBP1 interactions mediated by its BRCT5 specifically during meiotic prophase I are also disrupted. Apart from disrupting protein interactions, it is also possible that the observed changes in TOPBP1 protein stability in the <italic>Topbp1 B5</italic> mutant can contribute to impairing its roles in silencing. Such change in protein stability is consistent with a previous report showing that the TOPBP1-BLM interaction contributes to protein stabilization (<xref ref-type="bibr" rid="bib7">Balbo Pogliano et al., 2022</xref>; <xref ref-type="bibr" rid="bib102">Wang et al., 2013</xref>). Further work will be necessary to determine if the phenotypes observed in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes are caused specifically by disruption of specific protein interactions or by a combination of disrupted interactions and reduced protein abundance. It is worth mentioning that the <italic>Topbp1<sup>B5/B5</sup></italic> phenotype is distinct from the <italic>Topbp1</italic> CKO despite the reduction in protein abundance.</p><p>Our finding that SETX localization to chromatin loops of the XY is impacted in <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes, together with our previous report that SETX undergoes ATR-dependent phospho-regulation in spermatocytes (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>), suggest that an ATR-TOPBP1-SETX signaling axis is important for the silencing reinforcement in late MSCI. Genetic data support that impairment of this specific signaling axis would impact silencing without impacting synapsis. For example, <italic>Topbp1</italic> CKO, <italic>Rad1</italic> CKO, and <italic>Atr</italic> CKO spermatocytes display strong synapsis defect and defective entry in pachynema (<xref ref-type="bibr" rid="bib28">ElInati et al., 2017</xref>; <xref ref-type="bibr" rid="bib106">Widger et al., 2018</xref>), whereas <italic>Setx</italic> null spermatocytes complete autosomal synapsis, while still displaying MSCI defects. On the other hand, is it likely that ATR signaling is controlling a specific aspect of SETX function since <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes do not share all defects observed in <italic>Setx</italic> null spermatocytes, as noted by the localization of γH2AX, sumoylation events, ubH2A and ATR at chromatin loops, which are defective in <italic>Setx</italic> null spermatocytes but normal in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes. Moreover, <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes, but not <italic>Setx</italic> null spermatocytes, are able to reach the stage of crossover designation with MLH1 positive cells. Taken together, these observations suggest that <italic>Topbp1<sup>B5/B5</sup></italic> pachytene spermatocytes progress further in pachynema when compared to <italic>Setx</italic> null spermatocytes and are consistent with a model in which a ATR-TOPBP1 control only specific(s) mode of SETX regulation (<xref ref-type="bibr" rid="bib78">Pereira et al., 2022</xref>; <xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>).</p><p>The model involving SETX as a potential factor by which ATR controls silencing late in MSCI opens exciting directions to explore the interface of ATR-TOPBP1 with RNA processing. Given the established role for SETX in the resolution of R-loops (<xref ref-type="bibr" rid="bib11">Bennett and Spada, 2018</xref>), it is tempting to speculate that silencing defects in <italic>Topbp1<sup>B5/B5</sup></italic> mutant may be related to aberrant accumulation of RNA-DNA hybrids that may affect removal of nascent mRNAs that is necessary for imposing silencing. This hypothesis assumes that the silencing of X and Y genes is a dynamic process involving ongoing mechanisms of exclusion of RNA polymerase II and nascent RNA, as proposed recently (<xref ref-type="bibr" rid="bib3">Abe et al., 2022</xref>; <xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). Moreover, the model predicts that SETX function is specifically affected in the sex body, which is consistent with the observed defect in SETX localization. In support of this model, R-loops affect chromatin architecture at promoters and interfere with the recruitment of transcription factors and chromatin remodelers, as observed in regions harboring CpG islands where R-loops prevent the action of DNA methyltransferases, thus preventing silencing (<xref ref-type="bibr" rid="bib87">Santos-Pereira and Aguilera, 2015</xref>). Notably, highly transcribed genes, which tend to accumulate more R-loops (<xref ref-type="bibr" rid="bib66">Marnef and Legube, 2020</xref>), displayed increased silencing defects in the <italic>Topbp1<sup>B5/B5</sup></italic> mutant.</p><p>While we have provided strong evidence to suggest a defect in later stages of MSCI as the cause of the cell death observed in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes, we cannot exclude the potential contribution of other defects, beyond silencing, to the loss of diplotene cells. The increased number of MLH1 foci suggested an altered recombination pattern, possibly impairing the ratios of class I and class II crossovers. The BRCT 5 domain of TOPBP1 interacts with the BLM helicase (<xref ref-type="bibr" rid="bib7">Balbo Pogliano et al., 2022</xref>; <xref ref-type="bibr" rid="bib13">Blackford et al., 2015</xref>), which has been found to play a role in meiotic recombination in yeast and mice (<xref ref-type="bibr" rid="bib39">Holloway et al., 2010</xref>; <xref ref-type="bibr" rid="bib82">Rockmill et al., 2003</xref>). <italic>Blm</italic> CKO mice display severe defects in prophase I progression in spermatocytes, including, incorrect pairing and synapsis of homologs, and defective processing of recombination intermediates, leading to increased chiasmata (<xref ref-type="bibr" rid="bib39">Holloway et al., 2010</xref>). These observations raise the possibility that impaired meiotic progression and cell death in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes is a combination of defects in MSCI and recombination. <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes do not progress beyond pachytene hence we were not able to visualize chiasmata and directly infer whether or not <italic>Topbp1<sup>B5/B5</sup></italic> is defective in crossing over. Of note, MLH1 and MLH3 are known to form a heterodimer in the context of meiotic recombination (<xref ref-type="bibr" rid="bib62">Lipkin et al., 2000</xref>; <xref ref-type="bibr" rid="bib93">Svetlanov et al., 2008</xref>). While our data show increased MLH1 foci counts in <italic>Topbp1<sup>B5/B5</sup></italic>, MLH3 foci counts were not different from <italic>Topbp1<sup>+/+</sup></italic>, thus, we cannot exclude the possibility that the imbalance between MLH1 and MLH3 might affect the loss of diplotene cells in <italic>Topbp1<sup>B5/B5</sup></italic> through processes not related to crossing over. Importantly, while MLH3 works exclusively as a heterodimer with MLH1, MLH1 can function in a heterodimeric complex with other MutL homologs (<xref ref-type="bibr" rid="bib72">Nakagawa et al., 1999</xref>).</p><p>Our findings showing that TOPBP1 plays a specific role in silencing reinforcement after the first wave of MSCI are consistent with the recently proposed notion that the establishment and maintenance of MSCI is a dynamic process (<xref ref-type="bibr" rid="bib3">Abe et al., 2022</xref>; <xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). Also consistent with this notion is our recent finding showing that ATR signaling is itself also highly dynamic and constantly being cycled (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). For example, using mice treated with the ATR inhibitor (ATRi) AZ20 for 4 hr, we found that such a short treatment is already sufficient to cause a complete loss of γH2AX, pMDC1, and SETX localization from the XY chromosomes (<xref ref-type="bibr" rid="bib3">Abe et al., 2022</xref>; <xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). Furthermore, germ cells subjected to ATRi for 24 hr showed complete recovery of γH2AX only 3 hr after release from ATRi treatment (<xref ref-type="bibr" rid="bib3">Abe et al., 2022</xref>). We propose that TOPBP1 acts on this phospho-cycle to ensure proper silencing reinforcement and maintenance, potentially by counteracting the engagement of anti-silencing factors that dynamically enter the sex body and need to be actively antagonized at the XY. Future work involving the characterization of possible unknown interactors of the BRCT domain 5 of TOPBP1, as well as functional dissection of ATR targets in MSCI, is essential to understand how TOPBP1 modulates the silencing machinery and shapes silencing dynamics. Interestingly, while we propose that the lack of silencing maintenance is the major defect causing the pachytene cell death in <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes, we cannot exclude the possibility that the expression of XY-linked genes could represent a regulated response to meiotic defects more than a mere consequence of a defective MSCI. If this latter hypothesis is true, the cell death caused by defects in the XY chromosomes would be independent of MSCI. Notably, this hypothesis could not have been conceptualized prior to this work given that the majority of prophase I mutants characterized to this date are unable to reach the stage where MSCI is properly established. Thus, the <italic>Topbp1<sup>B5/B5</sup></italic> is a unique model allowing future studies that may uncouple MSCI from XY-triggered cell death during pachynema.</p><p>In summary, our study presents a unique model for investigating the role of DDR factors in XY silencing. By allowing the uncoupling of MSCI progression from sex body formation, the <italic>Topbp1<sup>B5/B5</sup></italic> mutant enables the study of MSCI dynamics during key stages late in pachynema. Notably, the inability of <italic>Topbp1<sup>B5/B5</sup></italic> to sustain or reinforce silencing opens the possibility of uncovering new insights into the MSCI-dependent pachytene checkpoint.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Materials availability</title><p>This study generated a unique antibody, RPA.</p></sec><sec id="s4-2"><title>Mice, genotyping, and treatment of mice with IR</title><p>All mice used in this work were handled following federal and institutional guidelines under a protocol approved by the Institutional Animal Care and Use Committee (IACUC protocol number 2011-0098) at Cornell University. CRISPR/Cas9 editing was used to engender the <italic>Topbp1B5</italic> allele and performed by the Cornell Mouse Modification core facility. To this end, the online tools CRISPR gold and ChopChop were used to generate high-quality (guide score &gt;9) CRISPR guide RNAs targeting the intronic sequences neighboring the genomic sequence of <italic>Mus musculus topbp1</italic> exon 13. The CRISPR crRNAs (purchased from IDT) harboring the sequences <named-content content-type="sequence"><underline>cca</underline>actcaggtcggccgctcttg</named-content> and <named-content content-type="sequence"><underline>cct</underline>cgattagtcctcaaggcgag</named-content> (PAM sites are underlined), both targeting the reverse strand, the repair template (below), and CAS9 RNA, were injected on embryos from super-ovulated, plugged C57BL/6J female mice crossed to C57BL/6J stud males. Two cell stage embryos were then implanted on pseudo pregnant females and pups were genotyped after 1 week old.</p><sec id="s4-2-1"><title>Repair template</title><p><named-content content-type="sequence">acagcagggcttctctgtgtaaccctctctccgtagaccagtttggccttgat<styled-content style="color: #366BFB;">cga</styled-content><styled-content style="color: #9C27B0;">actcaggtcggccgctcttg</styled-content>cctctagagtcctgggattaaaggcgtgcactgccaccacccagagtatgtttctctgacattaaccatgctattatttttttaaaatgagctaattgtgtgttcatttgctttatttccatgtaaaattttagTGTTCAAGAATTCTTTGTT<styled-content style="color: #D50000;"><underline>GA</underline></styled-content><styled-content style="color: #D50000;">CGAA</styled-content>GCCAATGCA<styled-content style="color: #D50000;"><underline>G</underline></styled-content><styled-content style="color: #D50000;">AG</styled-content><styled-content style="color: #D50000;"><underline>G</underline></styled-content><styled-content style="color: #D50000;">AA</styled-content>GGCATGCTCGCCAGCACACATCTTATAGTG<styled-content style="color: #D50000;"><underline>G</underline></styled-content><styled-content style="color: #D50000;">AG</styled-content>GAACCGACTGGTTCC<styled-content style="color: #D50000;"><underline>GA</underline></styled-content><styled-content style="color: #D50000;">A</styled-content>TACGAAGCTGCA<styled-content style="color: #D50000;"><underline>G</underline></styled-content><styled-content style="color: #D50000;">AG</styled-content><styled-content style="color: #D50000;"><underline>G</underline></styled-content><styled-content style="color: #D50000;">AA</styled-content>TGGAGTTTGCCGGCAGTTAACATTTCATGGCTCTTAGAAACTGCG<styled-content style="color: #D50000;"><underline>GA</underline></styled-content><styled-content style="color: #D50000;">A</styled-content>ATCGGG<styled-content style="color: #D50000;"><underline>G</underline></styled-content><styled-content style="color: #D50000;">AG</styled-content><styled-content style="color: #D50000;"><underline>GA</underline></styled-content><styled-content style="color: #D50000;">A</styled-content>GCAGATGAAAACCATTTTCTGGTTGACAACGCACCTAAACAAGgttagaagtccttgttttttttttatgtattttacaacttgatggtttctgaaatagggatgttccagtacttgctttaaaacatttgtatgaccctaacctcagtcagtggtgcttacttcagaacccctgagtgaaacacggaaagcagatcaatgaagaagcgcatcagggtcaac<styled-content style="color: #366BFB;">ggt</styled-content><styled-content style="color: #9C27B0;">cgattagtcctcaaggcgag</styled-content>tgacgagaaggtgacccccga atggctgttagaagcagtttttata</named-content> (purchased from IDT as a G-block).</p><p>Intronic sequence is shown in lower case, exon 13 sequence is shown in capital letters, underline represents the mutated residues, blue represents the mutated PAM residues, purple shows the guide RNA sequences, and red shows the targeted amino acid sequences. Of note, although this repair template encodes for 11 amino acid changes, only 8 were successfully inserted into the mouse topbp1 exon 13 locus. For mice genotyping, the following primers were used: 5′-<named-content content-type="sequence">tgcatttccattaaccaacctc</named-content>-3′ and 5′- <named-content content-type="sequence">ggtagagttcaaatgtgtgtcatg</named-content>-3′ (also shown in Key Resources Table).</p><p>For irradiation, <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> mice were placed in a 137 cesium-sealed source irradiator (J.L. Shepherd and Associates) with a rotating turntable and irradiated with 7 Gy IR.</p></sec></sec><sec id="s4-3"><title>MEFs and cell survival assays</title><p>MEFs were prepared from E13.5 mouse embryos as previously described (<xref ref-type="bibr" rid="bib8">Balmus et al., 2012</xref>). Briefly, embryos were dissected and mechanically disrupted using pipette aspiration until homogeneous. Cells were allowed to settle, and the supernatant was transferred into Dulbecco’s modified medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 1% nonessential amino acids. Following 4 days of growth, cells were then immortalized by transduction with a large-T antigen lentivirus. Subsequently, cells were selected with 10 µg/mL puromycin.</p><p>For colony survival assays, 500 cells were seeded per 10 cm dish, allowed to adhere for 24 hr, and treated with phleomycin or hydroxyurea for 24 hr (drug concentrations are displayed in <xref ref-type="fig" rid="fig2">Figure 2A–D</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). In the following day, cells were released and let to form colonies for 10–15 days. Cells were then washed once with PBS, fixed in 100% methanol for 1 hr, stained with 0.1% crystal violet (MP Biomedicals, 152511) solution overnight, and then washed with distilled water before imaging and counting.</p><p>For accessing DDR and checkpoint responses via western blot, 2 × 10<sup>6</sup> cells were seeded on a 60 cm dish, allowed to adhere for 24 hr, and treated with phleomycin or hydroxyurea for 3 hr (drug concentrations are displayed in <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p></sec><sec id="s4-4"><title>Cell culture</title><p>HEK-293T cells were cultured in Dulbecco’s modified medium supplemented with 10% fetal calf serum, 1% penicillin/streptomycin, and 1% nonessential amino acids. Immortalized MEFs were cultured in Dulbecco’s modified medium supplemented with 10% fetal calf serum, 1% penicillin/streptomycin, 1% nonessential amino acids, and 1% glutamine supplementation. All cells were kept at 37°C and 5% CO<sub>2</sub>. All the cell lines were regularly tested for mycoplasma contamination with the Universal Mycoplasma Detection Kit (ATCC). HEK-293T cells were transfected using homemade polyethylenimine (Polysciences, Inc). Then, 36 hr after transfection, cells were treated with 1 mM HU (hydroxyurea) and then harvested for immunoprecipitation experiments.</p></sec><sec id="s4-5"><title>Plasmids</title><p>The full-length TOPBP1 CDS was cloned on a p3xflag vector (Milipore/Sigma E7658) using Gibson assembly (NEB) following the manufacturer’s instructions. The p3xflag-TOPBP1 was used as a template to generate p3xflag-TOPBP-K155A, p3xflag-TOPBP-K250A, p3xflag-TOPBP-K704A, p3xflag-TOPBP-K1317A through site-directed mutagenesis using prime STAR master mix (Takara) and Gibson assembly to generate p3xflag-TOPBP-KE, using the following G-block (IDT) containing the eight charge-reversal point mutations at the BRCT 5 domain of <italic>TOPBP1</italic>:</p><p><named-content content-type="sequence">AACGAATCCAATGCAGAAGAAGGCATGTTTGCCAGTACTCATCTTATACTGGAAGAACGTGGTGGCTCTGAATATGAAGCTGCAAAGAAGTGGAATTTACCTGCCGTTACTATAGCTTGGCTGTTGGAGACTGCTAGAACGGGAGAAGA</named-content>.</p><p>All primers used for the cloning are shown in the Key Resources Table.</p></sec><sec id="s4-6"><title>Immunoblotting</title><p>Cells were harvested and lysed in modified RIPA buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% tergitol, 0.25% sodium deoxycholate, 5 mM ethylenediaminetetraacetic acid [EDTA]) supplemented with complete EDTA-free protease inhibitor cocktail (Roche), 1 mM phenylmethylsulfonyl fluoride (PMSF), and 5 mM NaF. Whole-cell lysates, after sonication, were cleared by 15 min centrifugation at 17,000 × <italic>g</italic> at 4°C. Then, 20 µg of protein extract were mixed with 3× sodium dodecyl sulfate sample buffer and resolved by SDS-PAGE. Gels were transferred on polyvinylidene difluoride membranes and immunoblotted using standard procedures. Western blot signal was acquired with a Chemidoc Imaging System (Bio-Rad). Antibody information is provided in the Key Resources Table.</p></sec><sec id="s4-7"><title>Immunofluorescence</title><p>MEFs were grown on coverslips and then submitted to IR, 5 Gy and allowed to recover for 1.5 hr at 37°C and 5% CO<sub>2</sub>. Cells were then fixed using 3.7% formaldehyde in phosphate-buffered saline (PBS) for 10 min at room temperature (RT). Fixed cells were then washed 3× with PBS, permeabilized for 5 min with 0.2% Triton X-100/PBS at RT and blocked in 10% bovine serum albumin/PBS for 20 min at RT. Coverslips were incubated first with primary antibodies for 2 hr at RT, followed by three washes with PBS, and then for 1 hr with relative secondary antibodies. After incubation with secondary antibodies, coverslips were washed three times with PBS and then mounted on glass microscope slides using DAPI–Vectashield mounting medium (Vector Laboratories). Slides were imaged on a Leica DMi8 Microscope with a Leica DFC9000 GTC camera using the LAS X (Leica Application Suite X) software with a ×100 objective. For micronuclei scoring, ∼ 50 cells/replicate were counted. Two-tailed Student’s <italic>t</italic>-test was used for statistical analysis. Antibody information is provided in the Key Resources Table.</p></sec><sec id="s4-8"><title>Meiotic spreads</title><p>Meiotic surface spreads were performed from 8- to 12-week-old mice as described by <xref ref-type="bibr" rid="bib52">Kolas et al., 2005</xref>. Briefly, decapsulated testis from mice were incubated on ice in a hypotonic extraction buffer for 45 min. Tubules were then minced into single-cell suspension in 100 mM sucrose, and cells were spread on slides coated with 1% PFA with 0.15% TritionX- 100 and incubated in a humidifying chamber for 4 hr. For immunostaining, slides were blocked using 10% goat serum and 3% BSA, followed by incubation overnight with primary antibody (listed in the Key Resources Table) at 4°C in a humidifying chamber. Secondary antibodies were incubated at 37°C for 2 hr in the dark, and slides were then cover-slipped using antifade mounting medium (2.3% DABCO, 20 mM Tris pH 8.0, 8 µg DAPI in 90% glycerol). Slides were imaged on a Leica DMi8 Microscope with a Leica DFC9000 GTC camera using the LAS X software. For every condition, a minimum of 50 images from at least two independent mice were acquired. To quantify fluorescence intensity, the LAS X software quantification tool was used as previously described (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). Antibody information is provided in the Key Resources Table. p-Values were calculated in Prism–GraphPad using a linear mixed effect model (Nested <italic>t</italic>-test) that takes into account the variability in cells within each mouse when comparing mice between groups (<italic>Topbp1<sup>+/+</sup></italic> vs <italic>Topbp1<sup>B5/B5</sup></italic>).</p></sec><sec id="s4-9"><title>3D-structured illumination super-resolution microscope (3D-SIM)</title><p>Higher resolution images were acquired using an ELYRA 3D-structured illumination super-resolution microscopy (3D-SIM) from Carl Zeiss with ZEN Black software (Carl Zeiss AG, Oberkochen, Germany). Images are shown as maximum intensity projections of z-stack images. To reconstruct high-resolution images, raw images were computationally processed with ZEN Black. The brightness and contrast of images were adjusted using ImageJ (National Institutes of Health, USA). Antibody information is provided in the Key Resources Table.</p></sec><sec id="s4-10"><title>Fertility assays</title><p>For fertility testing, 8-week-old <italic>Topbp1<sup>B5/B5</sup></italic> females and C57BL/6 males or C57BL/6 females and <italic>Topbp1<sup>B5/B5</sup></italic> males were singly housed, where pregnancies were monitored for a period of 1 month. Viable pups were counted on the first day of life. For <italic>Topbp1<sup>B5/B5</sup></italic> males, breeding cages remained active for a period of 6 months at no time pregnant females nor birth of pups were detected. No noticeable defects were found on fertility of Topbp<italic>1<sup>B5/+</sup></italic>, males or females (data not shown).</p></sec><sec id="s4-11"><title>TUNEL</title><p>TUNEL assay was conducted using the Apoptag kit (EMD Millipore) following the manufacturer’s instructions. The data were quantified in Image Scope by counting the number of positive cells per tubule for 100 tubules of each genotype, three mice each. Statistical differences between <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> were analyzed using Welch’s unpaired <italic>t</italic>- test in GraphPad.</p></sec><sec id="s4-12"><title>Hematoxylin and eosin staining</title><p>Adult testes – from 12-week-old mice – were dissected and incubated in Bouin’s fixative overnight, washed during 30 min each in 30%, then 50% and then 70% ethanol. The 70% ethanol wash was repeated three times more. Testes were then embedded in paraffin. 5 µm sections were mounted on slides. After rehydration in Safe Clear Xylene Substitute followed by decreasing amounts of ethanol, slides were stained with hematoxylin followed by eosin. The slides were then gradually dehydrated by incubation in increasing concentrations of ethanol before mounting using toluene mounting medium.</p></sec><sec id="s4-13"><title>Epididymal sperm counts</title><p>Caudal and epididymides from 8- to 12-week-old mice were minced with fine forceps at 37°C in a Petri dish containing Dulbecco’s modified medium supplemented with 10% fetal calf serum, 1% penicillin/streptomycin, 4% BSA, and 1% nonessential amino acids. Samples were then incubated at 37°C for 30 min allowing sperm to swim out into the media, then fixed in 10% neutral-buffered formalin (1:25 dilution). Sperm cells were counted using a hemocytometer and analyzed statistically using two-tailed Student’s <italic>t</italic>-test between <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic>.</p></sec><sec id="s4-14"><title>Enrichment of testes phosphopeptides and TMT labeling</title><p>The enrichment of testes phosphopeptides and TMT labeling were done as described previously (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). Briefly, whole decapsulated testes were collected from 8- to 12-week-old mice after which tissue was subject to lysis, protein quantification, and normalization, denaturation, alkylation, precipitation, digestion, and solid-phase extraction (SPE) C18 cartridge clean up as described by <xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>. Lyophilized tryptic peptides were then subject to phosphopeptide enrichment using a High-Select Fe-NTA Phosphopeptide Enrichment Kit according to the manufacturer’s protocol (Cat# A32992, Thermo Scientific). Phosphopeptide samples were dried in silanized glass shell vials, resuspended in 50 mM HEPES, and labeled with 100 µg of TMT sixplex Isobaric Label Reagents (Thermo Scientific) using three TMT channels for each condition (<italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic>). The TMT-labeling reaction was done at RT for 1 hr and quenched with 5% hydroxylamine for 15 min. After quenching, TMT-labeled peptides from all six channels were pooled, acidified with 0.1% TFA, and desalted using a SPE 1cc C18 cartridge (Sep-Pak C18 cc vac cartridge, 50 mg Sorbent, WAT054955, Waters). Bound TMT-labeled phosphopeptides were eluted with 80% acetonitrile, 0.1% acetic acid in water before being dried via vacuum concentrator.</p></sec><sec id="s4-15"><title>Mass spectrometric analysis of TMT-labeled phosphopeptides</title><p>The dried TMT-labeled phosphopeptides were prefractionated using offline HILIC HPLC prior to being analyzed by mass-spectrometry as described by <xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>. The LC-MS/MS was performed on an UltiMate 3000 RSLC nano chromatographic system coupled to a Q-Exactive HF mass spectrometer (Thermo Fisher Scientific). The chromatographic separation was achieved via a 35-cm-long 100 µm inner diameter column packed in-house with 3 µm C18 reversed-phase resin (Reprosil Pur C18AQ 3 μm). The Q-Exactive HF was operated in data-dependent mode with survey scans acquired in the Orbitrap mass analyzer over the range of 380–1800 m/z with a mass resolution of 120,000. MS/MS spectra were performed after selecting the top 7 most abundant +2, +3, or +4 ions and a precursor isolation window of 0.7 m/z. Selected ions were fragmented by higher-energy collisional dissociation (HCD) with normalized collision energies of 28, with fragment mass spectra acquired in the Orbitrap mass analyzer with a monitored first mass of 100 m/z, mass resolution of 15,000, AGC target set to 1 × 10<sup>5</sup>, and maximum injection time set to 100 ms. A dynamic exclusion window of 30 s was specified.</p></sec><sec id="s4-16"><title>Phosphoproteomic data analysis</title><p>Trans Proteomic Pipeline (TPP) version 6.0.0 was used for phosphopeptide identification and quantification. MS data were converted to mzXML using msConvert as packaged with the TPP, after which spectral data files were searched using the Comet search engine (v2021 rev 1) (<xref ref-type="bibr" rid="bib29">Eng et al., 2013</xref>). Peptide identifications were validated using PeptideProphet, phosphorylation site localization was performed using PTM Prophet, and TMT channel quantification was performed using Libra. Results from Libra were exported as tab-delimited files for further processing via R scripts as previously described (<xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). The mass spectrometry phosphoproteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (<xref ref-type="bibr" rid="bib80">Perez-Riverol et al., 2022</xref>) a partner repository with the dataset identifier PXD042199.</p></sec><sec id="s4-17"><title>Immunoprecipitation</title><p>The immunoprecipitation (IP) experiments were performed as described by <xref ref-type="bibr" rid="bib63">Liu et al., 2017</xref>. Briefly, cell pellets were lysed in 50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% tergitol, 0.25% sodium deoxycholate, and 5 mM EDTA, supplemented with EDTA-free protease inhibitor cocktail, 5 mM sodium fluoride, 10 mM β-glycerolphosphate, 1 mM PMSF, and 0.4 mM sodium orthovanadate. The protein extracts were cleared by 10 min centrifugation and then incubated with anti-FLAG agarose beads (Sigma-Aldrich) for 16 hr at 4°C. The beads were then washed four times with the same buffer used for IP and then eluted using three resin volumes of the elution buffer (100 mM Tris–HCl, pH 8.0, and 1% SDS, and 1 mM DTT).</p></sec><sec id="s4-18"><title>Mass spectrometric analysis of immunoprecipitates</title><p>HEK-293T cells were grown in stable isotope labeling with amino acids in cell culture (SILAC) as previously described (<xref ref-type="bibr" rid="bib63">Liu et al., 2017</xref>) and transfected as described above. Cells were treated with 1 mM HU for 16 hr before harvesting. Flag-TOPBP1 was immunoprecipitated using anti-FLAG agarose beads. Immunoprecipitates were then prepared for mass spectrometry analysis by reduction, alkylation, precipitation, and digestion by trypsin. The peptides were desalted, dried, and then fractionated by hydrophilic interaction chromatography as previously described (<xref ref-type="bibr" rid="bib63">Liu et al., 2017</xref>). Fractions were dried and analyzed by liquid chromatography–tandem mass spectrometry using a mass spectrometer (Q-Exactive HF Orbitrap; Thermo Fisher Scientific). The capillary column was 35 cm long with a 100 µm inner diameter, packed in-house with 3 µm C18 reversed-phase resin (Reprosil Pur C18AQ 3 μm). Peptides were separated over an 70 min linear gradient of 6–40% acetonitrile in 0.1% formic acid at a flow rate of 300 nL/min as described previously (<xref ref-type="bibr" rid="bib9">Bastos de Oliveira et al., 2015</xref>). Xcalibur 2.2 software (Thermo Fisher Scientific) was used for the data acquisition, and The Q-Exactive HF was operated in data-dependent mode with survey scans acquired in the Orbitrap mass analyzer over the range of 380–1800 m/z with a mass resolution of 120,000. The maximum ion injection time for the survey scan was 100 ms with a 3e6 automatic gain-control target ion. Tandem mass spectrometry spectra were performed by selecting up to the 20 most abundant ions with a charge state of 2, 3, or 4 and with an isolation window of 1.2 m/z. Selected ions were fragmented by higher energy collisional dissociation with a normalized collision energy of 28, and the tandem mass spectra were acquired in the Orbitrap mass analyzer with a mass resolution of 17,500 (at m/z 200). The TPP version 6.0.0 was used for peptide identification and SILAC quantification. MS data were converted to mzXML using msConvert as packaged with the TPP, after which spectral data files were searched using the Comet search engine (v2021 rev 1) (<xref ref-type="bibr" rid="bib29">Eng et al., 2013</xref>). The following parameters were used in the database search: semitryptic requirement, a mass accuracy of 15 ppm for the precursor ions, a differential modification of 8.0142 D for lysine and 10.00827 D for arginine, and a static mass modification of 57.021465 D for alkylated cysteine residues. Peptide identifications were validated using PeptideProphet and SILAC quantification was performed using XPRESS as described previously (<xref ref-type="bibr" rid="bib9">Bastos de Oliveira et al., 2015</xref>; <xref ref-type="bibr" rid="bib90">Sims et al., 2022</xref>). The mass spectrometry data have been deposited to the ProteomeXchange Consortium via the PRIDE (<xref ref-type="bibr" rid="bib80">Perez-Riverol et al., 2022</xref>) partner repository with the dataset identifier PXD042199.</p></sec><sec id="s4-19"><title>Total germ cells preparation</title><p>Mice testis were collected from 8- to 12-week-old mice (n = 5 mice, 10 testis for <italic>Topbp1<sup>+/+</sup></italic>, and n = 20–30 mice, 40–60 testis for <italic>Topbp1<sup>B5/B5</sup></italic>), and dissociated using standard protocols for germ cell extraction (<xref ref-type="bibr" rid="bib34">Grive et al., 2019</xref>). Briefly, decapsulated testes were held in 10 mL of preheated (35°C) DMEM-F12 buffer containing 2 mg of Collagenase 1A and DNAse 7 mg/mL, on a 50 mL conical tube. The collagenase digestion was performed at a 35°C shaker water bath, 150 rpm during 5 min. The collagenase digestion was stopped by the addition of 40 mL of DMEM-F12 and the tubules were let to decantate for 1 min. The supernatant was removed and added another 40 mL of DMEM-F12 to further wash the residual collagenase and remove somatic and excessive sperm cells. Next, the tubules were digested using 10 mL of DMEM-F12 buffer containing 5 mg of trypsin (Thermo Fisher 27250018) on a 50 mL conical tube and the reaction was carried out on a 35°C shaker water-bath, 150 rpm during 5 min. Digested tubules were strained on a 100 μm strainer containing 3 mL of FBS (100% FBS, heat-inactivated, Sigma F4135-500mL). Total germ cells were centrifuged at 300 × <italic>g</italic> for 5 min, 4°C and checked for single cells and viability.</p></sec><sec id="s4-20"><title>Flow cytometry analysis</title><p>Total germ cell extracts were stained with Vybrant dye cycle (VDG) (Invitrogen) 100 μM for 30 min at RT, kept on dark, and rocking. After staining, cells were sorted as previously described (<xref ref-type="bibr" rid="bib84">Rodríguez-Casuriaga et al., 2014</xref>) aiming to enrich for spermatocytes and using the Sony MA900 fluorescent-activated cell sorter (FACS), tuned to emit at 488 nm and with a 100 μm nozzle. Laser power was set to collect VDG-emitted fluorescence in FL1. Sorted cells were collected on 1.5 mL tubes containing 0.5 mL of DMEM-F12 buffer + 10% FBS. The FACS was done at the Flow Cytometry Facility, Cornell University.</p></sec><sec id="s4-21"><title>Single-cell RNA sequencing</title><p>Flow-sorted cells were submitted to the Cornell DNA Sequencing Core Facility and processed on the 10X Genomics Chromium System targeting 5000–7000 cells per sample as described previously (<xref ref-type="bibr" rid="bib34">Grive et al., 2019</xref>) using the 10X Genomics Chromium Single Cell 3′ RNA-seq v2 kit to generate the sequencing libraries, which were then tested for quality control on an ABI DNA Fragment Analyzer and ran on a NextSeq platform with 150 base-pair reads. The sequencing was carried out to an average depth of 98M reads (range 77–124M); on average, 91% of reads (range 89%–92%) and then mapped to the reference genome.</p></sec><sec id="s4-22"><title>Single-cell RNA sequencing data analysis</title><p>Count matrices were generated for each sample using the Cell Ranger counts function and then imported into Seurat and integrated. Cells were filtered based on gene number, UMI, counts, and mitochondrial percentage. Cells with less than 500 genes, less than 1000 UMIs, or more than 5% of mitochondrial reads were excluded from further analysis (<xref ref-type="fig" rid="fig6s16">Figure 6—figure supplement 16</xref>). Raw counts were normalized using Seurat NormalizeData using default parameters and the top 4000 variable features were identified using the FindVariableFeatures function using ExpMean for the mean function and LogVMR for the dispersion function. Principal components were calculated from variable genes and used with Harmony to correct for batch effect. Harmony embeddings dimensions 1–20 were used for a Shared Nearest Neighbor graph with k = 30, unsupervised clustering with a resolution of 4, and Uniform Manifold Approximation and Projection (UMAP) analysis. Cell types were manually identified by use of marker genes, and the SingleR package was used to confirm cell identity. Chromosome X/autosome 9 ratios were calculated by taking the mean gene expression of all genes on chromosome 9 or X for a cell and dividing it by the mean gene expression for all autosomal genes in a cell. Ratios were visualized using ggplot and the introdataviz package geom_split_violin function. The single-cell heatmap was generated using the DoHeatmap function. The clustered analysis of the X-linked genes shown in <xref ref-type="fig" rid="fig7">Figure 7A</xref> was done by splitting the detected 233 X-linked genes into three distinct categories based on the difference of RNA level between the spermatocyte stages and normalized by pre-leptotene: reduced silencing (&gt;1), unaltered silencing (≥ –1 or ≤1), or increased silencing (&lt; –1). To further split the X-linked genes into three categories based on the severity of the silencing defect (detected at spermatocyte 3 stage) in <italic>Topbp1<sup>B5/B5</sup></italic> – no defect (13 genes), mild (45 genes), or strong defect (170 genes) – the difference in expression between SP3 genes from <italic>Topbp1<sup>+/+</sup></italic> or from <italic>Topbp1<sup>B5/B5</sup></italic> was calculated. The categories were defined as strong &gt; 2.5, mild ≥ 1 or ≤ 2.5, and no defect &lt; 1. The single-cell RNAseq data generated in this study have been deposited in the NCBI GEO database under accession number GSE232588.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con3"><p>Data curation, Software, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation</p></fn><fn fn-type="con" id="con5"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation</p></fn><fn fn-type="con" id="con7"><p>Resources, Funding acquisition</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Funding acquisition, Methodology</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was performed in strict accordance with the recommendations in the Guide for Care and Use of Laboratory Animals of the National Institute of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocol 2011-0098 of Cornell University.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-90887-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The mass spectrometry data generated in this study have been deposited to the ProteomeXchange Consortium via the PRIDE (<xref ref-type="bibr" rid="bib80">Perez-Riverol et al., 2022</xref>) partner repository with the dataset identifier PXD042199.The Single-cell RNAseq data generated in this study have been deposited in the NCBI GEO database under accession number GSE232588.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Ascencao</surname><given-names>CFR</given-names></name><name><surname>Sims</surname><given-names>JR</given-names></name><name><surname>Dziubek</surname><given-names>A</given-names></name><name><surname>Comstock</surname><given-names>W</given-names></name><name><surname>Fogarty</surname><given-names>EA</given-names></name><name><surname>Badar</surname><given-names>J</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Grimson</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>RS</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>TOPBP1 Shapes XY Silencing Dynamics Independently of Sex Body Formation to Ensure Male Fertility</data-title><source>ProteomeXchange</source><pub-id pub-id-type="accession" xlink:href="https://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD042199">PXD042199</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Ascencao</surname><given-names>CFR</given-names></name><name><surname>Sims</surname><given-names>JR</given-names></name><name><surname>Dziubek</surname><given-names>A</given-names></name><name><surname>Comstock</surname><given-names>W</given-names></name><name><surname>Fogarty</surname><given-names>EA</given-names></name><name><surname>Badar</surname><given-names>J</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Grimson</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>RS</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>TOPBP1 Shapes XY Silencing Dynamics during Meiosis to Ensure Male Fertility</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE232588">GSE232588</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>JR</given-names></name><name><surname>Faca</surname><given-names>VM</given-names></name><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Ascencao</surname><given-names>C</given-names></name><name><surname>Comstock</surname><given-names>W</given-names></name><name><surname>Badar</surname><given-names>J</given-names></name><name><surname>Arroyo-Martinez</surname><given-names>GA</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name><name><surname>Weiss</surname><given-names>RS</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Phosphoproteomics of ATR Signaling in Prophase I of Mouse Meiosis</data-title><source>ProteomeXchange</source><pub-id pub-id-type="accession" xlink:href="https://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD023803">PXD023803</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the members of Cohen lab, Weiss lab, Grimson lab, and Smolka lab for comments and suggestions. We thank Dr. Fenghua Hu and Dr. Tony Bretscher for the use of the microscopes and Beatriz Almeida for technical assistance. We thank Dr. Lydia Tesfa and the BRC Flow Cytometry Facility (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_021740">SCR_021740</ext-link>) for training and assistance with FACS at the Cornell Institute of Biotechnology, Peter Schweitzer and the BRC Genomics Facility (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_021727">SCR_021727</ext-link>) at the Cornell Institute of Biotechnology for sequencing experiments, Johana M de la Cruz and the BRC Imaging Facility (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_021741">SCR_021741</ext-link>) at the Cornell Institute of Biotechnology for training and assistance with the Elyra Super Resolution Microscope and the 3D-SIM imaging. We thank Marco Hiler and the BMS and Stem Cell Pathology Unit at the Cornell Veterinary Research Tower for training and assistance with imaging histological sections using ScanScope. We thank Dr. John Schimenti, Dr. Robert Munroe, Mr. Christian Abratte, and Cornell’s Stem Cell and Transgenic Core Facility for generating the <italic>Topbp1<sup>B5/B5</sup></italic> mouse. We thank Dr. Mary Ann Handel for the H1T antibody. This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD095296) to MBS and RW, National Institute of Health – General Medicine (R35-GM141159) to MBS, National Institute of Health (R01HD041012) to PEC, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD104454) to AG, the Spanish Agencia Estatal de Investigación (PID2019-109222RB-I00/AEI/10.13039/501100011033); European Union Regional Funds (FEDER) to RF, and 2022 CVG Scholar Award from the Center of Vertebrates Genomics and the 2022 ASCB International training Scholarship to CFRA.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Alavattam</surname><given-names>KG</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Castrillon</surname><given-names>DH</given-names></name><name><surname>Pang</surname><given-names>Q</given-names></name><name><surname>Andreassen</surname><given-names>PR</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CHEK1 coordinates DNA damage signaling and meiotic progression in the male germline of mice</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>1136</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy022</pub-id><pub-id pub-id-type="pmid">29360988</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Alavattam</surname><given-names>KG</given-names></name><name><surname>Hu</surname><given-names>YC</given-names></name><name><surname>Pang</surname><given-names>Q</given-names></name><name><surname>Andreassen</surname><given-names>PR</given-names></name><name><surname>Hegde</surname><given-names>RS</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Initiation of Meiotic Sex Chromosome Inactivation Sequesters DNA Damage Signaling from Autosomes in Mouse Spermatogenesis</article-title><source>Current Biology</source><volume>30</volume><fpage>408</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2019.11.064</pub-id><pub-id pub-id-type="pmid">31902729</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Yeh</surname><given-names>YH</given-names></name><name><surname>Munakata</surname><given-names>Y</given-names></name><name><surname>Ishiguro</surname><given-names>KI</given-names></name><name><surname>Andreassen</surname><given-names>PR</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Active DNA damage response signaling initiates and maintains meiotic sex chromosome inactivation</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>7212</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-34295-5</pub-id><pub-id pub-id-type="pmid">36443288</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Alavattam</surname><given-names>KG</given-names></name><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Sakashita</surname><given-names>A</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2018">2018</year><chapter-title>X-Chromosome inactivation</chapter-title><person-group person-group-type="editor"><name><surname>Sado</surname><given-names>T</given-names></name></person-group><source>Chromosome Spread Analyses of Meiotic Sex Chromosome inactivationMethods in Molecular Biology</source><publisher-name>Humana Press Inc</publisher-name><fpage>113</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-8766-5</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alavattam</surname><given-names>KG</given-names></name><name><surname>Maezawa</surname><given-names>S</given-names></name><name><surname>Andreassen</surname><given-names>PR</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Meiotic sex chromosome inactivation and the XY body: a phase separation hypothesis</article-title><source>Cellular and Molecular Life Sciences</source><volume>79</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1007/s00018-021-04075-3</pub-id><pub-id pub-id-type="pmid">34971404</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aran</surname><given-names>D</given-names></name><name><surname>Looney</surname><given-names>AP</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>E</given-names></name><name><surname>Fong</surname><given-names>V</given-names></name><name><surname>Hsu</surname><given-names>A</given-names></name><name><surname>Chak</surname><given-names>S</given-names></name><name><surname>Naikawadi</surname><given-names>RP</given-names></name><name><surname>Wolters</surname><given-names>PJ</given-names></name><name><surname>Abate</surname><given-names>AR</given-names></name><name><surname>Butte</surname><given-names>AJ</given-names></name><name><surname>Bhattacharya</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage</article-title><source>Nature Immunology</source><volume>20</volume><fpage>163</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0276-y</pub-id><pub-id pub-id-type="pmid">30643263</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balbo Pogliano</surname><given-names>C</given-names></name><name><surname>Ceppi</surname><given-names>I</given-names></name><name><surname>Giovannini</surname><given-names>S</given-names></name><name><surname>Petroulaki</surname><given-names>V</given-names></name><name><surname>Palmer</surname><given-names>N</given-names></name><name><surname>Uliana</surname><given-names>F</given-names></name><name><surname>Gatti</surname><given-names>M</given-names></name><name><surname>Kasaciunaite</surname><given-names>K</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Seidel</surname><given-names>R</given-names></name><name><surname>Altmeyer</surname><given-names>M</given-names></name><name><surname>Cejka</surname><given-names>P</given-names></name><name><surname>Matos</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The CDK1-TOPBP1-PLK1 axis regulates the Bloom’s syndrome helicase BLM to suppress crossover recombination in somatic cells</article-title><source>Science Advances</source><volume>8</volume><elocation-id>eabk0221</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abk0221</pub-id><pub-id pub-id-type="pmid">35119917</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balmus</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Lyndaker</surname><given-names>AM</given-names></name><name><surname>Hume</surname><given-names>KR</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Riccio</surname><given-names>ML</given-names></name><name><surname>Reeves</surname><given-names>AP</given-names></name><name><surname>Sutter</surname><given-names>NB</given-names></name><name><surname>Noden</surname><given-names>DM</given-names></name><name><surname>Peters</surname><given-names>RM</given-names></name><name><surname>Weiss</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>3408</fpage><lpage>3420</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds173</pub-id><pub-id pub-id-type="pmid">22575700</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastos de Oliveira</surname><given-names>FM</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Cussiol</surname><given-names>JR</given-names></name><name><surname>Das</surname><given-names>J</given-names></name><name><surname>Jeong</surname><given-names>MC</given-names></name><name><surname>Doerfler</surname><given-names>L</given-names></name><name><surname>Schmidt</surname><given-names>KH</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Phosphoproteomics Reveals Distinct Modes of Mec1/ATR Signaling during DNA Replication</article-title><source>Molecular Cell</source><volume>57</volume><fpage>1124</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.01.043</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becherel</surname><given-names>OJ</given-names></name><name><surname>Yeo</surname><given-names>AJ</given-names></name><name><surname>Stellati</surname><given-names>A</given-names></name><name><surname>Heng</surname><given-names>EYH</given-names></name><name><surname>Luff</surname><given-names>J</given-names></name><name><surname>Suraweera</surname><given-names>AM</given-names></name><name><surname>Woods</surname><given-names>R</given-names></name><name><surname>Fleming</surname><given-names>J</given-names></name><name><surname>Carrie</surname><given-names>D</given-names></name><name><surname>McKinney</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>C</given-names></name><name><surname>Lavin</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003435</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003435</pub-id><pub-id pub-id-type="pmid">23593030</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>CL</given-names></name><name><surname>Spada</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2018">2018</year><chapter-title>Senataxin, A novel Helicase at the interface of RNA Transcriptome regulation and Neurobiology: from normal function to pathological roles in motor neuron disease and cerebellar degeneration</chapter-title><person-group person-group-type="editor"><name><surname>Sattler</surname><given-names>R</given-names></name><name><surname>Donnelly</surname><given-names>CJ</given-names></name></person-group><source>RNA Metabolism in Neurodegenerative Diseases</source><publisher-name>Springer International Publishing</publisher-name><fpage>265</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-89689-2_10</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigot</surname><given-names>N</given-names></name><name><surname>Day</surname><given-names>M</given-names></name><name><surname>Baldock</surname><given-names>RA</given-names></name><name><surname>Watts</surname><given-names>FZ</given-names></name><name><surname>Oliver</surname><given-names>AW</given-names></name><name><surname>Pearl</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Phosphorylation-mediated interactions with TOPBP1 couple 53BP1 and 9-1-1 to control the G1 DNA damage checkpoint</article-title><source>eLife</source><volume>8</volume><elocation-id>e44353</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.44353</pub-id><pub-id pub-id-type="pmid">31135337</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackford</surname><given-names>AN</given-names></name><name><surname>Nieminuszczy</surname><given-names>J</given-names></name><name><surname>Schwab</surname><given-names>RA</given-names></name><name><surname>Galanty</surname><given-names>Y</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name><name><surname>Niedzwiedz</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TopBP1 Interacts with BLM to Maintain Genome Stability but Is Dispensable for Preventing BLM Degradation</article-title><source>Molecular Cell</source><volume>57</volume><fpage>1133</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.02.012</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackford</surname><given-names>AN</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response</article-title><source>Molecular Cell</source><volume>66</volume><fpage>801</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.05.015</pub-id><pub-id pub-id-type="pmid">28622525</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broering</surname><given-names>TJ</given-names></name><name><surname>Alavattam</surname><given-names>KG</given-names></name><name><surname>Sadreyev</surname><given-names>RI</given-names></name><name><surname>Ichijima</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Camerini-Otero</surname><given-names>RD</given-names></name><name><surname>Lee</surname><given-names>JT</given-names></name><name><surname>Andreassen</surname><given-names>PR</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>BRCA1 establishes DNA damage signaling and pericentric heterochromatin of the X chromosome in male meiosis</article-title><source>The Journal of Cell Biology</source><volume>205</volume><fpage>663</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1083/jcb.201311050</pub-id><pub-id pub-id-type="pmid">24914237</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>EJ</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>ATR disruption leads to chromosomal fragmentation and early embryonic lethality</article-title><source>Genes &amp; Development</source><volume>14</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1101/gad.14.4.397</pub-id><pub-id pub-id-type="pmid">10691732</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgoyne</surname><given-names>PS</given-names></name><name><surname>Mahadevaiah</surname><given-names>SK</given-names></name><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The consequences of asynapsis for mammalian meiosis</article-title><source>Nature Reviews. Genetics</source><volume>10</volume><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1038/nrg2505</pub-id><pub-id pub-id-type="pmid">19188923</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>M</given-names></name><name><surname>Falcon</surname><given-names>S</given-names></name><name><surname>Pages</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Org. mm. eg. dB: genome wide annotation for Mouse</data-title><version designator="3.8.2">3.8.2</version><source>R Package</source><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/data/annotation/html/org.Mm.eg.db.html">https://bioconductor.org/packages/release/data/annotation/html/org.Mm.eg.db.html</ext-link></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>AT</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Recombination nodules and synaptonemal complex in recombination-defective females of <italic>Drosophila melanogaster</italic></article-title><source>Chromosoma</source><volume>75</volume><fpage>259</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1007/BF00293472</pub-id><pub-id pub-id-type="pmid">119618</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cescutti</surname><given-names>R</given-names></name><name><surname>Negrini</surname><given-names>S</given-names></name><name><surname>Kohzaki</surname><given-names>M</given-names></name><name><surname>Halazonetis</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint</article-title><source>The EMBO Journal</source><volume>29</volume><fpage>3723</fpage><lpage>3732</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.238</pub-id><pub-id pub-id-type="pmid">20871591</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>N</given-names></name><name><surname>Hua</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Sha</surname><given-names>J</given-names></name><name><surname>Griswold</surname><given-names>MD</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Tong</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell RNA-seq uncovers dynamic processes and critical regulators in mouse spermatogenesis</article-title><source>Cell Research</source><volume>28</volume><fpage>879</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1038/s41422-018-0074-y</pub-id><pub-id pub-id-type="pmid">30061742</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cimprich</surname><given-names>KA</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>ATR: an essential regulator of genome integrity</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>9</volume><fpage>616</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1038/nrm2450</pub-id><pub-id pub-id-type="pmid">18594563</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Puget</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>YL</given-names></name><name><surname>Clouaire</surname><given-names>T</given-names></name><name><surname>Aguirrebengoa</surname><given-names>M</given-names></name><name><surname>Rocher</surname><given-names>V</given-names></name><name><surname>Pasero</surname><given-names>P</given-names></name><name><surname>Canitrot</surname><given-names>Y</given-names></name><name><surname>Legube</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>533</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-02894-w</pub-id><pub-id pub-id-type="pmid">29416069</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danielsen</surname><given-names>JMR</given-names></name><name><surname>Larsen</surname><given-names>DH</given-names></name><name><surname>Schou</surname><given-names>KB</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Falck</surname><given-names>J</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>HCLK2 Is Required for Activity of the DNA Damage Response Kinase ATR</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>4140</fpage><lpage>4147</lpage><pub-id pub-id-type="doi">10.1074/jbc.M808174200</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Klein</surname><given-names>A</given-names></name><name><surname>Muijtjens</surname><given-names>M</given-names></name><name><surname>van Os</surname><given-names>R</given-names></name><name><surname>Verhoeven</surname><given-names>Y</given-names></name><name><surname>Smit</surname><given-names>B</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name><name><surname>Lehmann</surname><given-names>AR</given-names></name><name><surname>Hoeijmakers</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice</article-title><source>Current Biology</source><volume>10</volume><fpage>479</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(00)00447-4</pub-id><pub-id pub-id-type="pmid">10801416</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delacroix</surname><given-names>S</given-names></name><name><surname>Wagner</surname><given-names>JM</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Karnitz</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1</article-title><source>Genes &amp; Development</source><volume>21</volume><fpage>1472</fpage><lpage>1477</lpage><pub-id pub-id-type="doi">10.1101/gad.1547007</pub-id><pub-id pub-id-type="pmid">17575048</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durinck</surname><given-names>S</given-names></name><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt</article-title><source>Nature Protocols</source><volume>4</volume><fpage>1184</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.97</pub-id><pub-id pub-id-type="pmid">19617889</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ElInati</surname><given-names>E</given-names></name><name><surname>Russell</surname><given-names>HR</given-names></name><name><surname>Ojarikre</surname><given-names>OA</given-names></name><name><surname>Sangrithi</surname><given-names>M</given-names></name><name><surname>Hirota</surname><given-names>T</given-names></name><name><surname>de Rooij</surname><given-names>DG</given-names></name><name><surname>McKinnon</surname><given-names>PJ</given-names></name><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>DNA damage response protein TOPBP1 regulates X chromosome silencing in the mammalian germ line</article-title><source>PNAS</source><volume>114</volume><fpage>12536</fpage><lpage>12541</lpage><pub-id pub-id-type="doi">10.1073/pnas.1712530114</pub-id><pub-id pub-id-type="pmid">29114052</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eng</surname><given-names>JK</given-names></name><name><surname>Jahan</surname><given-names>TA</given-names></name><name><surname>Hoopmann</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Comet: an open-source MS/MS sequence database search tool</article-title><source>Proteomics</source><volume>13</volume><fpage>22</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1002/pmic.201200439</pub-id><pub-id pub-id-type="pmid">23148064</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falck</surname><given-names>J</given-names></name><name><surname>Coates</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage</article-title><source>Nature</source><volume>434</volume><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1038/nature03442</pub-id><pub-id pub-id-type="pmid">15758953</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanning</surname><given-names>E</given-names></name><name><surname>Klimovich</surname><given-names>V</given-names></name><name><surname>Nager</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A dynamic model for replication protein A (RPA) function in DNA processing pathways</article-title><source>Nucleic Acids Research</source><volume>34</volume><fpage>4126</fpage><lpage>4137</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl550</pub-id><pub-id pub-id-type="pmid">16935876</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>S</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Control of meiotic crossovers: From double-strand break formation to designation</article-title><source>Annual Review of Genetics</source><volume>50</volume><fpage>175</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-120215-035111</pub-id><pub-id pub-id-type="pmid">27648641</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenlee</surname><given-names>AR</given-names></name><name><surname>Shiao</surname><given-names>MS</given-names></name><name><surname>Snyder</surname><given-names>E</given-names></name><name><surname>Buaas</surname><given-names>FW</given-names></name><name><surname>Gu</surname><given-names>T</given-names></name><name><surname>Stearns</surname><given-names>TM</given-names></name><name><surname>Sharma</surname><given-names>M</given-names></name><name><surname>Murchison</surname><given-names>EP</given-names></name><name><surname>Puente</surname><given-names>GC</given-names></name><name><surname>Braun</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Deregulated sex chromosome gene expression with male germ cell-specific loss of Dicer1</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e46359</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0046359</pub-id><pub-id pub-id-type="pmid">23056286</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grive</surname><given-names>KJ</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Shu</surname><given-names>E</given-names></name><name><surname>Grimson</surname><given-names>A</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Grenier</surname><given-names>JK</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dynamic transcriptome profiles within spermatogonial and spermatocyte populations during postnatal testis maturation revealed by single-cell sequencing</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1007810</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007810</pub-id><pub-id pub-id-type="pmid">30893341</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handel</surname><given-names>MA</given-names></name><name><surname>Schimenti</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genetics of mammalian meiosis: regulation, dynamics and impact on fertility</article-title><source>Nature Reviews. Genetics</source><volume>11</volume><fpage>124</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/nrg2723</pub-id><pub-id pub-id-type="pmid">20051984</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwell</surname><given-names>LH</given-names></name><name><surname>Kastan</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Cell cycle control and cancer</article-title><source>Science</source><volume>266</volume><fpage>1821</fpage><lpage>1828</lpage><pub-id pub-id-type="doi">10.1126/science.7997877</pub-id><pub-id pub-id-type="pmid">7997877</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>T</given-names></name><name><surname>Blakeley</surname><given-names>P</given-names></name><name><surname>Sangrithi</surname><given-names>MN</given-names></name><name><surname>Mahadevaiah</surname><given-names>SK</given-names></name><name><surname>Encheva</surname><given-names>V</given-names></name><name><surname>Snijders</surname><given-names>AP</given-names></name><name><surname>ElInati</surname><given-names>E</given-names></name><name><surname>Ojarikre</surname><given-names>OA</given-names></name><name><surname>de Rooij</surname><given-names>DG</given-names></name><name><surname>Niakan</surname><given-names>KK</given-names></name><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SETDB1 Links the Meiotic DNA Damage Response to Sex Chromosome Silencing in Mice</article-title><source>Developmental Cell</source><volume>47</volume><fpage>645</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.10.004</pub-id><pub-id pub-id-type="pmid">30393076</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holloway</surname><given-names>JK</given-names></name><name><surname>Morelli</surname><given-names>MA</given-names></name><name><surname>Borst</surname><given-names>PL</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mammalian BLM helicase is critical for integrating multiple pathways of meiotic recombination</article-title><source>The Journal of Cell Biology</source><volume>188</volume><fpage>779</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1083/jcb.200909048</pub-id><pub-id pub-id-type="pmid">20308424</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holloway</surname><given-names>JK</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Yokoo</surname><given-names>R</given-names></name><name><surname>Villeneuve</surname><given-names>AM</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mammalian CNTD1 is critical for meiotic crossover maturation and deselection of excess precrossover sites</article-title><source>The Journal of Cell Biology</source><volume>205</volume><fpage>633</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1083/jcb.201401122</pub-id><pub-id pub-id-type="pmid">24891606</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichijima</surname><given-names>Y</given-names></name><name><surname>Ichijima</surname><given-names>M</given-names></name><name><surname>Lou</surname><given-names>Z</given-names></name><name><surname>Nussenzweig</surname><given-names>A</given-names></name><name><surname>Camerini-Otero</surname><given-names>RD</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Andreassen</surname><given-names>PR</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MDC1 directs chromosome-wide silencing of the sex chromosomes in male germ cells</article-title><source>Genes &amp; Development</source><volume>25</volume><fpage>959</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1101/gad.2030811</pub-id><pub-id pub-id-type="pmid">21536735</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichijima</surname><given-names>Y</given-names></name><name><surname>Sin</surname><given-names>HS</given-names></name><name><surname>Namekawa</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sex chromosome inactivation in germ cells: emerging roles of DNA damage response pathways</article-title><source>Cellular and Molecular Life Sciences</source><volume>69</volume><fpage>2559</fpage><lpage>2572</lpage><pub-id pub-id-type="doi">10.1007/s00018-012-0941-5</pub-id><pub-id pub-id-type="pmid">22382926</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inselman</surname><given-names>A</given-names></name><name><surname>Eaker</surname><given-names>S</given-names></name><name><surname>Handel</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Temporal expression of cell cycle-related proteins during spermatogenesis: establishing a timeline for onset of the meiotic divisions</article-title><source>Cytogenetic and Genome Research</source><volume>103</volume><fpage>277</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1159/000076813</pub-id><pub-id pub-id-type="pmid">15051948</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>Y</given-names></name><name><surname>Ko</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Ko</surname><given-names>MJ</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Jeon</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Hwang</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>TopBP1 deficiency causes an early embryonic lethality and induces cellular senescence in primary cells</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>5414</fpage><lpage>5422</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.189704</pub-id><pub-id pub-id-type="pmid">21149450</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>MK</given-names></name><name><surname>Kim</surname><given-names>SM</given-names></name><name><surname>Bae</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TopBP1 deficiency impairs the localization of proteins involved in early recombination and results in meiotic chromosome defects during spermatogenesis</article-title><source>Biochemical and Biophysical Research Communications</source><volume>508</volume><fpage>722</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2018.12.001</pub-id><pub-id pub-id-type="pmid">30528234</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>MS</given-names></name><name><surname>Bishop</surname><given-names>DK</given-names></name><name><surname>Börner</surname><given-names>GV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gradual implementation of the meiotic recombination program via checkpoint pathways controlled by global DSB levels</article-title><source>Molecular Cell</source><volume>57</volume><fpage>797</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.12.027</pub-id><pub-id pub-id-type="pmid">25661491</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>M</given-names></name><name><surname>Wells</surname><given-names>D</given-names></name><name><surname>Rusch</surname><given-names>J</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Marchini</surname><given-names>J</given-names></name><name><surname>Myers</surname><given-names>SR</given-names></name><name><surname>Conrad</surname><given-names>DF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Unified single-cell analysis of testis gene regulation and pathology in five mouse strains</article-title><source>eLife</source><volume>8</volume><elocation-id>e43966</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.43966</pub-id><pub-id pub-id-type="pmid">31237565</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakarougkas</surname><given-names>A</given-names></name><name><surname>Ismail</surname><given-names>A</given-names></name><name><surname>Katsuki</surname><given-names>Y</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Shibata</surname><given-names>A</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>10298</fpage><lpage>10311</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt802</pub-id><pub-id pub-id-type="pmid">24013561</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kassambara</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><source>GGPlot2 Essentials: Great Data Visualization in R</source><publisher-name>Independently Published</publisher-name></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keeney</surname><given-names>S</given-names></name><name><surname>Giroux</surname><given-names>CN</given-names></name><name><surname>Kleckner</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Meiosis-specific DNA double-strand breaks are catalyzed by Spo11, a member of a widely conserved protein family</article-title><source>Cell</source><volume>88</volume><fpage>375</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81876-0</pub-id><pub-id pub-id-type="pmid">9039264</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalil</surname><given-names>AM</given-names></name><name><surname>Boyar</surname><given-names>FZ</given-names></name><name><surname>Driscoll</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Dynamic histone modifications mark sex chromosome inactivation and reactivation during mammalian spermatogenesis</article-title><source>PNAS</source><volume>101</volume><fpage>16583</fpage><lpage>16587</lpage><pub-id pub-id-type="doi">10.1073/pnas.0406325101</pub-id><pub-id pub-id-type="pmid">15536132</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolas</surname><given-names>NK</given-names></name><name><surname>Svetlanov</surname><given-names>A</given-names></name><name><surname>Lenzi</surname><given-names>ML</given-names></name><name><surname>Macaluso</surname><given-names>FP</given-names></name><name><surname>Lipkin</surname><given-names>SM</given-names></name><name><surname>Liskay</surname><given-names>RM</given-names></name><name><surname>Greally</surname><given-names>J</given-names></name><name><surname>Edelmann</surname><given-names>W</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Localization of MMR proteins on meiotic chromosomes in mice indicates distinct functions during prophase I</article-title><source>The Journal of Cell Biology</source><volume>171</volume><fpage>447</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1083/jcb.200506170</pub-id><pub-id pub-id-type="pmid">16260499</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I</given-names></name><name><surname>Millard</surname><given-names>N</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Slowikowski</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>Baglaenko</surname><given-names>Y</given-names></name><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Loh</surname><given-names>PR</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fast, sensitive and accurate integration of single-cell data with Harmony</article-title><source>Nature Methods</source><volume>16</volume><fpage>1289</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id><pub-id pub-id-type="pmid">31740819</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumagai</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Yoo</surname><given-names>HY</given-names></name><name><surname>Dunphy</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>TopBP1 activates the ATR-ATRIP complex</article-title><source>Cell</source><volume>124</volume><fpage>943</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.12.041</pub-id><pub-id pub-id-type="pmid">16530042</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>M</given-names></name><name><surname>Leibowitz</surname><given-names>ML</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Small but mighty: the causes and consequences of micronucleus rupture</article-title><source>Experimental &amp; Molecular Medicine</source><volume>52</volume><fpage>1777</fpage><lpage>1786</lpage><pub-id pub-id-type="doi">10.1038/s12276-020-00529-z</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanz</surname><given-names>MC</given-names></name><name><surname>Dibitetto</surname><given-names>D</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DNA damage kinase signaling: checkpoint and repair at 30 years</article-title><source>The EMBO Journal</source><volume>38</volume><elocation-id>e101801</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2019101801</pub-id><pub-id pub-id-type="pmid">31393028</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>X</given-names></name><name><surname>Munusamy</surname><given-names>P</given-names></name><name><surname>Ng</surname><given-names>MJ</given-names></name><name><surname>Sangrithi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-Cell RNA Sequencing of the Cynomolgus Macaque Testis Reveals Conserved Transcriptional Profiles during Mammalian Spermatogenesis</article-title><source>Developmental Cell</source><volume>54</volume><fpage>548</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.07.018</pub-id><pub-id pub-id-type="pmid">32795394</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Leek</surname><given-names>JT</given-names></name><name><surname>Johnson</surname><given-names>WE</given-names></name><name><surname>Parker</surname><given-names>HS</given-names></name><name><surname>Fertig</surname><given-names>EJ</given-names></name><name><surname>Jaffe</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Sva: Surrogate variable analysis</data-title><version designator="10">10</version><source>R Package</source><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/sva">https://bioconductor.org/packages/sva</ext-link></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leimbacher</surname><given-names>PA</given-names></name><name><surname>Jones</surname><given-names>SE</given-names></name><name><surname>Shorrocks</surname><given-names>AMK</given-names></name><name><surname>de Marco Zompit</surname><given-names>M</given-names></name><name><surname>Day</surname><given-names>M</given-names></name><name><surname>Blaauwendraad</surname><given-names>J</given-names></name><name><surname>Bundschuh</surname><given-names>D</given-names></name><name><surname>Bonham</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>R</given-names></name><name><surname>Fink</surname><given-names>D</given-names></name><name><surname>Kessler</surname><given-names>BM</given-names></name><name><surname>Oliver</surname><given-names>AW</given-names></name><name><surname>Pearl</surname><given-names>LH</given-names></name><name><surname>Blackford</surname><given-names>AN</given-names></name><name><surname>Stucki</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>MDC1 Interacts with TOPBP1 to Maintain Chromosomal Stability during Mitosis</article-title><source>Molecular Cell</source><volume>74</volume><fpage>571</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.02.014</pub-id><pub-id pub-id-type="pmid">30898438</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenzi</surname><given-names>ML</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Snowden</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Fishel</surname><given-names>R</given-names></name><name><surname>Poulos</surname><given-names>BK</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Extreme heterogeneity in the molecular events leading to the establishment of chiasmata during meiosis i in human oocytes</article-title><source>American Journal of Human Genetics</source><volume>76</volume><fpage>112</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1086/427268</pub-id><pub-id pub-id-type="pmid">15558497</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>CCY</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Glover</surname><given-names>JNM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>4292</fpage><lpage>4301</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.189555</pub-id><pub-id pub-id-type="pmid">21127055</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipkin</surname><given-names>SM</given-names></name><name><surname>Wang</surname><given-names>V</given-names></name><name><surname>Jacoby</surname><given-names>R</given-names></name><name><surname>Banerjee-Basu</surname><given-names>S</given-names></name><name><surname>Baxevanis</surname><given-names>AD</given-names></name><name><surname>Lynch</surname><given-names>HT</given-names></name><name><surname>Elliott</surname><given-names>RM</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability</article-title><source>Nature Genetics</source><volume>24</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/71643</pub-id><pub-id pub-id-type="pmid">10615123</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Cussiol</surname><given-names>JR</given-names></name><name><surname>Dibitetto</surname><given-names>D</given-names></name><name><surname>Sims</surname><given-names>JR</given-names></name><name><surname>Twayana</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>RS</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Marini</surname><given-names>F</given-names></name><name><surname>Pellicioli</surname><given-names>A</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TOPBP1Dpb11 plays a conserved role in homologous recombination DNA repair through the coordinated recruitment of 53BP1Rad9</article-title><source>Journal of Cell Biology</source><volume>216</volume><fpage>623</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1083/jcb.201607031</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manke</surname><given-names>IA</given-names></name><name><surname>Lowery</surname><given-names>DM</given-names></name><name><surname>Nguyen</surname><given-names>A</given-names></name><name><surname>Yaffe</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>BRCT repeats as phosphopeptide-binding modules involved in protein targeting</article-title><source>Science</source><volume>302</volume><fpage>636</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1126/science.1088877</pub-id><pub-id pub-id-type="pmid">14576432</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maréchal</surname><given-names>A</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DNA damage sensing by the ATM and ATR kinases</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>5</volume><elocation-id>a012716</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a012716</pub-id><pub-id pub-id-type="pmid">24003211</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marnef</surname><given-names>A</given-names></name><name><surname>Legube</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>m6A RNA modification as a new player in R-loop regulation</article-title><source>Nature Genetics</source><volume>52</volume><fpage>27</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0563-z</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modzelewski</surname><given-names>AJ</given-names></name><name><surname>Holmes</surname><given-names>RJ</given-names></name><name><surname>Hilz</surname><given-names>S</given-names></name><name><surname>Grimson</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>AGO4 regulates entry into meiosis and influences silencing of sex chromosomes in the male mouse germline</article-title><source>Developmental Cell</source><volume>23</volume><fpage>251</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2012.07.003</pub-id><pub-id pub-id-type="pmid">22863743</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modzelewski</surname><given-names>AJ</given-names></name><name><surname>Hilz</surname><given-names>S</given-names></name><name><surname>Crate</surname><given-names>EA</given-names></name><name><surname>Schweidenback</surname><given-names>CTH</given-names></name><name><surname>Fogarty</surname><given-names>EA</given-names></name><name><surname>Grenier</surname><given-names>JK</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name><name><surname>Grimson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dgcr8 and Dicer are essential for sex chromosome integrity during meiosis in males</article-title><source>Journal of Cell Science</source><volume>128</volume><fpage>2314</fpage><lpage>2327</lpage><pub-id pub-id-type="doi">10.1242/jcs.167148</pub-id><pub-id pub-id-type="pmid">25934699</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moens</surname><given-names>PB</given-names></name><name><surname>Tarsounas</surname><given-names>M</given-names></name><name><surname>Morita</surname><given-names>T</given-names></name><name><surname>Habu</surname><given-names>T</given-names></name><name><surname>Rottinghaus</surname><given-names>ST</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name><name><surname>Barlow</surname><given-names>C</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The association of ATR protein with mouse meiotic chromosome cores</article-title><source>Chromosoma</source><volume>108</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1007/s004120050356</pub-id><pub-id pub-id-type="pmid">10382071</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monesi</surname><given-names>V</given-names></name></person-group><year iso-8601-date="1965">1965</year><article-title>Differential rate of ribonucleic acid synthesis in the autosomes and sex chromosomes during male meiosis in the mouse</article-title><source>Chromosoma</source><volume>17</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/BF00285153</pub-id><pub-id pub-id-type="pmid">5833946</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mordes</surname><given-names>DA</given-names></name><name><surname>Glick</surname><given-names>GG</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TopBP1 activates ATR through ATRIP and a PIKK regulatory domain</article-title><source>Genes &amp; Development</source><volume>22</volume><fpage>1478</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1101/gad.1666208</pub-id><pub-id pub-id-type="pmid">18519640</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Datta</surname><given-names>A</given-names></name><name><surname>Kolodner</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Multiple functions of MutS- and MutL-related heterocomplexes</article-title><source>PNAS</source><volume>96</volume><fpage>14186</fpage><lpage>14188</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.25.14186</pub-id><pub-id pub-id-type="pmid">10588673</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Driscoll</surname><given-names>M</given-names></name><name><surname>Dobyns</surname><given-names>WB</given-names></name><name><surname>van Hagen</surname><given-names>JM</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling</article-title><source>American Journal of Human Genetics</source><volume>81</volume><fpage>77</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1086/518696</pub-id><pub-id pub-id-type="pmid">17564965</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Driscoll</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mouse models for ATR deficiency</article-title><source>DNA Repair</source><volume>8</volume><fpage>1333</fpage><lpage>1337</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2009.09.001</pub-id><pub-id pub-id-type="pmid">19782648</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>S</given-names></name><name><surname>Maldonado-Linares</surname><given-names>A</given-names></name><name><surname>Marcet-Ortega</surname><given-names>M</given-names></name><name><surname>Rojas</surname><given-names>C</given-names></name><name><surname>Martínez-Marchal</surname><given-names>A</given-names></name><name><surname>Fuentes-Lazaro</surname><given-names>J</given-names></name><name><surname>Lange</surname><given-names>J</given-names></name><name><surname>Jasin</surname><given-names>M</given-names></name><name><surname>Keeney</surname><given-names>S</given-names></name><name><surname>Fernández-Capetillo</surname><given-names>O</given-names></name><name><surname>Garcia-Caldés</surname><given-names>M</given-names></name><name><surname>Roig</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>ATR is required to complete meiotic recombination in mice</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2622</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04851-z</pub-id><pub-id pub-id-type="pmid">29977027</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrilla-Castellar</surname><given-names>ER</given-names></name><name><surname>Arlander</surname><given-names>SJH</given-names></name><name><surname>Karnitz</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Dial 9–1–1 for DNA damage: the Rad9–Hus1–Rad1 (9–1–1) clamp complex</article-title><source>DNA Repair</source><volume>3</volume><fpage>1009</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.dnarep.2004.03.032</pub-id><pub-id pub-id-type="pmid">15279787</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name><name><surname>Weiss</surname><given-names>RS</given-names></name><name><surname>Brieño-Enríquez</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ATR signaling in mammalian meiosis: From upstream scaffolds to downstream signaling</article-title><source>Environmental and Molecular Mutagenesis</source><volume>61</volume><fpage>752</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1002/em.22401</pub-id><pub-id pub-id-type="pmid">32725817</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Arroyo-Martinez</surname><given-names>GA</given-names></name><name><surname>Guo</surname><given-names>MZ</given-names></name><name><surname>Downey</surname><given-names>MS</given-names></name><name><surname>Kelly</surname><given-names>ER</given-names></name><name><surname>Grive</surname><given-names>KJ</given-names></name><name><surname>Mahadevaiah</surname><given-names>SK</given-names></name><name><surname>Sims</surname><given-names>JR</given-names></name><name><surname>Faca</surname><given-names>VM</given-names></name><name><surname>Tsai</surname><given-names>C</given-names></name><name><surname>Schiltz</surname><given-names>CJ</given-names></name><name><surname>Wit</surname><given-names>N</given-names></name><name><surname>Jacobs</surname><given-names>H</given-names></name><name><surname>Clark</surname><given-names>NL</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Turner</surname><given-names>J</given-names></name><name><surname>Lyndaker</surname><given-names>AM</given-names></name><name><surname>Brieno-Enriquez</surname><given-names>MA</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name><name><surname>Weiss</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis</article-title><source>eLife</source><volume>11</volume><elocation-id>e68677</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.68677</pub-id><pub-id pub-id-type="pmid">35133274</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perera</surname><given-names>D</given-names></name><name><surname>Perez-Hidalgo</surname><given-names>L</given-names></name><name><surname>Moens</surname><given-names>PB</given-names></name><name><surname>Reini</surname><given-names>K</given-names></name><name><surname>Lakin</surname><given-names>N</given-names></name><name><surname>Syväoja</surname><given-names>JE</given-names></name><name><surname>San-Segundo</surname><given-names>PA</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>TopBP1 and ATR colocalization at meiotic chromosomes: role of TopBP1/Cut5 in the meiotic recombination checkpoint</article-title><source>Molecular Biology of the Cell</source><volume>15</volume><fpage>1568</fpage><lpage>1579</lpage><pub-id pub-id-type="doi">10.1091/mbc.e03-06-0444</pub-id><pub-id pub-id-type="pmid">14718568</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Riverol</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Bandla</surname><given-names>C</given-names></name><name><surname>García-Seisdedos</surname><given-names>D</given-names></name><name><surname>Hewapathirana</surname><given-names>S</given-names></name><name><surname>Kamatchinathan</surname><given-names>S</given-names></name><name><surname>Kundu</surname><given-names>DJ</given-names></name><name><surname>Prakash</surname><given-names>A</given-names></name><name><surname>Frericks-Zipper</surname><given-names>A</given-names></name><name><surname>Eisenacher</surname><given-names>M</given-names></name><name><surname>Walzer</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Vizcaíno</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences</article-title><source>Nucleic Acids Research</source><volume>50</volume><fpage>D543</fpage><lpage>D552</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab1038</pub-id><pub-id pub-id-type="pmid">34723319</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reini</surname><given-names>K</given-names></name><name><surname>Uitto</surname><given-names>L</given-names></name><name><surname>Perera</surname><given-names>D</given-names></name><name><surname>Moens</surname><given-names>PB</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Syväoja</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>TopBP1 localises to centrosomes in mitosis and to chromosome cores in meiosis</article-title><source>Chromosoma</source><volume>112</volume><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1007/s00412-004-0277-5</pub-id><pub-id pub-id-type="pmid">15138768</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rockmill</surname><given-names>B</given-names></name><name><surname>Fung</surname><given-names>JC</given-names></name><name><surname>Branda</surname><given-names>SS</given-names></name><name><surname>Roeder</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The Sgs1 helicase regulates chromosome synapsis and meiotic crossing over</article-title><source>Current Biology</source><volume>13</volume><fpage>1954</fpage><lpage>1962</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2003.10.059</pub-id><pub-id pub-id-type="pmid">14614820</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Songyang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>52914</fpage><lpage>52918</lpage><pub-id pub-id-type="doi">10.1074/jbc.C300407200</pub-id><pub-id pub-id-type="pmid">14578343</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Casuriaga</surname><given-names>R</given-names></name><name><surname>Santiñaque</surname><given-names>FF</given-names></name><name><surname>Folle</surname><given-names>GA</given-names></name><name><surname>Souza</surname><given-names>E</given-names></name><name><surname>López-Carro</surname><given-names>B</given-names></name><name><surname>Geisinger</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Rapid preparation of rodent testicular cell suspensions and spermatogenic stages purification by flow cytometry using a novel blue-laser-excitable vital dye</article-title><source>MethodsX</source><volume>1</volume><fpage>239</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.mex.2014.10.002</pub-id><pub-id pub-id-type="pmid">26150958</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royo</surname><given-names>H</given-names></name><name><surname>Polikiewicz</surname><given-names>G</given-names></name><name><surname>Mahadevaiah</surname><given-names>SK</given-names></name><name><surname>Prosser</surname><given-names>H</given-names></name><name><surname>Mitchell</surname><given-names>M</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><name><surname>de Rooij</surname><given-names>DG</given-names></name><name><surname>Burgoyne</surname><given-names>PS</given-names></name><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Evidence that meiotic sex chromosome inactivation is essential for male fertility</article-title><source>Current Biology</source><volume>20</volume><fpage>2117</fpage><lpage>2123</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2010.11.010</pub-id><pub-id pub-id-type="pmid">21093264</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Royo</surname><given-names>H</given-names></name><name><surname>Prosser</surname><given-names>H</given-names></name><name><surname>Ruzankina</surname><given-names>Y</given-names></name><name><surname>Mahadevaiah</surname><given-names>SK</given-names></name><name><surname>Cloutier</surname><given-names>JM</given-names></name><name><surname>Baumann</surname><given-names>M</given-names></name><name><surname>Fukuda</surname><given-names>T</given-names></name><name><surname>Höög</surname><given-names>C</given-names></name><name><surname>Tóth</surname><given-names>A</given-names></name><name><surname>de Rooij</surname><given-names>DG</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ATR acts stage specifically to regulate multiple aspects of mammalian meiotic silencing</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>1484</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1101/gad.219477.113</pub-id><pub-id pub-id-type="pmid">23824539</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Pereira</surname><given-names>JM</given-names></name><name><surname>Aguilera</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>R loops: new modulators of genome dynamics and function</article-title><source>Nature Reviews. Genetics</source><volume>16</volume><fpage>583</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1038/nrg3961</pub-id><pub-id pub-id-type="pmid">26370899</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiloh</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>ATM and related protein kinases: safeguarding genome integrity</article-title><source>Nature Reviews. Cancer</source><volume>3</volume><fpage>155</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1038/nrc1011</pub-id><pub-id pub-id-type="pmid">12612651</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>Y-H</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Erdin</surname><given-names>SU</given-names></name><name><surname>Yatsenko</surname><given-names>SA</given-names></name><name><surname>Kloc</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>PJ</given-names></name><name><surname>Meistrich</surname><given-names>ML</given-names></name><name><surname>Rajkovic</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hormad1 mutation disrupts synaptonemal complex formation, recombination, and chromosome segregation in mammalian meiosis</article-title><source>PLOS Genetics</source><volume>6</volume><elocation-id>e1001190</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1001190</pub-id><pub-id pub-id-type="pmid">21079677</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>JR</given-names></name><name><surname>Faça</surname><given-names>VM</given-names></name><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Ascenção</surname><given-names>C</given-names></name><name><surname>Comstock</surname><given-names>W</given-names></name><name><surname>Badar</surname><given-names>J</given-names></name><name><surname>Arroyo-Martinez</surname><given-names>GA</given-names></name><name><surname>Freire</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name><name><surname>Weiss</surname><given-names>RS</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Phosphoproteomics of ATR signaling in mouse testes</article-title><source>eLife</source><volume>11</volume><elocation-id>e68648</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.68648</pub-id><pub-id pub-id-type="pmid">35133275</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solari</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>The behavior of the XY pair in mammals</article-title><source>International Review of Cytology</source><volume>38</volume><fpage>273</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/s0074-7696(08)60928-6</pub-id><pub-id pub-id-type="pmid">4854664</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>VV</given-names></name><name><surname>Hochwagen</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The meiotic checkpoint network: step-by-step through meiotic prophase</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>6</volume><elocation-id>a016675</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a016675</pub-id><pub-id pub-id-type="pmid">25274702</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svetlanov</surname><given-names>A</given-names></name><name><surname>Baudat</surname><given-names>F</given-names></name><name><surname>Cohen</surname><given-names>PE</given-names></name><name><surname>de Massy</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Distinct functions of MLH3 at recombination hot spots in the mouse</article-title><source>Genetics</source><volume>178</volume><fpage>1937</fpage><lpage>1945</lpage><pub-id pub-id-type="doi">10.1534/genetics.107.084798</pub-id><pub-id pub-id-type="pmid">18430927</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>A</given-names></name><name><surname>Schäfer</surname><given-names>J</given-names></name><name><surname>Kuhn</surname><given-names>K</given-names></name><name><surname>Kienle</surname><given-names>S</given-names></name><name><surname>Schwarz</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>G</given-names></name><name><surname>Neumann</surname><given-names>T</given-names></name><name><surname>Johnstone</surname><given-names>R</given-names></name><name><surname>Mohammed</surname><given-names>AKA</given-names></name><name><surname>Hamon</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS</article-title><source>Analytical Chemistry</source><volume>75</volume><fpage>1895</fpage><lpage>1904</lpage><pub-id pub-id-type="doi">10.1021/ac0262560</pub-id><pub-id pub-id-type="pmid">12713048</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Tiedemann</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Gghalves</data-title><version designator="e5c3c79">e5c3c79</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/erocoar/gghalves">https://github.com/erocoar/gghalves</ext-link></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JMA</given-names></name><name><surname>Aprelikova</surname><given-names>O</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Chandramouli</surname><given-names>GVR</given-names></name><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Burgoyne</surname><given-names>PS</given-names></name><name><surname>Deng</surname><given-names>CX</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>BRCA1, histone H2AX phosphorylation, and male meiotic sex chromosome inactivation</article-title><source>Current Biology</source><volume>14</volume><fpage>2135</fpage><lpage>2142</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2004.11.032</pub-id><pub-id pub-id-type="pmid">15589157</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JMA</given-names></name><name><surname>Mahadevaiah</surname><given-names>SK</given-names></name><name><surname>Ellis</surname><given-names>PJI</given-names></name><name><surname>Mitchell</surname><given-names>MJ</given-names></name><name><surname>Burgoyne</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Pachytene asynapsis drives meiotic sex chromosome inactivation and leads to substantial postmeiotic repression in spermatids</article-title><source>Developmental Cell</source><volume>10</volume><fpage>521</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.02.009</pub-id><pub-id pub-id-type="pmid">16580996</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Meiotic sex chromosome inactivation</article-title><source>Development</source><volume>134</volume><fpage>1823</fpage><lpage>1831</lpage><pub-id pub-id-type="doi">10.1242/dev.000018</pub-id><pub-id pub-id-type="pmid">17329371</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Meiotic Silencing in Mammals</article-title><source>Annual Review of Genetics</source><volume>49</volume><fpage>395</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-112414-055145</pub-id><pub-id pub-id-type="pmid">26631513</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernet</surname><given-names>N</given-names></name><name><surname>Mahadevaiah</surname><given-names>SK</given-names></name><name><surname>de Rooij</surname><given-names>DG</given-names></name><name><surname>Burgoyne</surname><given-names>PS</given-names></name><name><surname>Ellis</surname><given-names>PJI</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Zfy genes are required for efficient meiotic sex chromosome inactivation (MSCI) in spermatocytes</article-title><source>Human Molecular Genetics</source><volume>25</volume><fpage>5300</fpage><lpage>5310</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw344</pub-id><pub-id pub-id-type="pmid">27742779</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MDC1 collaborates with TopBP1 in DNA replication checkpoint control</article-title><source>Journal of Cell Biology</source><volume>193</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1083/jcb.201010026</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TopBP1 Controls BLM Protein Level to Maintain Genome Stability</article-title><source>Molecular Cell</source><volume>52</volume><fpage>667</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.10.012</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>T</given-names></name><name><surname>Simko</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>“R package “Corrplot”: visualization of a correlation Matri. ”</data-title><version designator="Version 0.84">Version 0.84</version><source>R Package</source></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Reshaping Data with the reshape Package</article-title><source>Journal of Statistical Software</source><volume>21</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.18637/jss.v021.i12</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name><name><surname>Averick</surname><given-names>M</given-names></name><name><surname>Bryan</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>McGowan</surname><given-names>L</given-names></name><name><surname>François</surname><given-names>R</given-names></name><name><surname>Grolemund</surname><given-names>G</given-names></name><name><surname>Hayes</surname><given-names>A</given-names></name><name><surname>Henry</surname><given-names>L</given-names></name><name><surname>Hester</surname><given-names>J</given-names></name><name><surname>Kuhn</surname><given-names>M</given-names></name><name><surname>Pedersen</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>E</given-names></name><name><surname>Bache</surname><given-names>S</given-names></name><name><surname>Müller</surname><given-names>K</given-names></name><name><surname>Ooms</surname><given-names>J</given-names></name><name><surname>Robinson</surname><given-names>D</given-names></name><name><surname>Seidel</surname><given-names>D</given-names></name><name><surname>Spinu</surname><given-names>V</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Vaughan</surname><given-names>D</given-names></name><name><surname>Wilke</surname><given-names>C</given-names></name><name><surname>Woo</surname><given-names>K</given-names></name><name><surname>Yutani</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Welcome to the Tidyverse</article-title><source>Journal of Open Source Software</source><volume>4</volume><elocation-id>1686</elocation-id><pub-id pub-id-type="doi">10.21105/joss.01686</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widger</surname><given-names>A</given-names></name><name><surname>Mahadevaiah</surname><given-names>SK</given-names></name><name><surname>Lange</surname><given-names>J</given-names></name><name><surname>ElInati</surname><given-names>E</given-names></name><name><surname>Zohren</surname><given-names>J</given-names></name><name><surname>Hirota</surname><given-names>T</given-names></name><name><surname>Pacheco</surname><given-names>S</given-names></name><name><surname>Maldonado-Linares</surname><given-names>A</given-names></name><name><surname>Stanzione</surname><given-names>M</given-names></name><name><surname>Ojarikre</surname><given-names>O</given-names></name><name><surname>Maciulyte</surname><given-names>V</given-names></name><name><surname>de Rooij</surname><given-names>DG</given-names></name><name><surname>Tóth</surname><given-names>A</given-names></name><name><surname>Roig</surname><given-names>I</given-names></name><name><surname>Keeney</surname><given-names>S</given-names></name><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>ATR is a multifunctional regulator of male mouse meiosis</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2621</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04850-0</pub-id><pub-id pub-id-type="pmid">29976923</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtasz</surname><given-names>L</given-names></name><name><surname>Daniel</surname><given-names>K</given-names></name><name><surname>Roig</surname><given-names>I</given-names></name><name><surname>Bolcun-Filas</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Boonsanay</surname><given-names>V</given-names></name><name><surname>Eckmann</surname><given-names>CR</given-names></name><name><surname>Cooke</surname><given-names>HJ</given-names></name><name><surname>Jasin</surname><given-names>M</given-names></name><name><surname>Keeney</surname><given-names>S</given-names></name><name><surname>McKay</surname><given-names>MJ</given-names></name><name><surname>Toth</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mouse HORMAD1 and HORMAD2, two conserved meiotic chromosomal proteins, are depleted from synapsed chromosome axes with the help of TRIP13 AAA-ATPase</article-title><source>PLOS Genetics</source><volume>5</volume><elocation-id>e1000702</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000702</pub-id><pub-id pub-id-type="pmid">19851446</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtasz</surname><given-names>L</given-names></name><name><surname>Cloutier</surname><given-names>JM</given-names></name><name><surname>Baumann</surname><given-names>M</given-names></name><name><surname>Daniel</surname><given-names>K</given-names></name><name><surname>Varga</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Anastassiadis</surname><given-names>K</given-names></name><name><surname>Stewart</surname><given-names>AF</given-names></name><name><surname>Reményi</surname><given-names>A</given-names></name><name><surname>Turner</surname><given-names>JMA</given-names></name><name><surname>Tóth</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Meiotic DNA double-strand breaks and chromosome asynapsis in mice are monitored by distinct HORMAD2-independent and -dependent mechanisms</article-title><source>Genes &amp; Development</source><volume>26</volume><fpage>958</fpage><lpage>973</lpage><pub-id pub-id-type="doi">10.1101/gad.187559.112</pub-id><pub-id pub-id-type="pmid">22549958</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Qiao</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A hypothesis: Linking phase separation to meiotic sex chromosome inactivation and sex-body formation</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>674203</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.674203</pub-id><pub-id pub-id-type="pmid">34485277</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival</article-title><source>Molecular and Cellular Biology</source><volume>22</volume><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.2.555-566.2002</pub-id><pub-id pub-id-type="pmid">11756551</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>AJ</given-names></name><name><surname>Becherel</surname><given-names>OJ</given-names></name><name><surname>Luff</surname><given-names>JE</given-names></name><name><surname>Graham</surname><given-names>ME</given-names></name><name><surname>Richard</surname><given-names>D</given-names></name><name><surname>Lavin</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Senataxin controls meiotic silencing through ATR activation and chromatin remodeling</article-title><source>Cell Discovery</source><volume>1</volume><elocation-id>15025</elocation-id><pub-id pub-id-type="doi">10.1038/celldisc.2015.25</pub-id><pub-id pub-id-type="pmid">27462424</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>ZW</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>TL</given-names></name><name><surname>Bruhn</surname><given-names>C</given-names></name><name><surname>Krueger</surname><given-names>A</given-names></name><name><surname>Min</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>ZQ</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name><name><surname>Horwitz</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>An essential function for the ATR-activation-domain (AAD) of TopBP1 in mouse development and cellular senescence</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003702</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003702</pub-id><pub-id pub-id-type="pmid">23950734</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">p3xflag-TOPBP1-Flag-N-terminal-F</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">attcatcgatagatctgataAT<break/>GTCCAGAAATGACAAAGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">p3xflag-TOPBP1-Flag-N-terminal-R</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tagagtcgactggtaccgatttag<break/>TGTACTCTAGGTCGTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>TOPBP1</italic>_K1317A_R</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Site-directed mutagenesis</td><td align="left" valign="bottom">tgccactgaggctaaatacg<break/>cctcgtttcgaagtggatgt</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>TOPBP1</italic>_K1317A_F</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Site-directed mutagenesis</td><td align="left" valign="bottom">acatccacttcgaaacgagg<break/>cgtatttagcctcagtggca</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>TOPBP1</italic>_K155A_F</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Site-directed mutagenesis</td><td align="left" valign="bottom">caggtttgcagcaactaaat<break/>atgctttgctaccaacttctcctgca</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>TOPBP1</italic>_K155A_R</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Site-directed mutagenesis</td><td align="left" valign="bottom">tgcaggagaagttggtagcaaa<break/>gcatatttagttgctgcaaacctg</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>TOPBP1</italic>_K250A_R</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Site-directed mutagenesis</td><td align="left" valign="bottom">tctcttggcacactcatacg<break/>cctgaccttttggttcttgc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>TOPBP1</italic>_K250A_F</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">Site-directed mutagenesis</td><td align="left" valign="bottom">gcaagaaccaaaaggtcagg<break/>cgtatgagtgtgccaagaga</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Topbp1</italic>_BRCT5-Fwd genotyping</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">tgcatttccattaaccaacctc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Topbp1</italic>_BRCT5 Rev genotyping</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">PCR primer</td><td align="left" valign="bottom">ggtagagttcaaatgtgtgtcatg</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho H2A.X (Ser139)<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Cat# 05-636; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_309864">AB_309864</ext-link></td><td align="left" valign="bottom">IF (meiotic spreads) 1:50,000<break/>IF 1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SCP3 antibody<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab97672; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10678841">AB_10678841</ext-link></td><td align="left" valign="bottom">IF (meiotic spreads) 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SYCP3<break/>(rabbit polyclonal)</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib60">Lenzi et al., 2005</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads) 1:10,000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SCP1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab15090</td><td align="left" valign="bottom">IF (meiotic spreads) 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Rad51<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">PC130</td><td align="left" valign="bottom">IF (meiotic spreads) 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ATR<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Cell signaling</td><td align="char" char="." valign="bottom">2790</td><td align="left" valign="bottom">IF (meiotic spreads) 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TOPBP1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib24">Danielsen et al., 2009</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:500<break/>Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-Chk1 (ser317)<break/>(rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="char" char="." valign="bottom">12302</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:100<break/>Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H1T<break/>(guinea pig polyclonal)</td><td align="left" valign="bottom">A gift from Dr. Mary Ann Handel; <xref ref-type="bibr" rid="bib43">Inselman et al., 2003</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HORMAD2<break/>(rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib108">Wojtasz et al., 2012</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-HORMAD1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib108">Wojtasz et al., 2012</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Phospho HORMAD2 (S271)<break/>(rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib107">Wojtasz et al., 2009</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GAPDH<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">AM4300</td><td align="left" valign="bottom">Western blot 1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-actin<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="char" char="." valign="bottom">4967</td><td align="left" valign="bottom">Western blot 1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho MDC1 (T4)<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab35967</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SETX<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab220827</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-MLH1<break/>(mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="char" char="." valign="bottom">550838</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-MLH3<break/>(guinea pig polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Holloway et al., 2014</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CHK1<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-8408</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CHK2<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Millipore</td><td align="char" char="ndash" valign="bottom">05-649 (clone7)</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho CHK1 (S345)<break/>(rabbit polyclonal)</td><td align="left" valign="bottom"> Cell Signaling</td><td align="char" char="." valign="bottom">2341</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200<break/>Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho RPA (S4/S8)<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Bethyl</td><td align="left" valign="bottom">A300-245A</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">RPA (made against full length RPA2 expressed and purified in <italic>E. coli,</italic> and injected to rabbit)<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-KAP1<break/>(rabbit monoclonal)</td><td align="left" valign="bottom">Bethyl</td><td align="left" valign="bottom">a700-014-T</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho KAP1 (S824)<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Bethyl</td><td align="left" valign="bottom">A300-767A-T</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-53BP1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="char" char="." valign="bottom">4937</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-53BP1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Novus Biologicals</td><td align="left" valign="bottom">NB100-304</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-BLM<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab2179</td><td align="left" valign="bottom">Western blot 1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Rad9<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Bethyl</td><td align="left" valign="bottom">A300-890A-T</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-BRCA1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Kakarougkas et al., 2013</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-BRCA1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Proteintech</td><td align="char" char="ndash" valign="bottom">22362-1-AP</td><td align="left" valign="bottom">Western blot 1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-MDC1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib68">Modzelewski et al., 2015</xref></td><td align="left" valign="bottom">Custom</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200<break/>IF<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RNA pol 2<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Millipore</td><td align="char" char="ndash" valign="bottom">05-623</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho RNA pol 2 (Ser2)<break/>(rat monoclonal)</td><td align="left" valign="bottom">Millipore</td><td align="char" char="ndash" valign="bottom">04-1571</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:400</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho RNA pol 2 (Ser5)<break/>(rat monoclonal)</td><td align="left" valign="bottom">Millipore</td><td align="char" char="ndash" valign="bottom">04-1572</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:400</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H3K9ac<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abclonal</td><td align="left" valign="bottom">A7255</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H3K9me3<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Active Motif</td><td align="char" char="." valign="bottom">39766</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H3K4me1<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abclonal</td><td align="left" valign="bottom">A2355</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CHD4<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abclonal</td><td align="left" valign="bottom">A10557</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Sumo_2/3<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Proteintech</td><td align="char" char="ndash" valign="bottom">11251-1-AP</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-USP7<break/>(mouse monoclonal)</td><td align="left" valign="bottom">Proteintech</td><td align="char" char="ndash" valign="bottom">66514-1-Ig</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H3K27ac<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Active Motif</td><td align="char" char="." valign="bottom">39134</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H3K36ac<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Active Motif</td><td align="char" char="." valign="bottom">61102</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H3K4me3<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Active Motif</td><td align="char" char="." valign="bottom">39160</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H4K16ac<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Abclonal</td><td align="left" valign="bottom">A5280</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H4c<break/>(rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="char" char="ndash" valign="bottom">06-598</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H2AK199ub<break/>(rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab193203</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit IgG (H+L) highly cross-adsorbed secondary antibody, Alexa Fluor 488<break/>(goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A-11034</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-mouse IgG (H+L) antibody, Alexa Fluor 488 conjugated<break/>(goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A-11017</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit IgG (H+L) antibody, Alexa Fluor 594 conjugated<break/>(goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A-11012</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-mouse IgG (H+L) highly cross-adsorbed secondary antibody, Alexa Fluor Plus 594<break/>(goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A32742</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-guinea pig IgG (H+L) highly cross-adsorbed secondary antibody, Alexa Fluor 647<break/>(goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A-21450</td><td align="left" valign="bottom">IF (meiotic spreads)<break/>1:1000</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ApopTag Plus Peroxidase In Situ Apoptosis Kit</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">S7101</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 9</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cellranger v7.0.0</td><td align="left" valign="bottom">10X Genomics</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/downloads/3.1">https://support.10xgenomics.com/single-cell-gene-expression/software/downloads/3.1</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R v4.2.1</td><td align="left" valign="bottom">R Foundation</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001905">SCR_001905</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seurat v4.3.0</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib36">Hao et al., 2021</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007322">SCR_007322</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">sva v3.44.0</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib58">Leek et al., 2023</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_012836">SCR_012836</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">SingleR v1.10.0</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib6">Aran et al., 2019</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_023120">SCR_023120</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Reshape2 v1.4.4</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib104">Wickham, 2007</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_022679">SCR_022679</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">biomaRt v2.52.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Durinck et al., 2009</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_019214">SCR_019214</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ggpubr v0.5.0</td><td align="char" char="." valign="bottom"><xref ref-type="bibr" rid="bib49">Kassambara, 2019</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_021139">SCR_021139</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Tidyverse v1.3.2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib105">Wickham et al., 2019</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_019186">SCR_019186</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ggnewscale v0.4.8</td><td align="left" valign="bottom">Campitelli</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://eliocamp.github.io/ggnewscale/index.html">https://eliocamp.github.io/ggnewscale/index.html</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Harmony v0.1.1</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib53">Korsunsky et al., 2019</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_022206">SCR_022206</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Org.Mm.eg.db v3.15.0</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Carlson et al., 2019</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_023488">SCR_023488</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Corrplot v0.92</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib103">Wei and Simko, 2017</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_023081">SCR_023081</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">SeuratWrappers v0.3.1</td><td align="left" valign="bottom">Satija Lab</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_022555">SCR_022555</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">gghalves v0.1.4</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib95">Tiedemann, 2022</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/erocoar/gghalves">https://github.com/erocoar/gghalves</ext-link></td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90887.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shinohara</surname><given-names>Akira</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Osaka University</institution><country>Japan</country></aff></contrib></contrib-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> study reports a new mutant mouse line with compromised function of a DNA damage response protein. The evidence supporting the conclusion that the mutants display defective maintenance of meiotic sex chromosome inactivation is <bold>solid</bold>. This work is of interest to biomedical researchers working on meiosis and meiotic sex chromosome inactivation.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90887.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>This is a very well-written and performed study describing a TOPBP1 separation of function mutation, resulting in defective MSCI maintenance but normal sex body formation. The phenotype differs from that of a previous TOPBP1 null allele, in which both MSCI and sex body formation were defective. Additional defects in CHK phosphorylation and SETX localization are also described.</p><p>Strengths:</p><p>The study is very rigorous, with a remarkably large number spectrum of techniques deployed to support the conclusions</p><p>Weaknesses</p><p>The study claims that MSCI is initiated but not maintained in the mutant. I think alternative hypotheses are possible.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90887.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This paper described the role of BRCT repeat 5 in TOPBP1, a DNA damage response protein, in the maintenance of meiotic sex chromosome inactivation (MSCI). By analyzing a Topbp1 mutant mouse with amino acid substitutions in BRCT repeat 5, the authors found reduced phosphorylation of a DNA/RNA helicase, Sentaxin, and decreased localization of the protein to the X-Y sex body in pachynema. Moreover, the authors also found decreased repression of several genes on the sex chromosomes in the male mice.</p><p>Strengths:</p><p>The works including phospho-proteomics and single-cell RNA sequencing with lots of data have been done with great care and most of the results are convincing.</p><p>Weaknesses:</p><p>No weakness.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90887.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The work presented by Ascencao and coworkers aims to deepen into the process of sex chromosome inactivation during meiosis (MSCI) as a critical factor in the regulation of meiosis progression in male mammals. For this purpose, they have generated a transgenic mouse model in which a specific domain of TOPBP1 protein has been mutated, hampering the binding of a number of protein partners and interfering with the regulatory cascade initiated by ATR. Through the use of immunolocalization of an impressive number of markers of MSCI, phosphoproteomics and single cell RNA sequencing (scRNAseq), the authors are able to show that despite a proper morphological formation of the sex body and the incorporation of most canonical MSCI makers, sex chromosome-liked genes are reactivated at some point during pachytene and this triggers meiosis progression breakdown, likely due to a defective phosphorylation of the helicase SETX.</p><p>The manuscript presents a clear advance in the understanding of MSCI and meiosis progression with two main strengths. First, the generation of a mouse model with a very uncommon phenotype. Second, the use of a vast methodological approach. The results are well presented and illustrated. Nevertheless, the discussion could be still a bit tuned by the inclusion of some ideas, and perhaps speculations, that have not been considered.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90887.3.sa4</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ascenção</surname><given-names>Carolline</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Sims</surname><given-names>Jennie R</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Dziubek</surname><given-names>Alexis</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Comstock</surname><given-names>William</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Fogarty</surname><given-names>Elizabeth A</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Badar</surname><given-names>Jumana</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Freire</surname><given-names>Raimundo</given-names></name><role specific-use="author">Author</role><aff><institution>Hospital Universitario de Canarias</institution><addr-line><named-content content-type="city">Tenerife</named-content></addr-line><country>Spain</country></aff></contrib><contrib contrib-type="author"><name><surname>Grimson</surname><given-names>Andrew</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Weiss</surname><given-names>Robert S</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Cohen</surname><given-names>Paula Elaine</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Smolka</surname><given-names>Marcus B</given-names></name><role specific-use="author">Author</role><aff><institution>Cornell University</institution><addr-line><named-content content-type="city">Ithaca</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:F</bold></p><p><bold>Reviewer #1 (Public Review):</bold></p><p>Summary:</p><p>This is a very well written and performed study describing a TOPBP1 separation of function mutation, resulting in defective MSCI maintenance but normal sex body formation. The phenotype differs from that of a previous TOPBP1 null allele, in which both MSCI and sex body formation were defective. Additional defects in CHK phosphorylation and SETX localization are also described.</p><p>Strengths:</p><p>The study is very rigorous, with a remarkably large number of MSCI marks assayed, phosphoproteomics (leading to the interesting SETX discovery) and 10X RNAseq, allowing the MSCI phenotype to be further deconvolved. The approaches in most cases are robust.</p><p>Weaknesses:</p><p>There aren't many; please find list below:</p><p>1. The authors are committed to the idea that maintenance of MSCI is the major defect here. However, based on the data, an alternative would be that some cells achieve sex body formation and MSCI normally, while others do not. It would only take a small percentage of cells exhibiting MSCI failure to kill all the cells in the same germinal epithelium, so this could still explain the complete pachytene block. This isn't a major point...this phenotype is clearly different to the TOPBP1 KO, but a broader discussion of possibilities in the discussion would help. I raise this in the context of both the cytology and 10X analysis:</p><p>(a) The assessment that sex body formation is normal is based on cytology in Figure 3-figure supplement 3 and Figure 3-figure supplement 4, but a more rigorous approach would be to assess condensation of the XY pair in stage-matched spread cells (maybe they have that data already) by measuring distances between the X and Y centromere, or looking at stage IV of the seminiferous cycle, where all cells should have oval sex bodies but sex body mutants have persistent elongated XY pairs (see work of Namekawa and Turner). The authors do actually mention that gH2AX spreading is defective in many cells....and if this is true, condensation to form a sex body would almost certainly not have taken place in those cells.</p></disp-quote><p>We appreciate the reviewer’s comment and have performed the experiment suggested, counting the number of elongated sex bodies in all sex body-positive cells in seminiferous tubules stained with γH2AX and DAPI (as done by Turner in Hirota et al., 2018). The experiment did not show significant differences between <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> as shown in Author response image 1.</p><fig id="sa4fig1" position="float"><label>Author response image 1.</label><caption><title><italic>Topbp1<sup>B5/B5</sup></italic> displays normal condensation of the XY-pair.</title><p>(A) Immunostaining of XY condensation in <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> testes sections (γH2AX: green and DAPI: gray). (B) Quantification of all sex body-positive cells per tubule (<italic>Topbp1<sup>+/+</sup></italic> number of cells counted = 781, number of tubules counted = 28, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells counted = 967, number of tubules counted = 28, number of mice = 3). (C) Quantification of elongated-sex body cells per tubule (<italic>Topbp1<sup>+/+</sup></italic> number of cells counted = 19 and 762 normal round/oval-sex bodies cells, number of tubules counted = 28, number of mice = 3; <italic>Topbp1<sup>B5/B5</sup></italic> number of cells counted = 45 and 922 normal round/oval-sex bodies cells, number of tubules counted = 28, number of mice = 3).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-sa4-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>(b) Regarding the 10X data, the finding that expression of some XY genes is elevated and others are not is also consistent with a &quot;partial&quot; phenotype (some cells have normal XY bodies and MSCI, others fail in both). In Fig 6E, X expression looks to be elevated in B5 vs wt at all stages...if this were a maintenance issue, shouldn't it be equal to that in wt and then elevate later?</p></disp-quote><p>We understand the point raised by the reviewer, however we do not favor the “partial” phenotype model because of the absence of any post-pachytene spermatocytes in the B5 mutant. If some cells had escaped the MSCI defect, we would expect to detect cells progressing further in meiosis. Because we cannot rule out completely the possibility of a subtle disruption in XY silencing initiation, we decided to better emphasize this point in the discussion (lines 391-394).</p><p>In Figure 6E, the X-linked genes were normalized against chromosome 9-linked genes. The normalization against pre-leptotene was done for the results displayed on Figure 7, in which we demonstrate the maintenance issue. Furthermore, for the 10X analysis, while the same number of cells were loaded for wild-type and mutant, the composition of cells varied between these two samples. Despite the fact that very few “spermatocyte 3” cells were detected in the mutant, those cells displayed much higher X-linked gene expression than the wild-type spermatocyte 3 cells.</p><disp-quote content-type="editor-comment"><p>1. How is the quantitation showing impaired localization of select markers (e.g. SETX) normalized? How do we know that the antibody staining simply didn't work as well on the mutant slides?</p></disp-quote><p>The quantification showing impaired localization of the selected markers such as SETX was done as described by Sims, et al. 2022 and Adams, et al. 2018. In brief, the green signal was measured along (XY cores) or across (XY DNA loops) the X and Y chromosomes and normalized against the analogous signal on the autosomal chromosomes. The possibility that the antibody simply did not work as well on the mutant is unlikely since multiple biological replicates were performed and we reproducibly followed standard practices in the field for meiotic spreads staining, imaging, and quantification. We also note that our findings published in Sims et al, 2022 show that ATR inhibition strongly impairs SETX localization to the sex body, further substantiating our claim that signaling via ATR-TOPBP1 controls SETX.</p><disp-quote content-type="editor-comment"><p>1. Is testis TOPBP1 protein expression reduced in the B5 mutant?</p></disp-quote><p>TOPBP1 protein abundance in the B5 mutant is reduced in lysates from whole testis, measured via western blot. We did not detect a significant reduction in TOPBP1 signal intensity measured by immunofluorescence in pachytene spreads of the B5 mutant.</p><disp-quote content-type="editor-comment"><p>1. 10X analysis: how were the genes on the y-axis in Figure 6-figure supplement 13 arranged? Is this by location on the X chromosome?</p></disp-quote><p>These genes were sorted by location across the chromosome X.</p><disp-quote content-type="editor-comment"><p>1. The final analyses in Fig 7: X-genes are subdivided based on their behavior (up, down, unchanged). What isn't clear to me is whether the authors have considered the fact that there are global changes in gene expression during meiosis (very low in lep , zyg and early pach, then ramps up hugely from mid pach). In other words, is this normalized to autosomal gene expression?</p></disp-quote><p>For the final analysis in Fig7, the normalization was done by their expression at the pre-leptotene stage. Moreover, the analysis was made comparing X-linked gene behavior in Wild-type vs B5 mutant.</p><disp-quote content-type="editor-comment"><p>1. Again regarding the 10X analysis, my prediction would be that not ALL X and Y gene would increase in pach if MSCI were ablated...we should remember that XY genes have been subject to MSCI for some 160 million years of evolution, and this will mean that many enhancers that originally drove their expression prior to the evolution of MSCI will now be lost. This has been our experience: many XY genes aren't elevated at pach even in mutants in which MSCI is totally defective. I'd urge the authors to consider this possibility when they use XY gene expression patterns to diagnose the severity or timing of the MSCI phenotype. This could be a discussion point.</p></disp-quote><p>We greatly appreciate the reviewer’s suggestion and have added discussion about this point to lines 392400.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>Summary:</p><p>This paper described the role of BRCT repeat 5 in TOPBP1, a DNA damage response protein, in the maintenance of meiotic sex chromosome inactivation (MSCI). By analyzing a Topbp1 mutant mouse with amino acid substitutions in BRCT repeat 5, the authors found reduced phosphorylation of a DNA/RNA helicase, Sentaxin, and decreased localization of the protein to the X-Y sex body in pachynema. Moreover, the authors also found decreased repression of several genes on the sex chromosomes in the male mice.</p><p>Strengths:</p><p>The works including phospho-proteomics and single-cell RNA sequencing with lots of data have been done with great care and most of the results are convincing.</p><p>Weaknesses:</p><p>One concern is that, although the Topbp1 mutant spermatocytes show very severe defects after the stage of late pachynema, the defect in the gene silencing in the sex body is relatively weak. It is a bit difficult to explain how such a weak mis regulation of the gene silencing in mice causes the complete loss of cells in the late stage of spermatogenesis.</p></disp-quote><p>We appreciate the reviewer’s comment. We note that even subtle mis-regulation of XY gene silencing has been reported to lead to significant loss of cells in late stage of prophase I (Ichijima et al., 2011; Modzelewski et al., 2012). Moreover, it is possible that some cells with drastic changes in X-gene expression were excluded from the downstream analysis due to high levels of mitochondrial gene expression (cells that were likely dying due to apoptosis). The exclusion of cells with high levels of mitochondrial gene expression is a common practice in downstream analysis of sc-RNA sequencing data.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public Review):</bold></p><p>The work presented by Ascencao and coworkers aims to deepen into the process of sex chromosome inactivation during meiosis (MSCI) as a critical factor in the regulation of meiosis progression in male mammals. For this purpose, they have generated a transgenic mouse model in which a specific domain of TOPBP1 protein has been mutated, hampering the binding of a number of protein partners and interfering with the regulatory cascade initiated by ATR. Through the use of immunolocalization of an impressive number of markers of MSCI, phosphoproteomics and single cell RNA sequencing (scRNAseq), the authors are able to show that despite a proper morphological formation of the sex body and the incorporation of most canonical MSCI makers, sex chromosome-liked genes are reactivated at some point during pachytene and this triggers meiosis progression breakdown, likely due to a defective phosphorylation of the helicase SETX.</p><p>The manuscript presents a clear advance in the understanding of MSCI and meiosis progression with two main strengths. First, the generation of a mouse model with a very uncommon phenotype. Second, the use of a vast methodological approach. The results are well presented and illustrated. Nevertheless, the discussion could be still a bit tuned by the inclusion of some ideas, and perhaps speculations, that have not been considered.</p></disp-quote><p>We appreciate the reviewer’s comment and have improved the discussion section addressing the points raised in the “recommendation For the Authors”.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>I don't have any additional points here</p><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>The paper by Ascencao et al. describes a separation-in-function allele of TOPBP1 critical for DNA damage response (DDR) that confers a specific defect in XY sex chromosome inactivation during male mouse meiosis. The authors constructed a Topbp1 separation-of-function mouse by introducing amino acid substitutions in BRCT repeat 5 and found the mice with normal DDR response in mitosis and meiosis show male infertility. Topbp1(B5/B5) mice do not contain spermatocytes after diplonema, as a result, little spermatids/sperms. In the mice, most of the meiotic events in prophase I including chromosome synapsis and meiotic recombination as well as the formation of the sex body are normal. The detailed proteomic analysis revealed the reduced ATR-dependent phosphorylation of a DNA/RNA helicase, Sentaxin. And also single-cell RNA sequencing found that the expression of some of genes from sex chromosomes are not silenced well compared to the control. The works with lots of data have been done with great care and most of the results are convincing. One clear concern is that, although the authors nicely showed a defect in gene silencing in sex chromosomes in the Topbp1(B5/B5) mice, how a small defect in the gene silencing leads to the complete loss of diplotene spermatocytes remains unaddressed.</p><p>Major points:</p><p>Although the authors showed a change in the transcriptome in spermatocytes of Topbp1(B5/B5) male mice, the authors cannot explain the complete lack of spermatids in this mouse. Even the transcriptome seems not to provide a clue.</p><p>1. Given that the TOPBP1-B5 protein cannot bind to both 53BP1 and BLM, it is interesting to check the localization of both proteins on meiotic chromosome spreads (in the case of 53BP1, the localization in MEFs with DNA damage).</p></disp-quote><p>We appreciate the reviewer’s comment. We have tried to stain BLM in meiotic spreads using several different antibodies, however we were not successful getting specific signals for BLM. In the case of 53BP1, we monitored its localization, and it was not significantly different from <italic>Topbp1<sup>+/</sup></italic><sup>+</sup> meiotic spreads, please refer to Figure 4-supplement figure 1. While we appreciate the reviewer’s suggestion of looking at the localization of 53BP1 in MEFs with DNA damage, we opted not to perform the experiment because we have shown that 53BP1 can still bind the BRCT 1 and 2 domains of TOPBP1 as previously described (Bigot et al., 2019; Cescutti et al., 2010; Liu et al., 2017). Additionally, both male and female 53BP1 KO mice are fertile (Ward et al., 2003), thus the partial disruption in binding to 53BP1 that we observed in TOPBP1 B5 mutant is likely not causing the infertility phenotype.</p><disp-quote content-type="editor-comment"><p>1. A recent preprint by Fujiwara et al. (doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2023.04.12.536672">https://doi.org/10.1101/2023.04.12.536672</ext-link>) showed the accumulation of R-loops in spermatocyte spreads in Senataxin knockout mice. The authors may check the R-loop on the sex body in Topbp1-B5 mice.</p></disp-quote><p>We thank the reviewer for the suggestion. We have tried several protocols to stain R-loops (including the protocol used in the paper mentioned above) but were not successful.</p><disp-quote content-type="editor-comment"><p>1. The authors need to check the protein level (and band shift) of Senataxin in the testis by western blotting analysis.</p></disp-quote><p>We have tried several SETX antibodies, and none worked for western blot analysis.</p><disp-quote content-type="editor-comment"><p>1. If possible, the authors can see any protein interaction between TOPBP1 and Senataxin.</p></disp-quote><p>We appreciate the suggestion, and we will investigate this interaction in future work.</p><disp-quote content-type="editor-comment"><p>1. The authors need to check the statistics in the paper.</p></disp-quote><p>(1) It is better to show actual P-values in the case of &quot;ns&quot;.</p><p>P-values were added to the respective figure legends.</p><p>(2) In focus counting such as Figures 3D, G, H, 4B, D, F, H, 5E, and F (and in Supplemental Figures), please indicate how many spreads were counted in each mouse. Moreover, the distribution of focus numbers and intensity of fluorescence are not parametric (not normal distribution). It is better to use a non-parametric method such as Mann-Whitney's U test.</p><p>We appreciate the reviewer's comment and upon consulting with a Statistician at Cornell Statistical Consulting Unit (CSCU), we were advised to use a linear mixed effect model to take into account the variability in cells within each mouse when comparing mice between groups (<italic>Topbp1<sup>+/+</sup></italic> vs <italic>Topbp1<sup>B5/B5</sup></italic>). We then reanalyzed all quantified meiotic spreads using this mixed effect model, and the p-value, number of mice, and number of cells counted for each group are displayed in the respective figure legends. Upon going through all the quantified meiotic spreads, we realized a minor error in one of the previous data points related to SETX staining in <italic>Topbp1<sup>+/+</sup></italic> and have fixed it. Using the previous quantification data and the new stats analysis the p-value for cores was 0.5598 and *p-value for loops was 0.0273. Now using the correct values and the new stats analysis the p-value for cores is 0.5987 and *p-value for loops is 0.0452. The correction did not change the conclusion of this data and is now displayed in the new Figure 5. We also realized a mistake in the ATR quantification when the spreadsheet was moved from excel to Graphpad. Using the previous quantification and the new stats analysis the p-value for cores was 0.2451 and p-value for loops was 0.8933. Now using the correct values and the new stats analysis the p-value for cores is 0.4068 and p-value for loops is 0.9396. The correction did not change the conclusion of this data and is now displayed in the new Figure 4. Moreover, we realized that we used n = 8 (n = number of mice) for MDC1 quantification and n = 2 for pCHK1_S345, instead of n = 3 as shown in the preprint version of the manuscript. Corrected values were added to their respective figures and figure legends.</p><p>(3) From Figures 6E, 7B, and 7C, the authors conclude the difference in the expression profile between wild type and Topbp1(B5) spermatocytes. It is better to show P-values for the comparison. Particularly, in Figure 7C, Xiap expression kinetics look similar between wild type and the mutant.</p><p>We have added p-values to figures 6E and 7B and their respective figures or figure legends.</p><p>In figure 7C, we now recognize that the Δ could have been misleading as we meant to compare Wild-type SP2 to Wild-type SP3 and Mutant SP2 to SP3; and not comparing Wild-type SP3 to Mutant SP3.Therefore, the Δ was excluded from Figure 7C. For the comparisons between expression levels of SP2 and SP3, it is challenging to calculate p-values for a single gene since these cells have started X-gene silencing and expression values are very low. Meaningful p-values for the comparisons between Wildtype SP3 to Mutant SP3 can be visualized in Figure 7B, where the comparison is based on number of genes instead of expression levels of each gene.</p><disp-quote content-type="editor-comment"><p>Minor comments:</p><p>1. Line 34: SPO11 is NOT a nuclease. Just delete it.</p></disp-quote><p>It has been deleted (see line 34).</p><disp-quote content-type="editor-comment"><p>1. Line 71, a protein: Is this protein ATR? Is so, please write it. If not, please give the name of the protein.</p></disp-quote><p>In line 71 (now lines 79-80), we refer to TOPBP1-interacting proteins in general since many of these interactions happen through a phosphorylation in the TOPBP1’s interactor. This is the case for BLM, 53BP1, FANCJ, and RAD9. ATR interacts with TOPBP1 through TOPBP1’s AAD domain and this is not a phospho-mediated interaction. We restructured the sentence for clarity.</p><disp-quote content-type="editor-comment"><p>1. In the Introduction, the authors often refer to a review by Cimprich and Cortez (2008) in various places. It is better to cite an original paper or the other an appropriate review.</p></disp-quote><p>We have accepted the reviewer’s suggestion and added original papers when appropriate.</p><disp-quote content-type="editor-comment"><p>1. Line 143-145: The authors generated eight charge reversal point mutations in the BRCT domain 5 of TOPBP1. If possible, it is helpful to mention the logic to generate these substitutions and also why BRCT domain 5, is not other domains.</p></disp-quote><p>We generated eight charge reversal point mutations to abrogate all possible phospho-dependent interactions and avoid potential residual interactions. We have mutated other BRCT domains as well, which will be published separately.</p><disp-quote content-type="editor-comment"><p>1. Line 174 (and Figure 2E): RPA should be either RPA2 or RPA32.</p></disp-quote><p>Corrected (it is RPA2).</p><disp-quote content-type="editor-comment"><p>1. Figure 5C-F: Please explain in more detail how the authors quantified the SETX signals. Why the two results are different?</p></disp-quote><p>The quantification was done as described by Sims, et al. 2022, yielding separate data for XY cores and DNA loops. In brief, the green signal was measured along (XY cores) or across (XY DNA loops) the X and Y chromosomes. Signals were normalized by the signal in the autosomal chromosomes.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>I have no major criticisms, but I include a list of comments and suggestions (some of them conceptual, and disputable) that could help the authors to improve some parts of the manuscript.</p><p>1. Line 52: I realize that the term protein &quot;sequestration&quot; (used in many instances along the manuscript) has been widespread in the literature related to MSCI in the last years. While this might be a cool way to describe the dynamics of proteins accumulating in the sex body, this reviewer considers this term is totally inappropriate. It is confusing and introduces at least to mistakes to the fact of protein accumulation in the sex body. First, it seems to indicate that once trapped in the sex body, proteins are incapable of leaving it, which might be completely wrong (histone replacement refutes this idea). Second, it is suggested that DDR proteins are attracted by the sex body and cannot remain associated to autosomes even if DNA repair has not been completed. This has also been demonstrated to be incorrect (see for example PDMI 19714216). Moreover, DDR proteins can associate de novo to chromosomes if needed, for instance upon DNA damage caused by chemicals or irradiation. Thus, I suggest that the use of &quot;sequestration&quot; should be evaluated more critically, evaluating the misleading ideas that are subjacent to this term. The use of protein &quot;accumulation&quot; is much more objective and descriptive of the real facts.</p></disp-quote><p>We thank the reviewer’s suggestion and have addressed it in lines 52, 97 and 324.</p><disp-quote content-type="editor-comment"><p>1. Line 88: Just as a deference to the original ideas, it would be nice to acknowledge that the inactivation of sex chromosomes and the formation of a sex body in mouse meiosis was described more than 50 years ago (PDMI 5833946; 4854664). Likewise, the ideas about the sequential achievement and reinforcement of MSCI during pachytene have been developed during the last 20 years, far before the recent reports cited in the manuscript. Citations to these &quot;old fashion&quot; works would be great.</p></disp-quote><p>We appreciate the reviewer’s suggestion and have addressed it in line 86.</p><disp-quote content-type="editor-comment"><p>1. Line 90. Please, take into consideration that such a strong effect on meiosis progression occurs mainly in some knockout mice models and that in many other models (including hybrid mice models from natural populations) autosomal regions can remain unsynapsed and accumulate DDR proteins without impairing meiosis. In other mammalian species, meiosis is even more permissive to these MSUC phenomena.</p></disp-quote><p>We appreciate the reviewer’s suggestion and have addressed it at line 88.</p><disp-quote content-type="editor-comment"><p>1. Line 211: The differences in the abundance of MLH1 and MLH3 are remarkable. If these two proteins are supposed to form a heterodimer leading to crossover formation, then the increase of only MLH1 might be related to a different process, not leading to crossover (even not class II ones).</p></disp-quote><p>We agree with the reviewer’s comment and have included this point in the discussion (lines 491- 497).</p><disp-quote content-type="editor-comment"><p>1. Line 217: I have some doubts about the results presented in Figure 3-figure supplement 4. First, it is not clear to me how the represented cells counts were performed. Each spot is supposed to represent cell counts in a single individual, but how many cells were counted per individual? The proportion of cells could be a better indicator. Second, some B5/B5 individuals' counts were close to the ones displayed in the wild type. Did mutant animals show a high divergence compared to each other? It could be great to have each individual data displayed in a pie chart, and not only the aggregated data.</p></disp-quote><p>We have now addressed this in the Figure 3—figure supplement 4 legend. Each dot in the graph represents the sum of cells counted for each individual. We counted cells from 8 mice for each, <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic>.</p><p>Here we summarize the total cells counted per individual:</p><table-wrap id="sa4table1" position="float"><label>Author response table 1.</label><table frame="hsides" rules="groups"><thead><tr><th>Mouse</th><th>Topbpl</th><th>Topbpl</th></tr></thead><tbody><tr><td align="left" valign="top">1</td><td align="left" valign="top">26</td><td align="left" valign="top">43</td></tr><tr><td align="left" valign="top">2</td><td align="left" valign="top">46</td><td align="left" valign="top">72</td></tr><tr><td align="left" valign="top">3</td><td align="left" valign="top">43</td><td align="left" valign="top">84</td></tr><tr><td align="left" valign="top">4</td><td align="left" valign="top">79</td><td align="left" valign="top">64</td></tr><tr><td align="left" valign="top">5</td><td align="left" valign="top">37</td><td align="left" valign="top">29</td></tr><tr><td align="left" valign="top">6</td><td align="left" valign="top">48</td><td align="left" valign="top">52</td></tr><tr><td align="left" valign="top">7</td><td align="left" valign="top">74</td><td align="left" valign="top">67</td></tr><tr><td align="left" valign="top">8</td><td align="left" valign="top">52</td><td align="left" valign="top">8</td></tr></tbody></table></table-wrap><disp-quote content-type="editor-comment"><p>1. Line 222: The data on 53BP1 deserve further attention. On the one side, from the analysis presented in Figure 4-figure supplement 1, it seems that 53BP1 tends to show a lower intensity in Topbp1B5/B5 mice. Since only 2 mice were analyzed, while for most of the other proteins 3-8 animals were studied, I suggest increasing the number of animals analyzed for 53BP1 localization, to test if this slight difference turns significant. This is relevant since: (1) the association of 53BP1 protein in somatic cells was clearly affected, and (2) 53BP1 is one of the last MSCI markers incorporated to the sex body at mid-late pachytene. These results should be moved to the main text and not appear as supplementary data. On the other hand, if no differences were to be found in meiosis, compared to somatic cells, how do authors explain these differences? Would 53BP1 have another partner at the sex body apart from TOPBP1? Could TOPBP1 have other BRCT domains (apart from domain 5) able to bind 53BP1?</p></disp-quote><p>We appreciate the reviewer’s suggestion; however, we had an issue with 53BP1 antibody. We analyzed 2 mice and needed to re-order the antibody. This antibody was backordered for almost one year, and when we finally received the order, the company had changed the clone for this antibody, and it no longer worked for meiotic spreads. In somatic cells, we see in HEK-293T a partial disruption in the binding to TOPBP1 B5 through IP-MS and IP-Western blot. The disruption is only partial due to the binding of 53BP1 to other domains in TOPBP1 such as BRCT 1 and 2 (Bigot et al., 2019; Cescutti et al., 2010; Liu et al., 2017). However, in assays in which we would expect a phenotypic response caused by impaired 53BP1, we did not see any effect, such as survival after IR (using the mice) and survival after phleomycin challenge (using Mefs). Moreover, 53BP1 KO mice, males and females, are fertile (Ward et al., 2003) so, the partial disruption in binding to 53BP1 that we observed in TOPBP1 B5 mutant is likely not causing the infertility phenotype.</p><disp-quote content-type="editor-comment"><p>1. Line 250: I do not understand what is represented in Figure 5A. Why did the author mix two different experiments (differences in phosphoprotein abundance in B5/B5 compared to wild type and the interference of ATR with AZ20)?</p></disp-quote><p>To account for the differences in cell population observed in the whole testis between <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic>, and to know exactly which phosphorylation changes were due to disruption in the ATR signaling and not pleiotropic effects, we combined two different phosphoproteomes: One phosphoproteome from the comparison between <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> and another one from the comparison between Vehicle or ATR inhibitor-treated mice. By utilizing this approach, we only consider hits that were disrupted in both analyses. A similar method was used by Sims et.al, 2022 (Sims et al., 2022).</p><disp-quote content-type="editor-comment"><p>1. It is not clearly explained what is represented in Figure 6B. There is no explanation in the text or the figure legend. Do this represent the difference between scRNAseq in control and Topbp1B5/B5? If so, please, clarify.</p></disp-quote><p>We thank the reviewer’s comment and have addressed it in the legend of Figure 6B.</p><disp-quote content-type="editor-comment"><p>1. Line 342 and following. The authors describe a decrease of gene silencing. The use of two negative concepts is always confusing and results in the conversion to a positive one. I suggest considering the possibility of just talking about increase of gene expression, in order to make the message clearer.</p></disp-quote><p>We appreciate the reviewer’s point here, but it is important to note that the phenomenon disrupted in our mutants is MSCI, which is by definition a gene silencing mechanism. This phenotype is not as simple as “increased gene expression”, it is the removal of a mechanism that is a key feature of prophase I. Thus, because we are focusing on the mechanism of MSCI, it is crucial to maintain this (albeit unusual) terminology.</p><disp-quote content-type="editor-comment"><p>1. As for the classification of spermatocytes into 9 categories, I am curious about which spermatocytes are included in each of these categories. For instance, from cytology it seems that in Topbp1B5/B5 mice, spermatocytes are able to reach mid-late pachytene. However, in the spermatocyte categories established by scRNAseq they only reach class 3. Therefore, which are the populations included in the remaining 6 classes of spermatocytes? Do authors have any morphological correlation to these scRNAseq categories? Is it possible that in this mutant morphological advance of meiosis and gene expression profiles are uncoupled?</p></disp-quote><p>The clustering of cells to a specific group is based on RNA expression, which does not always match cytological features. Moreover, during the analysis, cells with high expression of mitochondrial genes are excluded (these are dying cells that do not pass the quality control). Thus, while <italic>Topbp1<sup>B5/B5</sup></italic> reaches a mid-late-pachytene stage according to cytological analyses, in the single-cell RNA seq analysis we could only detect one pachytene stage. The other 6 remaining categories of spermatocytes can be classified according to their best-fit profile of gene expression. For that, we use the classification described by Chen et al., 2018 and Lau et al.,2020. Spermatocytes 3-5 = Pachytene, Spermatocytes 6-7 = Diplotene, Spermatocytes 8-9 = secondary spermatocytes (metaphase I/II). The gene markers used for this classification are displayed in Author response image 2.</p><fig id="sa4fig2" position="float"><label>Author response image 2.</label><caption><title>Genes used as markers of spermatocytes captured in the scRNAseq analysis.</title><p>Violin plots display the distribution of cells expressing Gm960 (Leptotene marker), Meiob(Leptotene/Zygotene marker), Psma8 (Pachytene marker), Pwill1 (Pachytene marker), Pou5f2 (Diplotene marker), and Ccna1 (Secondary Spermatocytes marker).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-sa4-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>1. Figure 6E shows that overexpression of X-linked genes is not a feature of spermatocytes but it is initiated in spermatogonia. This fact has not been properly stated in the text and perhaps not sufficiently highlighted.</p></disp-quote><p>We noticed subtle changes during the spermatogonia stage and have addressed the reviewer’s comment in lines 317-322, however the downstream analyses related to a defect in X-gene silencing maintenance displayed in Figure 7 were done based on normalization of gene expression to its respective pre-leptotene stage.</p><disp-quote content-type="editor-comment"><p>1. Figure 6-figure supplement 13 shows that some X-linked genes are more expressed in Topbp1B5/B5 compared to control mice. In the figure it can be observed that many genes accumulate at the bottom of the graph. Does this have any correlation to the location of these genes along the X chromosome, for instance near or within the PAR? This could correlate with the defects in γH2AX accumulation at this region.</p></disp-quote><p>These are the locations along the chromosome. Only the bottom 5 rows are within the PAR region, so this accumulation is not within the PAR region specifically. The bottom tenth of the genes in the heatmap correspond to roughly a 17 Mb region.</p><disp-quote content-type="editor-comment"><p>1. The authors only analyzed the overexpression of genes located on the X chromosome. It would be interesting to show the behavior of Y-linked genes as well.</p></disp-quote><p>The coverage of Y-linked genes was not very high and that is why we have not shown the results in the paper. However, the results for Y-linked genes were similar to the X-linked genes and can be visualized in Author response image 3.</p><fig id="sa4fig3" position="float"><label>Author response image 3.</label><caption><title>Single cell RNAseq reveals that <italic>Topbp1<sup>B5/B5</sup></italic> spermatocytes initiate MSCI but fail to promote full silencing of Y chromosome-linked genes.</title><p>Violin plot displaying the ratio of the average expression of Y chromosome genes by the average expression of chromosome 9 genes at different stages of spermatogenesis for <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90887-sa4-fig3-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>1. Line 425: Authors indicate that it is not known if association of TOPBP1 and BLM, 53BP1 or other proteins is disrupted in Topbp1B5/B5 spermatocytes. Could these experiments be performed in the testis, as they were in somatic cells?</p></disp-quote><p>The cellular composition in <italic>Topbp1<sup>+/+</sup></italic> and <italic>Topbp1<sup>B5/B5</sup></italic> testes is very different so it would not be a fair comparison. While we have tried to isolate pachytene cells to perform these experiments, we were successful only when using <italic>Topbp1<sup>+/+</sup></italic> but not <italic>Topbp1<sup>B5/B5</sup></italic>, likely due to the extremely small size of the mutant testis.</p><disp-quote content-type="editor-comment"><p>1. Line 455 and following. I find that the discussion about the role of SETX is not completely clear. It seems that a failure of SETX function could result in defective or no transcription, as a consequence of the impossibility to resolve RNA-DNA hybrid molecules. Therefore, should impairment of SETX lead to reduced or enhanced transcription? Please clarify. On the other hand, this defect in SETX function should affect the whole genome, and not only sex chromosomes. Do authors have any clues about this broad effect?</p></disp-quote><p>We thank the reviewer’s comment and have expanded on discussion in lines 470-474. While we agree with the reviewer’s point that an impairment on SETX should affect the whole genome, however, during pachytene stage, SETX is mostly localized to the sex body. The <italic>Topbp1<sup>B5/B5</sup></italic> shows a specific defect in X and Y silencing maintenance during pachytene stage, thus we hypothesized that an impairment in SETX localization during pachytene should especially impair the X and Y chromosomes.</p><disp-quote content-type="editor-comment"><p>1. As a general comment to the discussion section, I think authors could extend into some specific ideas or speculations. It is shocking that sex chromosome-linked genes are able to escape silencing without dismantling the complex (almost complete) MSCI response in the Topbp1 mutant (although perhaps this is not so surprising considering the high number of escapees reported in the inactivated X chromosome in female somatic cells).</p><p>How to explain this paradox? One possibility (which would make a real breakthrough) is that the expression of sex chromosome-linked genes represents a regulated response to meiotic defects, and not just an unfortunate consequence of a defective MSCI. Thus, MSCI might be somehow irrelevant to prevent the execution of this sex chromosome-based program to stop meiosis progression when needed. The fact that this regulated activation was never proposed is perhaps due to the fact that most of the meiosis mutants characterized so far are unable to reach the stage at which MSCI is properly established, which is the most remarkable difference with the Topbp1 mutant studied here.</p><p>Although naïve, the critical point for the activation of this sex chromosome-based program seems to depend simply on the transcription of Zfy1 and Zfy2 (encoding for transcription factors). The signaling cascades up and downstream these genes are the real mystery, awaiting further studies.</p></disp-quote><p>We thank the very interesting point raised by the reviewer. Our interpretation of the data is that X and Y silencing being a dynamic process requires an initiation step and a maintenance step driven/controlled by the DDR machinery, and that <italic>Topbp1<sup>B5/B5</sup></italic> shows a grossly normal initiation of X and Y silencing but fails on maintain MSCI. Moreover, the expression of <italic>Zfy1</italic> and <italic>Zfy2</italic> have been previously demonstrated as enough to trigger cell death (Royo et al., 2010; Vernet et al., 2016), and <italic>Topbp1<sup>B5/B5</sup></italic> cells show increased expression of these genes. However, we do not exclude the very interesting possibility, raised by the reviewer, that the expression of XY-linked genes represents a regulated response to meiotic defects to stop meiosis progression, leading to the cell death observed in <italic>Topbp1<sup>B5/B5</sup></italic>, which makes the <italic>Topbp1<sup>B5/B5</sup></italic> an unique model for these studies as most of the previous meiosis mutants are unable to reach the stage at which MSCI is properly established. We add discussion about this exciting point in lines 513-522.</p><disp-quote content-type="editor-comment"><p>1. Scale bars are impossible to read in Figures 1I and J, and are missing in all the other image figures. Please, correct.</p></disp-quote><p>We have addressed this in the new Figure 1. For figures displaying meiotic spreads, adding a scale bar is not a common practice in the field as these cells are swollen while being prepared.</p><disp-quote content-type="editor-comment"><p>1. Line 828. Since Paula Cohen is an author of the manuscript, it seems weird to acknowledge herself in this section.</p></disp-quote><p>Corrected.</p><p>References</p><p>Adams SR, Maezawa S, Alavattam KG, Abe H, Sakashita A, Shroder M, Broering TJ, Sroga Rios J, Thomas MA, Lin X, Price CM, Barski A, Andreassen PR, Namekawa SH. 2018. RNF8 and SCML2 cooperate to regulate ubiquitination and H3K27 acetylation for escape gene activation on the sex chromosomes. PLoS Genet 14. doi:10.1371/journal.pgen.1007233</p><p>Bigot N, Day M, Baldock RA, Watts FZ, Oliver AW, Pearl LH. 2019. Phosphorylation-mediated interactions with topbp1 couple 53bp1 and 9-1-1 to control the g1 DNA damage checkpoint. Elife 8:1–28.</p><p>Cescutti R, Negrini S, Kohzaki M, Halazonetis TD. 2010. TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint. EMBO J 29:3723–3732.</p><p>Chen Y, Zheng Y, Gao Y, Lin Z, Yang S, Wang T, Wang Q, Xie N, Hua R, Liu M, Sha J, Griswold MD, Li J, Tang F, Tong M-H. 2018. Single-cell RNA-seq uncovers dynamic processes and critical regulators in mouse spermatogenesis. Cell Res 28:879–896.</p><p>Hirota T, Blakeley P, Sangrithi MN, Mahadevaiah SK, Encheva V, Snijders AP, ElInati E, Ojarikre OA, de Rooij DG, Niakan KK, Turner JMA. 2018. SETDB1 Links the Meiotic DNA Damage Response to Sex Chromosome Silencing in Mice. Dev Cell 47:645-659.e6.</p><p>Ichijima Y, Ichijima M, Lou Z, Nussenzweig A, Daniel Camerini-Otero R, Chen J, Andreassen PR, Namekawa SH. 2011. MDC1 directs chromosome-wide silencing of the sex chromosomes in male germ cells. Genes and Development 25:959–971.</p><p>Lau X, Munusamy P, Ng MJ, Sangrithi M. 2020. Single-Cell RNA Sequencing of the Cynomolgus Macaque Testis Reveals Conserved Transcriptional Profiles during Mammalian Spermatogenesis. Dev Cell 54:548-566.e7.</p><p>Liu Y, Cussiol JR, Dibitetto D, Sims JR, Twayana S, Weiss RS, Freire R, Marini F, Pellicioli A, Smolka MB. 2017. TOPBP1Dpb11 plays a conserved role in homologous recombination DNA repair through the coordinated recruitment of 53BP1Rad9. J Cell Biol 216:623–639.</p><p>Modzelewski AJ, Holmes RJ, Hilz S, Grimson A, Cohen PE. 2012. AGO4 regulates entry into meiosis and influences silencing of sex chromosomes in the male mouse germline. Dev Cell 23:251–264. Royo H, Polikiewicz G, Mahadevaiah SK, Prosser H, Mitchell M, Bradley A, De Rooij DG, Burgoyne PS, Turner JMA. 2010. Evidence that meiotic sex chromosome inactivation is essential for male fertility. Curr Biol 20:2117–2123.</p><p>Sims JR, Faça VM, Pereira C, Ascenção C, Comstock W, Badar J, Arroyo-Martinez GA, Freire R, Cohen PE, Weiss RS, Smolka MB. 2022. Phosphoproteomics of ATR signaling in mouse testes. Elife</p><p>1. doi:10.7554/eLife.68648</p><p>Vernet N, Mahadevaiah SK, de Rooij DG, Burgoyne PS, Ellis PJI. 2016. Zfy genes are required for efficient meiotic sex chromosome inactivation (MSCI) in spermatocytes. Hum Mol Genet 25:5300–5310.</p><p>Ward IM, Minn K, van Deursen J, Chen J. 2003. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol 23:2556–2563.</p><p>Yeo AJ, Becherel OJ, Luff JE, Graham ME, Richard D, Lavin MF. 2015. Senataxin controls meiotic silencing through ATR activation and chromatin remodeling. Cell Discovery 1. doi:10.1038/celldisc.2015.25</p></body></sub-article></article>